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CHAPTER 1 INTRODUCTION 
Tobacco is the most widely used drug of abuse during pregnancy (Behnke & 
Smith, 2013; Substance Abuse and Mental Health Services Administration [SAMHSA], 
2011). Smoking during pregnancy leads to significant adverse effects for the developing 
fetus, in addition to negative outcomes for women and their children (Wakschlag et al., 
2003). Although a range of effective treatments exist to treat tobacco dependence and 
promote long-term abstinence, most pregnant women who smoke during pregnancy 
neither seek nor receive any kind of treatment (Terplan, McNamara, & Chisolm, 2012). 
This gap between the need for and receipt of services has substantial and long-term 
effects on the health of these pregnancies and leads to substantial unnecessary 
financial burden to the health care system (Andrulis & Hopkins, 2001; Chavkin, 1990). 
Further, despite efforts to reduce perinatal tobacco use, since 2000 there have been no 
significant decreases in smoking prevalence among pregnant women in the United 
States (Tong et al., 2013). The stability of the prevalence of perinatal smoking suggests 
that efforts to reduce smoking prevalence before and during pregnancy have not been 
effective (Tong et al., 2013).  
Alternative approaches, able to reach and assist a higher proportion of smokers, 
are needed. Complementary and alternative medicine (CAM) methods—meaning non-
mainstream practices or products used as primary treatment or as a complement to 
mainstream health care (National Center for Complementary and Integrative Health, 
2015)—are one possible example of the kind of alternative that is needed. CAM is an 
emerging approach for treating physical and mental health issues, tobacco and other 
substance use. CAM methods have gained wider acceptance in the United States within 
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that last few decades, with mindfulness meditation, yoga, acupuncture, massage, and 
some herbal supplements, in particular, becoming accepted therapies for a variety of 
physical and mental health conditions. The prenatal and postpartum periods represent a 
time of significant physical, psychological, and emotional changes (Da Costa, Larouche, 
Drista, & Brender, 1999), which have been shown to affect a woman’s quality of life and 
ability to cope with changing roles (Gjerdigen, Froberg, & Fontaine, 1991). Therefore, 
CAM interventions that influence both mind and body may be especially appealing to 
and appropriate for pregnant women (Beddoe & Lee, 2008). The use of CAM methods 
has also become common during pregnancy, perhaps given the hesitancy of some 
women to take medications while pregnant (Hall, Griffiths, & McKenna, 2011). 
CAM approaches may be ideal, low-cost treatments to help pregnant women 
reduce craving to smoke, manage nicotine withdrawal symptoms, stress and negative 
mood symptoms, and increase self-efficacy to quit smoking. Compared to conventional 
approaches that are largely based on a mental health/substance abuse model (and 
therefore associated with stigma in some communities), CAM approaches may be a 
more attractive treatment option to many pregnant women, thus increasing the 
proportion of women who obtain some form of assistance. Further, developing healthier 
mind-body practices may encourage pregnant and parenting women to make other 
healthy choices for themselves and their families. To date, however, no published study 
has examined the use of CAM among pregnant smokers.  
The present study therefore seeks to examine factors associated with smoking 
and smoking cessation during pregnancy among two nationally representative samples 
of women, with an emphasis on the extent to which CAM approaches are or might be 
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relevant. It is expected that a better understanding of the characteristics of those 
women who quit or reduce smoking during pregnancy compared to those who do not 
will facilitate the design of effective interventions for persistent smokers during the 
perinatal period. In addition, investigating the conventional mental health and CAM 
treatment utilization practices among pregnant smokers may suggest future directions 
for intervention. Details of the proposed study will be described following presentation of 
the significance, theoretical basis, and rationale for the study.  
Smoking among Women 
Epidemiological data indicate that 25% of women of reproductive age and 23.6% 
of men are current smokers (Substance Abuse and Mental Health Administration, 
2013). The rate of smoking in the U.S. has generally declined over the last several 
decades; however, the rate of tobacco use has declined among men by approximately 
50% since 1960, whereas among women tobacco use has declined by only 38% 
(Giovino, 2002). For the first time in history, women are as likely as men to die from 
diseases caused by smoking (U.S. Department of Health and Human Services, 2014). 
Importantly, rates are still above national health objectives and these declines appear to 
have reached a plateau (Centers for Disease Control and Prevention, 2008; Fiore et al., 
2008).  
Gender differences in tobacco-related mortality and morbidity—particularly with 
respect to risk for cancer and myocardial infarction—are well-documented, and 
demonstrate that female smokers are at greater risk for some adverse outcomes 
compared to male smokers (Schnoll, Patterson, & Lerman, 2007). Although a number of 
common factors associated with smoking hold for both men and women (e.g., 
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depression, nicotine dependence, living with other smokers) there may be risk factors 
that are especially relevant to treating tobacco use among women. Previous studies 
have indicated that women may have more difficulty quitting smoking and may face 
more barriers to smoking cessation than men (Bock et al., 2009; Reynoso, Susabda, & 
Cepeda-Benito, 2005; Schnoll et al., 2007). For example, women report lower levels of 
motivation to quit, and lower confidence/self-efficacy. They also perceive greater 
difficulty with quitting (Etter, Prokhorov, & Perneger, 2002). As a result, it has been 
suggested that a gender-specific approach to treating tobacco dependence may be 
most effective for women (Schnoll et al., 2007; Piper, Welsch, Baker, Fox, & Fiore, 
2000).  
Prevalence of Smoking during Pregnancy 
Prenatal smoking is considered a highly stigmatized behavior (Bessa et al., 2010; 
Kline, Ng, Schittini, Levin, & Susser, 1997; Markovic et al., 2000; Ostrea, Brady, Bause, 
Raymundo, & Stevens, 1992), which likely hinders attempts to accurately estimate its 
prevalence. Underreporting of smoking is illustrated in studies that have compared 
biologically-verified smoking with self-report (Markovic et al., 2000; Russell, Crawford, & 
Woodby, 2004). Although rates of smoking during pregnancy are likely underestimated 
due to disclosure issues (England et al., 2007), national surveys suggest that 
approximately 10-20% of pregnant women smoke at some point during pregnancy 
(Alshaarawy & Anthony, 2014; SAMHSA, 2007; SAMHSA, 2010; SAMHSA, 2012; Tong 
et al., 2013) Rates of smoking during pregnancy appear to decline across trimesters, 
with 21.8% of women in the first trimester, 14.4% of women in their second trimester, 
and 13.9% of women in their third trimester reporting smoking in the past month 
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(SAMHSA, 2009). Motivation to quit smoking during pregnancy is typically high (Andres 
& Day, 2000); in general, approximately half of all pregnant smokers stop for at least 
part of their pregnancy and nearly all of these women quit either prior to or early in their 
pregnancy without seeking any formal support or treatment (Bolling, Grant, Hamlyn, & 
Thornton, 2007). Rates of cessation may differ though, depending on the sample. For 
example, in a sample of low-income pregnant women receiving prenatal care in rural 
southern Appalachia, Bailey (2006) found that only 27% of women quit smoking 
completely by their second to third trimester. Regardless, even in more normative 
samples, only about 25% of those who quit are able to maintain abstinence throughout 
their pregnancy (Flick et al., 2006), and two thirds of women who do quit smoking in 
pregnancy are likely to re-start following the birth of their child (Owen & Penn, 1999). 
Nearly half of those women who relapse do so within two weeks of delivery (Colman & 
Joyce, 2003). Thus, a significant subset of pregnant women have greater difficulty in 
quitting smoking during their pregnancy. 
Effects of Prenatal Smoking 
The range of health, social, and financial consequences of smoking are well-
known, and become even more severe during pregnancy due to the long-term effects of 
prenatal smoking on a developing fetus (Andres & Day, 2000; Lester, Andreozzi, & 
Appiah, 2004). Smoking during pregnancy is therefore a maternal behavior with a costly 
intergenerational impact (Wakschlag et al., 2003). Compared to women who do not 
smoke, the direct medical costs of a complicated birth are estimated to be 66% higher 
for smokers, likely due to a greater severity of complications and need for intensive care 
(Centers for Disease Control and Prevention, 1997; Orleans et al., 2001). Smoking 
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during pregnancy has been shown to add more than $700 in neonatal costs for each 
exposed child, for a total annual expenditure of $367 million in the U.S. alone (Adams et 
al., 2002). Pregnant women who smoke are more likely to experience complications 
such as ecotopic pregnancy (U.S. Department of Health and Human Services, 2014), 
placenta previa, placental abruption, and uterine bleeding than pregnant women who 
are non-smokers (Ananth, Savitz, & Luther, 1996; Cnattingius, 2004). Prenatal smoking 
has been linked to fetal growth retardation, low birth weight, and sudden infant death 
syndrome, as well as more long-term cognitive and behavioral deficits (Andres & Day, 
2000; Ness et al., 1999; Shea & Steiner, 2008; Stroud et al., 2009). Analysis of over a 
million births revealed that risk of stillbirth was elevated by nearly 30% among pregnant 
smokers, with risk being even higher among pregnant smokers over 35 (Aliyu, Salihu, 
Wilson, Alio, & Kirby, 2008). Compared to nonsmokers, women who smoke during 
pregnancy are twice as likely to give birth to a low birth weight baby (Ventura et al., 
2003). Smoking is a factor in 20% of underweight births, 8% of preterm births, and 5% 
of perinatal deaths (Orleans et al., 2001).  
Further, the effects of smoking extend far beyond the perinatal and neonatal 
period. Tobacco exposure during the perinatal period has been linked to adverse effects 
on children, including congenital defects such as orofacial cleft (U.S. Department of 
Health and Human Services, 2014), asthma, and increased rates of ear infection (U.S. 
Department of Health and Human Services, 2006). Tobacco exposure is also 
associated with lasting neurological, behavioral, and learning difficulties, such as 
greater risk of externalizing behaviors among toddlers (McCormick, 1985; Stene-
Larson, Borge, & Vollrath, 2009) and future educational difficulties (McCormick, 1985). 
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Without question, both the health and financial costs of smoking during pregnancy are 
significant and lasting.   
Pregnancy-Specific Factors Related to Smoking 
 Sociodemographic factors, pre-pregnancy smoking behaviors and patterns, and 
mental health symptoms have all been identified as correlates of prenatal smoking.  
Sociodemographic Factors 
Smoking during pregnancy appears to disproportionately affect women of lower 
socioeconomic status, women who engage in other adverse health behaviors, and 
women who are the most heavily nicotine dependent; it is also more prevalent among 
women with limited resources with which to access treatment (Goldenberg, Klerman, 
Windsor, & Whiteside, 2000). Rates of persistent smoking are especially high among 
unmarried, low-income women with limited education (Cornelius, Leech, & Goldschmidt, 
2004). Family income in some samples has accounted for approximately 8% of the 
variance in smoking among pregnant women, with women from families with lower 
income being more likely to continue smoking during pregnancy (Bailey, 2006). One 
study found that 22% of low-income women smoked during their third trimester, as 
opposed to 14% of higher income women (Adams, Melvin, & Raskind-Hood, 2008). 
Results from a national survey indicated that lower income women were at a 2.8 times 
greater risk of smoking during pregnancy (Ebrahim, Floyd, Merritt, Decoufle, & 
Holtzman, 2000). Together these data reveal that low income, pregnant women might 
be especially in need of smoking cessation interventions (Kahn, Certain, & Whitaker, 
2002). 
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The evidence appears to be mixed with regard to age, race, and ethnicity. 
Although some investigations suggest that younger women may be more likely to 
continue smoking during pregnancy (Cornelius et al., 2004; Kratz & Vaughan, 2012), 
others have found that younger women are more likely to be nonsmokers or to quit 
smoking during pregnancy (Coleman & Joyce, 2003; Holtrop et al., 2010; Kahn et al., 
2002; Ma, Goins, Pbert, & Ockene, 2005). Some findings suggest that European 
American women are more likely to smoke during pregnancy than those of other 
racial/ethnic groups (Martin et al., 2008; Muhuri & Gfroerer, 2009), and may be as much 
as three times more likely to be prenatal smokers (Ebrahim et al., 2000). Hispanic 
ethnicity has been found to be a protective factor in some investigations (Kratz & 
Vaughan, 2012). Results among African American women have been conflicting, with 
some suggesting that African American women are more likely to be nonsmokers 
(Maxson, Edwards, Ingrahm, & Miranda, 2012) or to quit during pregnancy (Ma et al., 
2005), others finding that they are less likely to quit (Ockene et al., 2002), and still 
others finding no association at all between African American race and prenatal 
smoking (Kratz & Vaughan, 2012). Recent national estimates show that, among 
pregnant women between 15 and 44, 21.8% of European American women, 14.2% of 
African American women, and 6.5% of Hispanic women reported smoking in the past 30 
days (SAMHSA, 2012). 
Educational attainment may be one of the strongest demographic predictors of 
prenatal smoking. Data from the National Epidemiological Survey on Alcohol and 
Related Conditions (NESARC) indicated that educational attainment was the strongest 
predictor of smoking during pregnancy out of the measured demographic factors. 
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Compared to women with at least some college education, women with less than a high 
school education were 7.87 times more likely to smoke during pregnancy, and women 
with a high school diploma or GED were 2.80 times more likely to smoke (Gilman et al., 
2008). It is possible that women with less education may have more limited access to or 
experience greater barriers to participating in smoking cessation programs, and/or that 
programs available to them may be less effective (Bonollo et al., 2002; Gilman et al., 
2008; Pullon, Webster, McLeod, Benn, & Morgan, 2004).  
Consistent with increased risk for smoking in the general population (e.g., Dollar, 
Homish, Leonard, & Kozlowski, 2009; Homish & Leonard, 2005), close relationships 
with other smokers, including spouses or romantic partners, relatives, and peers, has 
been shown to be a risk factor for prenatal and postpartum smoking (Homish, Eiden, 
Leonard, & Kozlowski, 2012; Lu, Tong, & Oldenburg, 2001). Ma and colleagues (2005) 
found that, in a sample of pregnant women participating in a smoking cessation trial, 
having a partner who smokes was associated with smoking at time of delivery. Further, 
having a partner who smokes and living with other smokers were both associated with 
increased likelihood of postpartum relapse among those who reported abstinence at 
delivery (Ma et al., 2005). Among another sample of pregnant women participating in a 
smoking cessation intervention trial who quit smoking during pregnancy, one of the 
main risk factors for smoking at 1 month postpartum was having another smoker living 
in the household; having a partner who continued to smoke during their pregnancy 
predicted risk of smoking at 12 months postpartum (Simmons, Sutton, Quinn, Meade, & 
Brandon, 2014). These findings underscore the importance of contextual factors related 
to smoking maintenance and cessation. 
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Pregnancy Variables 
Pregnancy-related variables including number of prior pregnancies and access to 
prenatal care have also been examined as potential correlates of prenatal smoking. In a 
regional sample of rural low-income women, a greater number of prior pregnancies and 
lack of access to adequate prenatal care were significant predictors of smoking during 
pregnancy, accounting for nearly 5% and over 12% of the variance in smoking status, 
respectively, even after controlling for quantity and frequency of smoking. In particular, 
receipt of intermediate or inadequate prenatal care increased the probability of 
continued smoking during pregnancy sevenfold (Bailey, 2006). Such pregnancy-specific 
risk factors may be relevant to designing prevention and intervention efforts for prenatal 
smoking. 
Smoking History and Use Pattern 
Smoking history and patterns of use (e.g., quantity and frequency) also appear to 
predict risk for prenatal smoking. For example, Chen and colleagues (2006) found that 
smoking onset prior to age 14 was a significant predictor of smoking during pregnancy, 
such that women who began smoking at age 15 or later were significantly more likely to 
be abstinent than women who began smoking earlier. Similarly, in a study using data 
from the NESARC, early onset smoking (by age 14) was significantly associated with 
smoking during pregnancy, as was smoking at least a pack per day in the year 
preceding the interview (Gilman et al., 2008). In addition, among a sample of women in 
southern Appalachia, those who continued to smoke during pregnancy were heavier 
smokers and had smoked for a longer time compared to those who quit (Bailey, 2006). 
Taking into account sociodemographic and pregnancy-related factors, the amount of 
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pre-pregnancy smoking was the single best predictor of persistent smoking during 
pregnancy in this sample: each quarter-pack of cigarettes smoked per day increased 
the probability of prenatal smoking by 65%. Length of time smoking accounted for 
another 6% of the variance in pregnancy smoking status (Bailey, 2006). Thus, it is likely 
that women who have been heavier smokers for a longer period of time may have more 
difficulty quitting smoking once they become pregnant.  
Alcohol and Other Substance Use 
As noted previously, disclosure rates for prenatal smoking are considered 
underestimates given the stigmatized nature of smoking during pregnancy. Similarly, 
rates of prenatal alcohol and illicit substance use are expected to be even further 
hindered by this disclosure bias (Colon, Robles, & Sahai, 2001; Magura & Kang, 1996; 
Ondersma et al., 2012). Notably, previous investigations have revealed significant 
comorbidity between smoking and other substance use during pregnancy, with drug and 
alcohol use being more prevalent among pregnant smokers than pregnant nonsmokers. 
Data from the 2010 National Survey on Drug Use and Health (NSDUH) survey indicated 
that 24.2% of pregnant smokers also reported illicit drug use in the past month, 
compared to only 2.4% of nonsmoking pregnant women (SAMHSA, 2010). Another 
population-based study conducted in Australia found that 85% of women with a 
substance use disorder smoked during pregnancy, compared to only 15% of women 
without a substance use disorder (Burns, Mattick, & Cooke, 2006). Among low-income 
women receiving Medicaid benefits, alcohol use and drug use in the month prior to 
learning of pregnancy predicted continued smoking during pregnancy, with odds ratios 
of 2.81 and 5.32, respectively (Holtrop et al., 2010). Gaalema and colleagues (2013) re-
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tested urine specimens of 115 pregnant women who were participating in clinical trials 
for smoking cessation. Specimens were collected near 10 weeks and 28 weeks 
gestation. Approximately 34% of specimens collected during the first trimester and 25% 
of specimens collected around the beginning of the third trimester tested positive for an 
illicit drug. The most commonly detected illicit drug was marijuana, present in 90% of 
the positive specimens, followed by opioids (detected in 18% of positive specimens), 
cocaine (present in 5% of positive specimens), benzodiazepines and methadone, 
detected in 3% of specimens, respectively. These data indicate that other substance 
use both during pregnancy and prior to pregnancy are strongly associated with prenatal 
smoking.  
Externalizing Behaviors 
Several investigations have focused on antisocial or externalizing behaviors as 
predictors of prenatal smoking. For example, Kodl and Wakschlag (2004) found that 
women were more likely to smoke during pregnancy if they had exhibited conduct 
disorder symptoms as children. Katz and Vaughan (2012) also found that past year 
legal involvement (e.g., driving under the influence, having been arrested, being on 
parole or probation) was significantly associated with smoking during the second and 
third trimesters in a nationally representative sample of women. Further, women with 
problematic or violent interpersonal relationships, disruptive interpersonal behaviors, 
(e.g., lying and aggressiveness), and those who admitted to engaging in deviant 
behaviors (e.g., truancy, stealing, running away from home, arrest history) were more 
likely to smoke during pregnancy (Wakschlag et al., 2003). Wakschlag and colleagues 
(2003) suggest that women displaying such externalizing behaviors who are unable to 
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“suspend their smoking” (DiClemente, Dolan-Mullen, & Windsor, 2000) during 
pregnancy may also exhibit difficulty modulating their behavior in other domains of life. 
In other words, the association between persistent prenatal smoking and externalizing 
behavior may reflect a broader pattern of problematic behavior among women who 
have demonstrated risk in several domains of adaptive functioning.  
Negative Affect, Stress and Mental Health 
During the perinatal period, a significant proportion of women experience 
symptoms of poor mental health, including negative affect, psychological distress, 
depression and anxiety. One study of pregnant smokers found that approximately 45% 
had at least one mental health disorder (Goodwin, Keyes, & Simuro, 2007). National 
estimates indicate that between 7.4% and 12.8% of pregnant women between ages 15 
and 44 meet criteria for major depressive disorder, which is similar to estimated rates of 
depression for non-pregnant adult women (Bennett, Einarson, Taddio, Koren, & 
Einarson, 2004). Perinatal distress and depression have also been associated with 
negative infant outcomes, including preterm birth and low birth weight (Li, Liu, & Odouli, 
2009; Mancuso, Schetter, Rini, Roesch, & Hobel, 2004).  
The association between smoking and negative affect is well-established in both 
the general population (Grant, Hasin, Chou, Stinson, & Dawson, 2004; Grant et al., 
2004b) and among pregnant women (Maxson et al., 2012; Zhu & Valbo, 2002). 
Depressed women may be as much as four times more likely to smoke during 
pregnancy (Zhu & Valbo, 2002). In fact, depressive symptoms have been shown to 
predict prenatal smoking even after controlling for demographic factors and quantity and 
frequency of smoking (Linares Scott, Heil, Higgins, Badger, & Bernstein, 2009). 
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Pregnant women using tobacco and other substances are more likely to experience 
depression than women who remain abstinent (Kuo et al., 2014). Further, studies of 
treatment-seeking, pregnant women with substance use disorders indicate that 36-40% 
also meet criteria for comorbid major depressive disorder (Fitzsimons, Tuten, Vaidya, & 
Jones, 2007; Martin et al., 2009). A more general measure of mental health, 
psychological distress, is also positively correlated with substance use during 
pregnancy (Havens, Simmons, Shannon, & Hansen, 2009), with persistent smokers 
endorsing higher levels of prenatal stress and symptoms of negative affect compared to 
quitters and nonsmokers (Eiden et al., 2011). Prenatal cigarette smoking has been 
associated with elevated depression and stress, particularly among low-income women 
(Bullock, Mears, Woodcock, & Record, 2001; Ludman et al., 2000; Munafo, Heron, & 
Araya, 2008). Holtrop and colleagues (2010) found that, among low-income pregnant 
women receiving Medicaid, having a history of mental health issues and experiencing 
high levels of stress were associated with smoking. Further, compared to non-
depressed smokers, smokers with depression are less likely to report confidence in 
being able to quit (Zhu & Valbo, 2002), which can impact their ability to quit smoking. 
Although most studies have examined depressive symptoms, anxiety, or general 
distress, a few have also looked at other features of negative mood, including anger and 
hostility. In one study, pregnant smokers reported higher hostile mood and greater 
maternal hostility than pregnant non-smokers (Schuetze, Lopez, Granger, & Eiden, 
2008). Additionally, Eiden and colleagues (2011) examined structural equation models 
including several facets of negative affect and found that maternal anger, hostility and 
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aggression accounted for unique variance in persistent prenatal smoking, while 
depression and stress did not.  
In contrast, other studies have failed to find to a clear, direct link between 
distress or mental health and smoking during pregnancy. For example, Bailey (2006) 
found that smoking cessation status was not significantly associated with depression 
history in a regional sample of low-income women. Despite observing associations 
between mental health history, greater stress and smoking, Holtrop and colleagues 
(2010) did not find an association between current symptoms of depression and 
smoking during pregnancy once demographic and other factors were accounted for. 
These authors posited that nicotine dependence might have played a role in their 
findings, given the strong relationship between nicotine dependence and depressive 
symptoms in their sample. In sum, the extent to which negative affect, stress, and/or 
mental health symptoms impact prenatal smoking remains unclear. 
Nicotine Dependence 
Nicotine dependence (also called tobacco dependence or tobacco use disorder) 
is characterized by symptoms such as nicotine craving and withdrawal (American 
Psychiatric Association, 2013). Nicotine dependence appears to be another robust 
predictor of persistent smoking during the perinatal period, and--as noted above--may 
potentially account for the relationship between depression and smoking. In 
epidemiological studies including the NESARC and the National Comorbidity Study, 
nicotine dependence has been shown to be highly correlated with depression (Breslau, 
Novak, & Kessler, 2004; Goodwin et al., 2007; Grant et al., 2004a). Goodwin and 
colleagues (2007) found that 57.5% of pregnant smokers meeting nicotine dependence 
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criteria also met criteria for at least one mental disorder, compared to 45.1% of those 
who were not nicotine dependent. After adjusting for demographic factors and 
comorbidity, nicotine dependence significantly predicted the odds of having any mental 
health disorder (OR = 3.3), including any mood disorder (OR = 2.5), major depression 
(OR = 2.07), dysthymia (OR = 6.9), or panic disorder (OR = 3.1) in the past year; 
however, among non-nicotine dependent smokers, associations between smoking and 
mental health disorders became non-significant after accounting for demographic 
factors. Similarly, Ludman and colleagues (2000) found that stress and depressive 
symptoms were unrelated to smoking cessation but were related to nicotine 
dependence and demographic factors. Gilman and colleagues (2008) found that, 
among current or previous year daily smokers, current year nicotine dependence was 
associated with a significantly greater likelihood of smoking during pregnancy (OR = 
2.63), even after taking into account sociodemographic factors, smoking history, mood 
or anxiety disorders, and substance use disorders. Importantly, the association between 
prenatal smoking and mood or anxiety disorders was solely attributable to nicotine 
dependence. Taken together, these results suggest that nicotine dependence may be 
among the top mental health barriers to smoking cessation during pregnancy (Gilman et 
al., 2008).  
It is important to note that many of the above factors are also correlated with 
each other. For example, lower educational attainment is related to younger age at 
smoking initiation, which may suggest that cessation is more difficult to achieve given 
the longer duration of smoking history and greater severity of nicotine dependence 
(Chassin, Presson, Rose, & Sherman, 1996; Gilman et al., 2008; Lindqvist & Aberg, 
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2001; Pierce & Gilpin, 1996; Siahpush, Heller, & Singh, 2005). Therefore, further 
investigation is necessary to better understand the complex and interacting risk factors 
related to prenatal smoking. 
Factors Associated with Changes in Smoking During Pregnancy 
 Smoking cessation during the perinatal period appears to involve slightly different 
determinants compared to cessation among non-pregnant adults. Cessation for many of 
the spontaneous pregnant quitters likely reflects a concerted effort to quit smoking for 
the health of their baby, rather than a step toward a personal, longer-tem intention to 
quit (Stotts, DiClemente, Carbonari, & Mullen, 1996; Wakschlag et al., 2003). Only a 
handful of studies have examined the factors that are most strongly associated with 
changes in smoking during pregnancy, or what factors distinguish quitters from 
persistent smokers. Further, the few studies in this area have focused primarily on 
treatment-seeking samples (e.g., Forray, Merry, Lin, Ruger, & Yonkers, 2015; Ma et al., 
2005; Wakschlag et al., 2003), and treatment-seekers may be more highly motivated to 
quit than non-treatment-seekers. In other words, exactly what enables some women to 
make changes for themselves and their growing families when others are unable to do 
so is still poorly understood. This deficit in the literature impedes efforts to design 
effective prevention and intervention programs.  
Overall, those who successfully quit during pregnancy appear to be 
characterized by a less risky constellation of sociodemographic and pre-pregnancy 
smoking factors compared to persistent smokers; however, these factors are not 
necessarily appropriate intervention targets. Therefore, identifying factors amenable to 
change may prove crucial for designing effective interventions aimed at reaching the 
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subset of pregnant women for whom existing interventions have been inaccessible or 
unsuccessful. Several potential change-related factors are worth further consideration, 
including self-efficacy or autonomy, improvement in mental health symptoms, and 
managing nicotine dependence.    
Self-efficacy and the related concept of autonomy have been the focus of several 
theoretical models of health behavior change and have been considered potential 
mechanisms of action for established behavioral interventions. Broadly speaking, these 
models posit that individuals who have confidence or believe that they are able to make 
behavior changes are more likely to do so (Bandura, 1977; Brandon, Herzog, Werner, & 
Gwaltney, 2004). For example, in a large prospective cohort study examining 
psychosocial factors related to pregnancy outcomes, higher self-efficacy was one factor 
related to decreased odds of being a smoker (Maxson et al., 2012). Given that women 
often report lower levels of self-efficacy or confidence with regard to quitting smoking 
(Etter et al., 2002), interventions that boost self-efficacy may be more effective for 
promoting cessation. 
Some have also suggested that women’s greater difficulty with cessation may in 
part be due to differences in negative affect. Women report greater levels of pre-
cessation and post-cessation stress (Peiper & Rodu, 2013; Wetter et al., 1999), greater 
pretreatment depression (Killen, Fortmann, Varady, & Kraemer, 2002; Peiper & Rodu, 
2013), and a greater reliance on smoking to manage symptoms of depression and 
negative affect (Ward, Klesges, Zbikowski, Bliss, & Garvey, 1997; Wetter et al., 1999). 
Recent analysis of NSDUH data revealed that female smokers may be more vulnerable 
to depression compared to males; no differences were observed for serious 
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psychological distress or anxiety disorders (Peiper & Rodu, 2013). Maxson and 
colleagues (2012) found that higher depression and perceived stress were associated 
with a greater likelihood of smoking but higher self-efficacy is associated with decreased 
likelihood of smoking. Therefore, it is plausible that interventions that decrease 
depression and stress while also enhancing self-efficacy may be more effective for 
promoting smoking cessation among pregnant women. 
Because nicotine dependence is a risk factor for prenatal smoking, as noted 
above, management of dependence symptoms, including reducing craving and other 
signs of nicotine withdrawal, is a natural target of smoking cessation interventions. To 
better characterize nicotine withdrawal and craving among pregnant cigarette smokers, 
Heil and colleagues (2006) examined ratings of nicotine withdrawal symptoms during 
the first 5 days of a quit attempt among a small sample of treatment-seeking pregnant 
smokers participating in a contingency management trial. Compared to those women 
who were unable to stop smoking or substantially reduce cigarette use, abstainers 
reported significantly more impatience, anger, and difficulty concentrating. In a rough 
comparison to other studies of non-pregnant smokers, these authors estimated that 
pregnant smokers may have elevated baseline levels of withdrawal (Heil, Higgins, 
Mongeon, Badger, & Bernstein, 2006). 
Additionally, biological aspects of nicotine dependence may warrant further 
investigation to understand the difficulties highly-addicted pregnant women may 
experience in quitting smoking. Among reproductive-age women, for example, 
variations in menstrual cycle phase and corresponding hormonal fluctuations have been 
associated with cigarette craving (Carpenter, Upadhyaya, LaRowe, Saladin, & Brady, 
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2006; Franklin et al., 2004), as well as tobacco withdrawal and negative affect 
(Carpenter et al., 2006; Perkins et al., 2000; Weinberger et al., 2015). Thus, smoking 
cessation may be especially challenging for some women due to complex interactions 
between underlying biological processes and behavioral determinants of smoking. It is 
unclear, however, the extent to which hormonal or other physiological changes related 
to pregnancy may impact or exacerbate nicotine craving (Lynch & Sofuoglu, 2010).  
Weight concerns also appear to be a barrier to smoking cessation among 
women, including pregnant women (Berg, Park, Chang, & Rigotti, 2008; Pomerlau, 
Brouwer, & Jones, 2000). Compared to men, women endorse greater appetite and 
weight control expectancies related to smoking (Wetter et al., 1999) and are twice as 
likely to anticipate post-cessation weight gain (Clark et al., 2006). There is also some 
evidence to support the concern that women may be more likely to gain weight than 
men after quitting (Flegal, Troiano, Pamuk, Kuczmarski, & Campbell, 1995). One study 
examining weight concerns among pregnant smokers found that those with high weight 
and body concerns gained significantly more weight during their pregnancy compared to 
those with low concerns; those with high concerns also gained weight in amounts that 
exceeded the guidelines for recommended weight gain during pregnancy (Pomerlau et 
al., 2000). Although weight gain is a natural part of pregnancy, some women may fear 
that quitting will exacerbate weight issues and thus be more hesitant to stop smoking 
(Berg et al., 2008).  
Identifying factors associated with changes in smoking during pregnancy is key 
to better differentiating who is more likely to quit smoking during pregnancy. 
Furthermore, better understanding of these change-related factors will also help to 
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distinguish the treatment needs of those women who have more difficulty quitting 
smoking. Negative affect associated with nicotine withdrawal or depression and weight 
concerns may be particularly significant barriers to smoking cessation in the perinatal 
period, given pregnancy weight gain and perinatal distress and depression. However, 
the perinatal period may present a unique and opportune time to assess and potentially 
change behaviors for many women for several primary reasons: (a) women almost 
invariably choose to participate in at least some prenatal care and are thus easy to 
reach; (b) interventions at this stage may take advantage of a particularly salient 
juncture in a woman’s life, in which she may be more open to considering behavior 
change; and (c) any positive change made has the possibility of a dual impact, on the 
woman’s health as well as that of her unborn child. Understanding the treatment needs 
and preferences of women during the perinatal period is therefore important to 
effectively target treatment and relapse prevention efforts.  
Currently Available Treatments for Smoking and their Limitations 
Given the immense health and financial impact of perinatal smoking, 
considerable efforts have been made to design effective screening and treatment. 
Importantly, a range of effective treatments exist to treat tobacco dependence and 
promote long-term abstinence (Fiore et al., 2008). These treatments when utilized 
successfully have been associated with small but significant overall reductions in 
smoking, low birth weight, and premature birth (Lumley, Oliver, Chamberlain, & Oakley, 
2004). Smoking cessation interventions have also been tailored for specific subgroups. 
For the significant proportion of smokers struggling with current or past depression, 
adding a psychosocial mood management component to smoking cessation treatment 
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is recommended and has been shown to increase long-term cessation rates (van der 
Meer, Willemsen, Smit, & Cuijpers, 2013). Antidepressants including buproprion and 
nortriptyline (though not SSRIs or MAOIs) have also been shown to facilitate long-term 
smoking cessation in controlled trials, but only a few trials have included pregnant 
women (Hughes, Stead, Hartmann-Boyce, Cahill, & Lancaster, 2014). However, 
although a number of interventions have been shown to be efficacious for smoking 
during pregnancy (Lumley et al, 2004), including brief (Ferreira-Borges, 2005; 
Ondersma et al., 2012) and computer-based interventions (Ondersma et al., 2011), 
there is no obvious gold standard currently available for pregnant smokers (Goldenberg 
et al., 2000). Additionally, evidence-based treatments remain particularly underutilized 
by low-education populations (Fiore et al., 2008).  
Many pregnant women in the U.S. are eligible for Medicaid (Andrulis & Hopkins, 
2001) or have expanded access to treatment due to the Affordable Care Act (Johnson, 
2010), and should therefore encounter fewer barriers to treatment related to cost or 
insurance coverage; however, in reality, a significant proportion of pregnant women do 
not obtain treatment when needed. Available approaches also fail to significantly 
improve quit rates among pregnant women (Hebert, 2004), with sustained quit rates for 
some effective approaches rarely exceeding 20% (Wen, Miller, Lazev, Fang, & 
Hernandez, 2012). Further, available approaches also fail to even reach most women 
who are in need of treatment for a variety of reasons. For example, psychosocial 
smoking cessation programs are often delivered in multiple sessions and typically 
involve professional counseling and ongoing support. However, drop-out rates are high 
and treatment sessions are frequently rescheduled or missed, particularly among 
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underserved women (Wen et al., 2012). Therefore, it can be difficult to adequately 
assess the effectiveness of smoking cessation interventions for some pregnant women, 
and interventions that are effective may not be as potent if only a portion of the 
treatment is delivered (Wen et al., 2012). Overall, most women who smoke during 
pregnancy neither seek nor receive treatment (Goldenberg et al., 2000). Among 
reproductive-aged women who use drugs or alcohol, pregnant women are more likely to 
need treatment, but they are not more likely to actually receive it (Terplan et al., 2012). 
Thus, there is a general unmet need for treatment among pregnant women using 
substances, including cigarettes.  
Time and costs associated with training (Baer et al., 2004; Miller & Mount, 2001) 
and implementation (Chapin & Root, 2004) are also a frequently cited barrier to 
treatment. For example, physician time constraints have been a consistent barrier to 
implementation of recommended guidelines among obstetricians/gynecologists (e.g., 
Chapin & Root, 2004). One analysis suggested that primary care physicians attempting 
to comply with just the A and B recommendations of the United States Preventive 
Services Task Force (ask about tobacco and provide augmented pregnancy-tailored 
counseling for women who smoke; U.S. Preventive Services Task Force, 2009) would 
need to spend an additional 4.4 hours per working day to do so (Yarnall, Pollak, Ostbye, 
Krause, & Michener, 2003). Further, despite evidence of modest efficacy, even when 
interventions are implemented, existing interventions do not consistently lead to 
subsequent reductions in smoking among pregnant patients (Lancaster, Silagy, & 
Fowler, 2000).  
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Regarding pharmacological interventions for smoking cessation like nicotine 
replacement therapy (NRT), evidence from existing studies is somewhat mixed and 
difficult to interpret considering that compliance has been poor. Conclusions about the 
safety of pharmacological interventions during pregnancy are also risky due to 
insufficient data (Bauld & Coleman, 2009). It is possible that some women may be 
reluctant to seek out pharmacological interventions such as NRT or antidepressant 
medication during pregnancy or may believe that natural or holistic therapies provide 
safer alternatives to pharmacological interventions (Adams et al., 2009; Nordeng & 
Havnen, 2004; Lapi et al., 2008; Holst, Wright, Haavik, & Nordeng, 2009).  
Overall, despite the existence of treatments that efficaciously treat tobacco 
dependence during pregnancy, these interventions do not fully meet the needs of health 
care providers or their patients. Moreover, in line with treatment principles suggested by 
the National Institute on Drug Abuse, no single treatment is likely to be appropriate for 
everyone (Heil, Linares Scott, & Higgins, 2009; National Institute on Drug Abuse, 2009); 
therefore, pregnant smokers are in need of alternative treatment options for smoking 
cessation. 
Complementary and Alternative Treatments 
The National Center for Complementary and Integrative Health (NCCIH) is the 
branch of the National Institutes of Health that oversees research on a wide range of 
health practices that are often referred to as mind-body or CAM techniques, including 
(but not limited to) acupuncture, massage therapy, contemplative practice (i.e. 
meditation, mindfulness), yoga, relaxation exercises, tai chi and qi gong, chiropractic, 
herbs or other natural products, traditional healers, Reiki or healing touch, Ayurveda, 
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traditional Chinese medicine, homeopathy, naturopathy, and hypnotherapy (NCCIH, 
2015). CAM practices have been used for health promotion as well as treatment 
(Clarke, Black, Stussman, Barnes, & Nahin, 2015; Davis, West, Weeks, & Sirovich, 
2011). Some insurance plans may at least partially cover provider-based CAM 
treatments; however, costs associated with CAM usage are generally paid out-of-
pocket. 
As of 2007, results from the National Health Interview Study (NHIS) indicated 
that over 15% of the general population (an estimate of more than 17 million people) 
reported utilizing a provider-based CAM treatment (e.g., acupuncture, Ayurveda, 
biofeedback, chiropractic care, energy therapy, hypnosis, massage, and naturopathy) 
within the past 12 months, reflecting an increase of nearly 3% from 2002. Of those who 
endorsed utilizing provider-based CAM treatments, 19.4% (or over 1 million) were 
current smokers. The results of this survey suggested that smokers used CAM 
approaches in roughly the same proportions as nonsmokers, and that their 
sociodemographic characteristics reflected a moderate level of education and higher 
incomes compared to typical smoking populations (Hamm, Muramoto, Howerter, 
Floden, & Govindarajan, 2014).  
CAM approaches or mind-body therapies may hold promise as a treatment 
option for pregnant smokers. In healthy women, such approaches have been found to 
help lower stress, improve sleep, and reduce pain (Beddoe & Lee, 2008). Women also 
appear to be greater consumers of CAM approaches (Upchurch et al., 2007); however, 
there have been no thorough examinations conducted to investigate the characteristics 
of individuals who are more likely to access or be interested in CAM treatments. 
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Furthermore, although the use of CAM interventions has grown considerably in the last 
several decades, rigorous studies demonstrating the effectiveness of these approaches 
are considerably lacking. The limited evidence that does exist suggests that such 
treatments, when used correctly, are efficacious for a number of physical and mental 
health issues, including smoking and other substance use and stress.  
Despite a lack of adequate research support for CAM treatments, data indicate 
that pregnant women in the U.S. are already using a variety of mind-body treatments to 
enhance well-being and manage distress, and that some prenatal care providers are 
already referring pregnant patients to yoga classes, massage therapists, and other CAM 
practitioners (Wang et al., 2005). Interest in CAM approaches may reflect a growing 
preference for utilizing a more “holistic” approach to healthcare and not necessarily 
dissatisfaction with conventional treatment approaches (e.g., Adams et al., 2009; 
Gaffney & Smith, 2004; Hall et al., 2011). Additionally, preference for CAM approaches 
may also be related to traditional cultural practices, but the evidence is not clear (e.g., 
Hall et al., 2011).  
Though few studies have examined who is more likely to use CAM, some have 
found that those who have higher education (Chuang et al., 2009) or those who used 
CAM prior to pregnancy (Holst et al., 2009) may be more likely to consider using CAM 
during their pregnancy. Unfortunately, due in part to the dearth of rigorous research on 
CAM treatments, evidence-based guidance and safety information are not clearly 
available to consumers. This is of particular concern during the perinatal period due to 
potential maternal and fetal harms when treatments are used inappropriately 
(Pallivalapila et al., 2015). Therefore, much CAM that is currently practiced during 
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pregnancy is not considered to be evidence-based (Anderson & Johnson, 2005). 
Several common CAM approaches are reviewed below. 
Acupuncture and Acupressure 
Acupuncture is a traditional Chinese medicine therapy utilizing fine needles that 
are inserted into the skin at specific points in the body. It has gained increasing interest 
as a treatment for a variety of physical and mental health issues. A national cross-
sectional survey conducted in 2002 revealed that lifetime and past year usage of 
acupuncture was approximately 4% and 1%, respectively. Of the 1% of past year users, 
52% were women (Burke, Upchurch, Dye, & Chyu, 2006). However, patterns of 
acupuncture use are not yet well understood (Smith & Cochrane, 2009).  
Acupuncture and acupressure (a similar treatment that uses stimulation of 
specific points in the body without the use of needles) have been evaluated as potential 
CAM treatments for smoking cessation (e.g., White, Rampes, Liu, Stead, & Campbell, 
2014; White & Taylor, 2014) and depression (e.g., Stub, Alraek, & Liu, 2011). In 
particular, some have suggested that these treatments may be effective for smoking 
cessation by reducing nicotine withdrawal symptoms; however, these studies were 
uncontrolled (White et al., 2014). A recent Cochrane Review of acupuncture and related 
treatments for smoking cessation suggested possible short-term effects (White et al., 
2014). Specifically, of 16 studies that compared acupuncture to sham acupuncture, 
acupuncture was shown to have a small short-term effect (RR = 1.22, 95% CI 1.08-
1.38). Compared to existing conventional treatments, though, acupuncture was less 
effective than NRT and not superior to psychological interventions in the short- or long-
term. Systematic review of 38 studies failed to demonstrate consistent, unbiased 
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evidence that these treatments provided sustained smoking cessation for six or more 
months; however, the majority of studies included had methodological problems. 
Overall, no firm conclusions could be drawn about the effectiveness of acupuncture and 
related treatments for smoking cessation (White et al., 2014). To date, no study has 
systematically examined the use of acupuncture during the perinatal period for smoking 
cessation.  
Research on acupuncture for the treatment of various pregnancy- and childbirth-
related health issues has also continued to grow. Smith and Cochrane (2009) 
conducted a systematic review of studies on acupuncture treatment during the perinatal 
period to treat nausea, emotional distress, back pain, labor pain, and breech 
presentation. This review determined that evidence supporting the use of acupuncture 
during pregnancy varied by the indication, with strongest evidence for the benefit of 
acupuncture or acupressure in treating for pregnancy-related nausea. In a randomized 
trial of acupuncture for depression, 150 pregnant women were randomly assigned to 
acupuncture specific for depression (12 treatment sessions of acupuncture to 
specifically address depression over an 8-week period), acupuncture not specific for 
depression/control acupuncture over the same time period, and Swedish massage 
(Manber et al., 2010). Compared to the combined control groups, the acupuncture for 
depression intervention group reported a greater decrease in depressive symptoms and 
a greater response rate, as measured by the Hamilton Rating Scale for Depression.   
Smith and Cochrane (2009) also concluded that the quality of research on 
acupuncture appears to be improving. In designing quality research studies on 
acupuncture, finding a suitable control for acupuncture is an often-cited challenge 
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(Smith & Cochrane, 2009; White et al., 2014). Since findings from some controlled trials 
have found insufficient evidence supporting the efficacy of acupuncture when compared 
to sham or control acupuncture, some have attributed any reported acupuncture 
findings to a placebo effect (Smith & Cochrane, 2009). Notably, regardless of exact 
mechanisms, these treatments appear to be popular and safe when applied correctly 
(White et al., 2014). Overall, evidence for the use of acupuncture as a treatment is 
mixed, and efficacy may depend on the indication. Although there is little support for 
acupuncture as a treatment for smoking cessation, there appears to be stronger 
evidence supporting acupuncture as a treatment for pregnancy-related nausea and 
possibly for perinatal depression. More rigorous research is therefore necessary in 
order to help reach definitive conclusions.  
Massage Therapy 
Massage therapy has been associated with a range of benefits, including pain 
reduction, decreases in depression, weight gain in preterm infants, and enhanced 
attentiveness and immune system functioning (Field, 2014). However, scant evidence is 
available on the use of massage therapy for tobacco and other substance use. A pilot 
study by Hernandez-Reif and colleagues (1999) evaluated the effect of self-massage of 
the hand or ear on anxiety and withdrawal symptoms among a sample of 20 smokers 
interested in smoking cessation. Compared to those in the control group, those who 
utilized the 5-minute massage practice during craving episodes reported lower anxiety, 
fewer withdrawal symptoms, and improved mood. At the end of the 4-week study, those 
in the self-massage group also reported a significant reduction in the number of 
cigarettes smoked per day; however, no biological indicators of smoking were used. 
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These results suggest that further investigation is warranted regarding the use of 
massage therapy to aid smoking cessation.   
A handful of studies examining massage during the perinatal period have 
revealed that it may promote reductions in depression, anxiety, pain, and prematurity 
rates (Field et al., 1999; Field, Diego, Hernandez-Reif, Schanberg, & Kuhnm 2004; 
Field, Diego, Hernandez-Reif, Deeds, & Figueiredo, 2009). For example, one study 
demonstrated that, compared to a control group that received only routine prenatal care, 
pregnant women who received a 20-minute massage therapy intervention twice weekly 
for 12 weeks showed improvements in depression, anxiety and physical pain, as well as 
greater relationship satisfaction. Additionally, infants of women in the massage group 
had greater gestational age and birth weight than infants of women in the control group 
(Field, Diego, Medina, Delgado, & Hernandez, 2012). In another study by Field and 
colleagues (2004), pregnant women with depression who received a 20-minute 
massage intervention from their significant others twice per week for 12 weeks during 
their second to third trimesters had fewer symptoms of depression and lower cortisol 
levels compared to relaxation and treatment-as-usual groups. The massage group also 
experienced fewer obstetric and postnatal complications.  
In sum, massage therapy appears to offer benefits to women and their infants, 
particularly with regard to reduced depression and anxiety and enhanced infant 
outcomes. No study has yet to examine, though, whether massage therapy may be 
useful for promoting smoking cessation during pregnancy. In comparison to the 
acupuncture literature, there appears to be somewhat stronger evidence supporting 
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massage therapy as a treatment aid for smoking cessation and perinatal depression, for 
example, perhaps due to the more rigorous studies conducted by Field and colleagues. 
Herbal and Dietary Supplements 
A nearly endless list of herbal and dietary supplements have been purported to 
treat a variety of physical and mental health issues. The Dietary Supplement Health and 
Education Act (DSHEA) of 1994 changed the classification of herbal medicines to 
dietary supplements, allowing their sale without prior efficacy or safety testing, and 
therefore dismissing manufacturers of the requirement to report serious adverse events 
to the U.S. Food and Drug Administration (FDA, 2015; Marcus & Snodgrass, 2005). 
Therefore, herbs and dietary supplements are not approved or regulated by the FDA, 
which makes many healthcare professionals hesitant to recommend them to the general 
public and particularly to pregnant women (Marcus & Snodgrass, 2005). 
Research has only recently begun to examine the efficacy and safety of using 
such supplements. Herbs and supplements, such as ginger, raspberry leaf, blue 
cohosh, castor oil, evening primrose oil, and St. John’s Wort (Hypericum perforatum), 
have been used for a variety of pregnancy-related complaints, including 
nausea/vomiting, sleep, stress or to induce labor (Dante, Bellei, Neri, & Facchinetti, 
2014). Despite the uncertainty about safety and lack of adequate supporting evidence, 
use of herbal medicines and dietary supplements during and throughout pregnancy is 
not uncommon, particularly outside of the US. However, estimates of use vary widely; 
for example, one observational study from an urban hospital in the Midwest estimated 
that 4.1% of pregnant patients used herbal or alternative remedies (Refuerzo et al., 
2005). In another survey study, 51% respondents from an antenatal clinic in Australia 
32 
 
reported using herbal medicines daily during the second and third trimesters (Maats & 
Crowther, 2002). Another sample of Norwegian women found that 36% had used herbal 
medicines during pregnancy, and the proportion of women using herbal medicines 
during pregnancy increased through the first, second, and third trimesters. The most 
commonly used herbal medicines in this sample included Echinacea, iron-boosting 
herbs, ginger, chamomile, and cranberry. Of particular concern, 39% reported using 
herbs that were considered either potentially harmful or that lacked safety information 
(Nordeng & Havnen, 2004). These findings underscore the need to better understand 
the safety and efficacy of herbal and dietary supplements for pregnant women, 
especially because women are using them regardless of available information.  
Several reviews have focused on the use of herbs and supplements for 
depression, anxiety, and stress. St. John’s Wort in particular has received significant 
attention as an herbal antidepressant for mild to moderate depression, and has been 
shown to be of comparable efficacy to a number of common pharmaceutical 
antidepressants (Schulz, 2002). Data also reveal that St. John’s Wort appears to be 
safe during pregnancy and breastfeeding, but the efficacy of St. John’s Wort for treating 
depressive symptoms has not yet been demonstrated among pregnant women (Dante 
et al., 2014). Another review investigating the use of various herbs and supplements for 
anxiety disorders, including passionflower, kava, L-lysine, L-arginine, magnesium, and 
St. John’s Wort, concluded that herbal and dietary supplements may be an effective 
method for treating anxiety without serious side effects. Out of the 24 studies that 
investigated CAM monotherapies or combination treatments for anxiety and related 
disorders, 21 were randomized controlled trials (RCT), including 18 double-blind RCTs. 
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Of the 21 RCTs, 15 (or 71%) demonstrated a positive effect for herbs or supplements 
with only mild to moderate side effects; however, authors also noted that positive effects 
may be due to a placebo effect. The strongest evidence reviewed regarding herbal 
medicine as a treatment for anxiety was in support of supplements containing 
passionflower or kava, or combinations of L-Lysine and L-arginine; less evidence was 
available for magnesium and St. John’s Wort (Lakhan & Viera, 2010).   
A few studies have also evaluated the efficacy of St. John’s Wort for smoking 
cessation. One randomized, blinded, placebo-controlled trial of 118 smokers found that 
St. John’s Wort did not promote smoking abstinence or attenuate withdrawal symptoms 
(Sood et al., 2010). These results indicate that St. John’s Wort is not indicated for 
smoking cessation. Other herbs and dietary supplements may promote smoking 
cessation, but firm conclusions cannot be drawn given the dearth of research in this 
area.  
Chiropractic 
Chiropractic, including spinal manipulation therapy, is one of the most commonly 
used CAM techniques (Shelley, Clark, & Caulfield, 2015), and is often utilized as a 
treatment for low back pain (Rubinstein, Terwee, Assendelft, de Boer, & van Tulder, 
2013; Rubinstein, van Middlekoop, Assendelft, de Boer, & van Tulder, 2011). Despite 
claims by chiropractors that chiropractic treatment is efficacious in treating a wide range 
of health issues, including low back pain, migraines, headaches, neck pain, ADHD, 
asthma, infertility, and pregnancy-related discomfort (Shelley et al., 2015), many have 
determined that evidence is insufficient to make such claims. Two Cochrane Review 
articles indicated that chiropractic was no more effective than other interventions in 
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relieving low back pain (Rubenstein et al., 2011; Rubenstein et al., 2013), and others 
have also observed a similar lack of convincing evidence for chiropractic treatment 
overall (e.g., Ernst & Posadzki, 2011; Posadzki & Ernst, 2011).  
Regarding use of chiropractic during pregnancy, a handful of studies have 
examined the use of spinal manipulation for low back pain associated with pregnancy. 
In a review of several studies, Stuber and Smith (2008) concluded that chiropractic 
treatment appears to be associated with improved outcomes in pregnancy-related low 
back pain. However, given the low-to-moderate quality of evidence and study design 
issues such as lack of control groups or randomization, it is not possible to make firm 
statements regarding the efficacy or safety of chiropractic care during pregnancy. 
Overall, research on chiropractic care during pregnancy is lacking, and existing studies 
appear to have methodological limitations. Furthermore, no known research has 
examined links between chiropractic, mental health and smoking cessation. Therefore, 
at present, research does not support the use of chiropractic treatment during 
pregnancy, particularly for smoking cessation or perinatal depression or distress. 
Mindfulness 
The emergence of and research support for third-wave cognitive behavioral 
therapies—mindfulness-based stress reduction (MBSR; Kabat-Zinn, 1990), acceptance 
and commitment therapy (ACT; Hayes, Strosahl, Wilson, 1999), dialectical behavior 
therapy (DBT; Linehan, 1993), mindfulness-based cognitive therapy (MBCT; Segal, 
Williams & Teasdale, 2002), and mindfulness-based relapse prevention (MBRP; 
Witkiewitz, Marlatt, & Walker, 2005)— have helped to legitimize mindfulness as a 
treatment for a variety of physical and mental health disorders, including chronic pain, 
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stress, depression, anxiety, substance use disorders, borderline personality disorder, 
and eating disorders (Hayes et al., 2011). Mindfulness, according to Kabat-Zinn (1994, 
p.4), means “paying attention in a particular way; on purpose, in the present moment, 
and nonjudgmentally.” One particular third-wave CBT program, mindfulness-based 
stress reduction (MBSR), helped to introduce the West to mind-body and contemplative 
practices as a treatment approach. MBSR consists of practices including seated 
meditation, body scans, everyday mindfulness activities (e.g., walking, eating), and 
yoga, as well as psychoeducation, group discussion, and homework (Kabat-Zinn, 2005; 
Hayes et al., 2011). Mindfulness-based cognitive therapy (MBCT) and mindfulness-
based relapse prevention (MBRP) integrate the more general approach of MBSR but 
adapt and refine practices and teachings for dealing with depression, anxiety, and 
craving and relapse associated with substance use disorders.  
The use of meditation to treat smoking and substance use disorders is not novel. 
However, there has been a lack of substantial or rigorous research on meditation and 
addictions (Breslin, Zack, & McCain, 2002; Marlatt & Marques, 1977; Witkiewitz et al., 
2005). Several studies from the 1970’s describe using transcendental meditation with 
substance users with promising results (Benson, 1975; Marcus, 1974; Marlatt & 
Marques, 1977). For example, meditation and exercise were found to be equally 
effective in curbing daily drinking (Murphy, Pagano, & Marlatt, 1986). Marlatt and 
colleagues used mindfulness as the basis of an extension of their relapse prevention 
cognitive behavioral treatment; they suggest that mindfulness-based relapse prevention 
(MBRP) may help to disrupt the system of craving and resulting habitual use by 
providing increased awareness and acceptance of craving as a response to 
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environmental cues, positive outcome expectancies, and motivation to engage in an 
addictive behavior that provides positive and negative reinforcement. In particular, they 
conceived of mindfulness practice as a form of counterconditioning, whereby 
metacognitive awareness and relaxation replace the rewards associated with engaging 
in drug use. Further, they emphasized the value of MBRP as an alternative to other 
more cost-prohibitive treatments, like CBT, contingency management, 12-step 
programs, and motivational enhancement therapy (Witkiewitz et al., 2005). 
Importantly, mindfulness-based third-wave interventions like MBRP differ from 
conventional CBT for addiction in that conventional approaches emphasize avoiding 
cues and diverting attention from cravings (Fiore et al., 2000; Lando, McGovern, 
Barrios, & Etringer, 1990). However, because triggers are omnipresent, avoidance can 
be difficult. Additionally, distraction or diverting attention requires significant cognitive 
effort, which is often depleted by strong affective states (Brewer, Elwafi, & Davis, 2012). 
Mindfulness-based interventions, on the other hand, tend to emphasize approaching 
triggers and cravings with present moment awareness and acceptance or nonjudgment 
(Bishop et al., 2004). 
Several studies have examined the efficacy of mindfulness techniques for 
smoking cessation. A recent study found that even a brief, single session of mindfulness 
meditation can have a significant impact on smoking over a week later (Bowen & 
Marlatt, 2009). Brewer and colleagues (2012) found that compared to treatment as 
usual, individuals smoking a pack a day on average who received an 8-session 
mindfulness training intervention showed a significantly greater reduction in cigarette 
use during treatment and maintained those gains at 3-month follow-up. A recent meta-
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analysis also found support for the use of mindfulness and other mind-body practices as 
an alternative, drug-free treatment for smoking cessation, despite the small number of 
studies available (only 4 for mindfulness) and methodological issues with the studies 
reviewed (Carim-Todd, Mitchell, & Oken, 2013). In sum, initial evidence supports the 
use of mindfulness as a component of smoking cessation treatment; however, more 
rigorous clinical trials are needed.  
Yoga 
Yoga is an ancient health and spiritual tradition that consists of a range of 
different practices, including postures (asana), meditation (dhyana), breathing exercises 
(pranayama), moral and ethical behavior (yama), self-discipline (niyama), sensory 
awareness (pratyahara), concentration (dharana), and deep meditative awareness 
(samadhi). There are various yogic styles, including Hatha, Iyengar, Ashtanga, and 
Kundalini, but most incorporate some form of posture, breath, and meditation. Although 
yoga has ancient roots, the practical use of yoga for the purposes of physical fitness 
and treating health difficulties appears to have only gained prominence within that last 
century (Alter, 2004; Evans, Tsao, Sternlieb, & Zeltzer, 2009). It is estimated that 
between 2002 and 2007, 6.1% of adults in the US practiced yoga (Barnes, Bloom, & 
Nahin, 2008). Additionally, yoga has been increasingly used as a treatment for physical 
and mental health conditions. However, despite its growing popularity and acceptance 
as a treatment, a systematic model of the mechanisms through which yoga impacts an 
individual’s physical, mental, and spiritual functioning has yet to be investigated. Evans 
and colleagues (2009) suggest a biopsychosocial model of yoga, which is compatible 
with our existing conceptualization of well-being from a Western medicine perspective. 
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In particular, their proposed biopsychosocial model focused on activation of physical 
systems (e.g., musculoskeletal, cardiopulmonary, autonomic nervous and endocrine 
systems), psychological benefits (e.g., enhanced coping, self-efficacy, and positive 
affect), and spiritual mechanisms (e.g., acceptance, mindful awareness) that are 
triggered by yoga (Evans et al., 2009).  
Compared to other forms of physical activity, yoga offers an alternative strategy 
to treating physical and mental health problems. In particular, various forms of yoga 
have been used for chronic pain management, stress reduction, mood symptom 
management, and relapse prevention (Bock et al., 2012; Mehta & Sharma, 2010; Ross 
& Thomas, 2010; Smith, Hancock, Blake-Mortimer, & Eckert, 2007; Varambally & 
Gangadhar, 2012). Several studies have also examined the use of various forms of 
yoga practice in managing symptoms of tobacco addiction and withdrawal, ranging from 
single session laboratory studies to multiple session adjunct interventions. For example, 
in a single-session laboratory study individuals who participated in 30 minutes of hatha 
yoga reported decreased craving to smoke, increased positive affect, and decreased 
negative affect (Elibero, Van Rensburg, & Drobes, 2011). In another pilot study, patients 
in a residential substance use treatment program participated in 5 sessions of yoga and 
breath awareness practice, in which cigarette smoking was neither encouraged nor 
discouraged, experienced statistically significant shifts in their intention to quit smoking, 
with 30% moving from pre-contemplation to contemplation (McIver, O’Halloran, & 
McGartland, 2004). Bock and colleagues (2012) examined the feasibility and efficacy of 
vinyasa yoga as a complementary treatment for smoking cessation among a sample of 
women receiving group-based CBT. Compared to a control sample of women receiving 
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a general health and wellness program and CBT, women randomized to receive yoga 
had a greater rates of abstinence at the end of treatment (OR = 4.56) and at 6-months 
after treatment (OR = 1.54). Those who participated in the yoga supplement also 
reported reduced anxiety and increased perceived health and well-being compared to 
controls. In addition to these individual studies, a recent meta-analysis concluded that 
there is at least initial support for yoga as a treatment for smoking cessation (Carim-
Todd et al., 2013).  
Yoga has become popular as a way to help women cope with the significant 
physical and mental or emotional changes that they experience during and following 
pregnancy (Beddoe & Lee, 2008), which themselves present risks to fetal and maternal 
health. For example, stress and negative mood during pregnancy have been associated 
with a variety of adverse maternal and infant outcomes (Bonari, Bennett, Einarson, & 
Koren, 2004; Wadhwa, Sandman, & Garite, 2001), including low birth-weight, reduced 
gestation and pre-term birth (Alvarado, Medina, & Aranda, 2002), lower Apgar scores 
(Pagel, Smilkstein, Regen & Montano, 1990), and smaller head circumference (Lou et 
al., 1994). Stressful pregnancies have also been predictive of prenatal substance use 
(Nelson et al., 2003), more difficult labor and delivery (Nielsen et al., 2000), and 
postpartum depression (Da Costa, Larouche, Drista, & Brender, 2000). 
During the prenatal period, yoga has been used to reduce stress, general 
negative affect, perinatal depression, physical pain, and to help women prepare for 
labor and delivery. Unfortunately, rigorous trials demonstrating the effectiveness of 
prenatal yoga are lacking. Despite the dearth of empirical support, informal survey 
evidence indicates that prenatal yoga is appealing to pregnant women. For example, 
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83% of women who were surveyed at a hospital day program reported an interest in 
trying prenatal yoga. In particular, women identified several common reasons for their 
interest in prenatal yoga, including reducing stress, depression and anxiety symptoms, 
and participating in an exercise program (Battle, Howard, & Castaneda, 2010).  
In addition, there have been a handful of studies published on prenatal yoga that 
provide initial support for its efficacy in improving birth outcomes. One study of first-time 
mothers who participated in 6, 1-hour prenatal yoga sessions found that those who 
participated in the yoga program reported higher levels of comfort during labor and 2 
hours post-labor and less subjective labor pain, compared to controls. In addition, 
women in the yoga condition had a shorter duration of the first stage of labor and total 
time in labor (Chuntharapat et al., 2008). 
In a study focusing on pregnancy outcomes, Narendran and colleagues (2005) 
examined the efficacy of daily yoga practice versus moderate physical activity (walking 
for 30 minutes twice a day) on pregnancy outcome. Compared to women in the walking 
group, women who practiced yoga daily (beginning at 18 to 20 weeks gestation until the 
end of pregnancy) had significantly lower rates of preterm birth and significantly fewer 
complications, including intrauterine growth restriction and pregnancy-induced 
hypertension. Further, women in the yoga group also gave birth to infants of significantly 
higher birth weight. These findings provide preliminary support for the acceptability of 
prenatal yoga, as well as the use of yoga during the prenatal period to improve birth 
outcomes. 
In considering the available evidence, yoga appears to have potential as a 
treatment for smoking cessation during the perinatal period. Furthermore, yoga seems 
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to be an important component in established mindfulness approaches. For example, the 
pairing of mindfulness and yoga practices is emphasized in existing treatments for 
stress and chronic pain conditions (mindfulness-based stress reduction; Kabat-Zinn, 
1990), depression and anxiety (mindfulness-based cognitive therapy; Segal et al., 
2002), and addiction (mindfulness-based relapse prevention; Witkiewitz et al., 2005). To 
date, three prior studies have examined a mindfulness yoga program for pregnant 
women, and all demonstrated that mindfulness yoga may be an effective treatment for 
reducing distress and managing mood and anxiety symptoms, including stress and 
negative affect (Vietin & Astin, 2008), anxiety (Beddoe, Yang, Kennedy, Weiss, & Lee, 
2009), and depressive symptoms (Muzik, Hamilton, Rosenblum, Waxler, & Hadi, 2012). 
Reductions in physical pain across pregnancy were also observed (Beddoe et al., 
2009). In addition, Muzik and colleagues (2012) found a significant increase in 
maternal-fetal attachment among women at risk for perinatal depression who 
participated in a mindfulness yoga program. Together, these studies indicate that the 
combination of mindfulness and yoga practiced during pregnancy can increase stress 
tolerance and sleep quality, and decrease psychological distress, and chronic pain 
intensity, which is particularly powerful during prenatal period, when womens’ bodies 
are subject to physical and emotional changes, including stress and pain (Muzik et al., 
2012). However, the effectiveness of prenatal mindfulness yoga for treating tobacco or 
other substance dependence has yet to be examined.  
Limitations of Existing Research on CAM and Smoking Cessation during Pregnancy 
Despite growing evidence supporting the efficacy of CAM approaches for a 
variety of physical and mental health issues, including smoking, published studies suffer 
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from a number of limitations, leaving important gaps in the literature. Adams and 
colleagues (2009) identified several areas left unexplored, including: 1) nationally 
representative studies using large-scale samples in order to better characterize CAM 
users, prevalence rates, and types of CAM treatments used; 2) better understanding of 
the decision-making process and the extent of communication between women, their 
families, and their healthcare providers; 3) insight into perceived risks and the impact of 
these risks on use of CAM treatments; 4) longitudinal examination of CAM usage 
throughout and between pregnancies; 5) cross-cultural experiences with CAM 
approaches; and 6) focus on the therapeutic encounter between women, healthcare 
providers, and CAM practitioners to facilitate communication and improve women’s 
health outcomes.  
Similarly, research and guidelines for clinical practice regarding the use of CAM 
for smoking cessation is hindered by insufficient evidence. A recent meta-analysis 
concluded that--although CAM approaches appear to help promote smoking cessation--
there is still a scarcity of rigorous studies, and existing studies are hampered by 
methodological issues, including small sample sizes, limited study design, lack of 
treatment fidelity monitoring, lack of objective study outcomes, and lack of control 
conditions (Carim-Todd et al., 2013).  
CAM Treatments for Prenatal Smoking and Distress 
 As described above, there are few currently recommended approaches to 
smoking cessation for pregnant women, and none reach a majority of those in need of 
treatment. The limited impact of existing conventional approaches may reflect a lack of 
understanding of the characteristics and treatment needs of those women who have the 
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most difficulty quitting. It is therefore necessary to improve upon treatment approaches 
and access for women who continue to smoke during pregnancy. CAM techniques 
appear to be increasingly gaining interest in the general population. Although adequate 
research regarding the efficacy of CAM treatments for physical and mental health 
issues (including smoking cessation and managing perinatal distress) is lacking, such 
treatments have the potential to fill an important treatment gap. Examining the use of 
conventional mental health and CAM treatments among pregnant smokers may help us 
to better understand their needs and preferences. Further, a closer examination of the 
characteristics of those who use these approaches may be useful in designing and 
implementing interventions in healthcare and community settings. 
Aims and Hypotheses 
The primary goal of the present study is to explore the characteristics and 
treatment utilization practices of two national samples of pregnant smokers in order to 
better understand the unique treatment needs and preferences of pregnant smokers in 
the United States. Analyses will place special emphasis on the prevalence of and 
factors related to CAM use within this population. The present study will use data from 
the National Survey on Drug Use and Health (NSDUH) and the National Health 
Interview Survey (NHIS) in order to examine the following questions:  
Using the NSDUH sample: 
1) What are the characteristics of pregnant women who quit smoking 
during their pregnancy compared to those who do not? 
Although this aim is exploratory, it is hypothesized that pregnant women who 
are persistent smokers are more likely to be older, Caucasian, of lower 
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socioeconomic status, smokers for a longer period of time, and to report 
greater distress, lower perceived risk of smoking, and criminal justice 
involvement.   
Using both the NSDUH and NHIS samples: 
2) What are the rates of complementary and alternative health (CAM) 
treatment utilization among pregnant smokers, and how have trends 
changed across time? 
It is hypothesized that CAM treatment utilization will be low, but that trends will 
indicate an increase across years.  
3) What are the characteristics of pregnant smokers who have utilized 
CAM treatments? 
This is another exploratory aim. However, based on previous studies, it is 
hypothesized that pregnant smokers who use CAM treatments will report 
higher levels of education and higher family income.  
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CHAPTER 2 METHOD 
Survey and Sample Descriptions 
National Survey on Drug Use and Health (NSDUH) 
The present study used a subset of data from the 2004-2013 NSDUH. Initiated in 
1971 and conducted on a yearly basis since 1990, the NSDUH collects information from 
a random sample of more than 70,000 individuals, providing cross-sectional, national 
estimates of alcohol and drug use for non-institutionalized U.S. civilians aged 12 and 
older. NSDUH employs independent, multistage area probability sampling for all 50 
states and the District of Columbia with oversampling of certain subpopulations (e.g., 
ages 12-17, African Americans, Hispanic/Latinos) in order to yield nationally 
representative estimates (SAMHSA, 20014). Survey years 2004-2013 were the focus of 
the current project because a question regarding use of alternative mental health 
treatment, including acupuncture, herbal medicine, massage therapy, and chiropractic 
adjustment was added to the survey beginning in 2004.  
A total of 8,895 pregnant women (age 12-44) participated in the NSDUH during 
these survey years. All pregnant women who participated between 2004 and 2013 and 
reported smoking within the past year were included in analyses (N = 3,252). Further, a 
subset of pregnant smokers who also reported using alternative mental health treatment 
were included in analyses focusing on smoking and CAM use (N = 251).    
National Health Interview Survey (NHIS) 
The present study also used a subset of data from the 2002, 2007, and 2012 
National Health Interview Survey (NHIS). Similar to the NSDUH, the NHIS surveys the 
civilian, non-institutionalized U.S. population. Initiated in 1956, the NHIS is a cross-
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sectional survey conducted annually by the National Center for Health Statistics (NCHS) 
with the purpose of collecting information on the health of the U.S. population. The 
NHIS employs a complex sampling design (multistage area probability design) that is 
redesigned after every decennial census to obtain a representative sampling of 
approximately 87,500 individuals from households in all 50 states and the District of 
Columbia, and includes oversampling of African American, Hispanic, and Asian 
individuals (CDC, 2015).  
Since 2002 the NHIS has included a special supplemental section on CAM 
utilization every 5 years; therefore, the present study examined the three waves of the 
NHIS that have included CAM questions to date (2002, 2007, and 2012). A total of 992 
pregnant women over the age of 17 participated in the NHIS during these survey years. 
All women who were pregnant and smoking at the time that they participated in the 
survey were included (N = 106). Data for each participant who completed either the 
2002, 2007, or 2012 Alternative Health/Complementary and Alternative Medicine 
supplements was matched to the corresponding Sample Adult Core and Family surveys 
(CDC, 2002, 2007, 2012). Only those respondents who completed all survey sections 
were included in analyses.  
 
Procedure 
Data Collection 
 All NSDUH data were collected face-to-face by trained interviewers using 
computer-assisted personal interviews (CAPI) and audio computer-assisted self-
interviews (ACASI). The use of these approaches is believed to enhance response 
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validity and disclosure on sensitive topics (SAMHSA, 2014). Data files for the years 
2004 through 2013 are publicly available and were obtained via the Inter-University 
Consortium for Political and Social Research (ICPSR). The sponsor removed identifying 
information from all data files to insure anonymity of participants.  
All NHIS data were collected through face-to-face household interviews 
conducted by trained interviewers from the U.S. Bureau of the Census. Interviews occur 
continuously throughout the year. The NHIS questionnaire uses CAPI administered via 
laptop with interviewers entering responses into the computer during the interview 
(CDC, 2015). Data files for the years 2002, 2007, and 2012 are publicly available and 
were obtained through the ICPSR (for years 2002 & 2007) and the CDC (for 2012 only). 
NSDUH Measures 
See Appendices A-K for all NSDUH measures. 
Sociodemographic variables. The publicly available NSDUH dataset included 
information on a range of demographic variables such as, respondent sex, age, race, 
ethnicity, marital status, number of children living in the household, highest level of 
education completed, employment status, family income and receipt of government 
assistance (e.g., social security income, food stamps, cash assistance). 
Pregnancy. All females aged 12-44 were asked whether they are currently 
pregnant (“Are you currently pregnant?”), and if so, how far along they are in their 
pregnancy (“How many months pregnant are you?”). Although month of pregnancy was 
not included in the publicly available dataset, trimester was included as a recoded 
variable.  
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Perceived general health. A single item was used to assess respondents’ 
perceived quality of general health: “This question is about your overall health. Would 
you say your health in general is: excellent, very good, good, fair, or poor?” 
Smoking 
Onset, frequency, recency. Respondents who endorsed ever smoking were 
queried further about their smoking, including the age at which they first smoked a 
cigarette, the age at which they first smoked daily, the age that they last smoked a 
cigarette, whether they had ever smoked 100 cigarettes, and, if currently smoking, how 
often and how much they smoke. Past month and past year cigarette use were also 
available.  
Change in smoking. Change or cessation in smoking was not directly queried in 
the NSDUH survey. Therefore, this outcome variable was created by determining 
whether pregnant women are current smokers (i.e., have smoked in the past 30 days) 
or have recently quit smoking (i.e., have smoked in the past year but not in the past 30 
days), and recoding these responses into a dichotomous variable.  
Perceived risk of smoking. A single item addressed perceived risk of heavy 
cigarette smoking:  “How much do people risk harming themselves physically and or in 
other ways when they smoke 1 or more packs of cigarettes per day?” 
Plan to return to or continue smoking. One item asked respondents whether they 
plan to be smoking in the next year: “Do you think you’ll smoke in the next 12 months?” 
Nicotine Dependence Syndrome Scale (NDSS; Shiffman, Hickcox, Gnys, Paty, & 
Kessel, 1995; Shiffman, Waters, & Hickox, 2004). The NDSS is a 19-item measure of 
dependence on nicotine, specifically in cigarettes, that focuses on five aspects of 
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dependence: smoking drive (i.e., the compulsion to smoke caused by nicotine craving 
and withdrawal symptoms), nicotine tolerance, continuous smoking, behavioral priority 
(i.e., preference to smoke rather than engage in other reinforcing activities), and 
stereotypy (i.e., fixed patterns of smoking). Out of the 19 items, 17 were used to 
calculate an average score of overall nicotine dependence (Shiffman et al., 2004). For 
respondents who answered 16 of the 17 NDSS nicotine dependence questions, 
imputation using the 16 answered items as covariates in a weighted least squares 
regression model was implemented; as a result, an NDSS score was only calculated for 
those individuals who had responses to all 17 nicotine dependence items after 
imputation. Respondents were categorized as nicotine dependent if their NDSS score 
was greater than or equal to 2.75 (SAMHSA, 2014).  
Nicotine craving. Two NDSS items related to nicotine craving (“When you don’t 
smoke for a few hours, you start to crave cigarettes.”; “You sometimes have strong 
cravings for a cigarette where it feels like you’re in the grip of a force you can’t control.”) 
were used to assess craving. 
Smoking cessation self-efficacy. A single NDSS item related to self-
efficacy/autonomy (“You feel a sense of control over your smoking — that is, you can 
“take it or leave it” at any time.”) was used to assess smoking cessation self-efficacy. 
Fagerström Test for Nicotine Dependence (FTND; Heatherton, Kozlowski, 
Frecker, & Fagerstrom, 1991). The FTND is a 6-item self-report measure of smoking 
behaviors and nicotine dependence. It is a widely-used and valid measure of nicotine 
dependency (Pomerleau, Carton, Lutzke, Flessland & Pomerleau, 1994). The NSDUH 
utilized the one item from this measure that has been shown to discriminate dependent 
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from nondependent smokers (SAMHSA, 2014): “How soon after you wake up do you 
have your first cigarette?” Respondents endorsing either “Within the first 5 minutes after 
you wake up” or “Between 6 and 30 minutes after you wake up” were categorized as 
nicotine dependent.  
Alcohol and other substance use. A main focus of the NSDUH is to thoroughly 
assess the use and misuse of alcohol, illicit substances, and prescription medication. 
Therefore, items regarding lifetime, past year, and current use of a range of substances 
were included, as were items assessing DSM-IV criteria for substance abuse and 
dependence.  
Distress and psychopathology 
The mental health module of the NSDUH is designed to collect data on serious 
psychological distress and major depression. Questions related to serious psychological 
distress and major depressive disorder were added to the NSDUH survey beginning in 
2005. Therefore data for these mental health indicators was only available for those 
who completed the survey between 2005 and 2013 (SAMHSA, 2014).   
K6 (Furukawa, Kessler, Slade, & Andrews, 2003; Kessler et al., 2003). The K6 is 
a well-validated, brief screener for nonspecific psychological distress. The K6 was used 
to measure serious psychological distress in two time periods: 1) in the past 30 days, 
and 2) during a month in the past year in which they felt more depressed, anxious, or 
emotionally stressed than in the past month. Only those who indicated that in the past 
year there was a worse month than the past 30 days were asked about the worst month 
in the past year. Respondents with a total K6 score of 13 or greater were classified as 
having had serious psychological distress (SAMHSA, 2014).  
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Major depression. DSM-IV criteria were used to determine whether respondents 
met criteria for a major depressive episode in their lifetime and within the past year.   
Anxiety. Respondents were asked whether they have ever had an anxiety 
disorder and whether a doctor had indicated to them that they had an anxiety disorder in 
the past 12 months.  
Externalizing and Risky Behavior 
Criminality. Items related to criminal justice involvement included: “Not counting 
major traffic violations, have you ever been arrested and booked for breaking the law?”; 
“In the past 12 months have you been arrested for driving under the influence of alcohol 
or drugs?” Respondents were also asked whether they had been arrested and charged 
with driving under the influence of alcohol or illicit drugs. Regarding probation status: 
“Were you on probation at any time during the past 12 months?” 
Risk taking. In addition, items related to the frequency of seeking out and 
engaging in risky behavior were included: “How often do you get a real kick out of doing 
things that are a little dangerous?” “How often do you like to test yourself by doing 
something a little risky?” Another indicator of risk-taking, seatbelt usage, was also 
assessed: “How often do you wear a seatbelt when you ride in the front passenger seat 
of a car?” “How often do you wear a seatbelt when you drive a car?”  
Treatment utilization 
Conventional mental health and substance use treatment. A series of items 
assessing the past year usage of various forms of conventional mental health and 
substance use treatment were included in the mental health treatment utilization and 
substance use treatment sections, respectively. Instructions for mental health treatment 
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emphasized that respondents not include episodes of substance use treatment, and 
instructions for substance use treatment emphasized that “questions deal with treatment 
for alcohol and drug problems, not including cigarettes.”  
Reasons for not receiving treatment. In addition to asking respondents about 
treatment they did receive, respondents were asked about reasons they did not receive 
treatment, including barriers to treatment, such as lack of insurance coverage and 
perceived lack of need for treatment. Questions pertaining to mental health treatment 
and substance use treatment are asked separately.  
CAM treatment. In addition to questions related to the use of conventional mental 
health and substance use treatment options, the NSDUH survey asked whether 
respondents have used an alternative mental health treatment in the past 12 months, 
specifically for help with a mental health problem. Response options for this item 
included visiting four common CAM treatment providers: acupuncturist, chiropractor, 
herbalist, and massage therapist.  
 
NHIS Measures 
See Appendices L-P for all NHIS measures. 
Sociodemographic variables. The NHIS included a range of demographic 
characteristics, including age, race, ethnicity, marital status, employment status, and 
family income. 
Pregnancy. A single item was included in the Sample Adult Core survey 
regarding current pregnancy (“Are you currently pregnant?”). Trimester or month of 
pregnancy was not assessed.  
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Smoking. Smoking status was identified by responses to questions in the Sample 
Adult Core survey: 1) “Have you smoked at least 100 cigarettes in your entire life?” and 
2) “Do you now smoke cigarettes every day, some days, or not at all?” For current 
smokers, questions related to quantity and frequency of cigarette smoking in the past 30 
days were included: “On how many days in the past 30 did you smoke a cigarette?” “On 
average, when you smoked during the past 30 days, about how many cigarettes did you 
smoke a day?” ”On average, how many cigarettes do you now smoke a day?” In 
addition, one item assessed age of regular smoking initiation (“How old were you when 
you first started to smoke fairly regularly?”). 
Quit status (“How long has it been since you quit smoking cigarettes?”) and past 
year quit attempts (“During the past 12 months, have you stopped smoking for more 
than one day because you were trying to quit smoking?”) were also included. 
Alcohol use. Several items related to alcohol use were included in the NHIS, 
including quantity and frequency of past year alcohol use and binge drinking.   
Mental health. Respondents were asked whether a doctor or other health 
professional had ever told them that they had depression or other mental health 
disorders. Those who endorsed that they had been told they had either depression or 
other mental health disorders were asked a follow up question to determine whether this 
occurred during the past 12 months.  
K6 (Furukawa et al., 2003; Kessler et al., 2003). As noted above, the K6 is a brief 
measure of psychological distress. In the NHIS, respondents were asked how often they 
had experienced the 6 symptoms of psychological distress during the past 30 days. 
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CAM utilization. In comparison to the NSDUH CAM questions, the NHIS primarily 
asked about the use of CAM in general, rather than treatment for a specific purpose 
(i.e., mental health or substance use); however, respondents also had the option to 
indicate whether they used a treatment for a specific health problem. Respondents were 
asked about whether they utilized a range of CAM treatments, including yoga, 
meditation/mindfulness practices, tai chi, qi gong, Pilates, acupuncture, Ayurveda, 
biofeedback, chiropractic care, massage, energy healing therapy, chelation therapy, 
craniosacral therapy, naturopathy, hypnosis, traditional healers, homeopathic 
treatments, and herbs or supplements. For the present study, yoga, 
meditation/mindfulness practices, acupuncture, chiropractic, herbs or supplements, and 
massage were examined because they: 1) represent some of the more commonly 
available and utilized CAM treatments; 2) have been the focus of previous empirical 
investigation; and 3) and may be relevant to pregnant smokers. Those who endorsed 
using a particular CAM treatment were asked a series of follow-up questions, including 
whether they used that treatment in the past 12 months and how many times they used 
the treatment in the past 12 months. For some CAM treatments, additional follow-up 
questions were also included.  
Respondents who endorsed use of CAM treatments were also asked about 
health benefits they associated with CAM treatments, including being motivated to cut 
back or stop drinking alcohol or cut back or quit smoking cigarettes, reducing stress or 
relaxing, sleeping better, feeling better emotionally, coping better with health problems, 
and improving health overall. Additionally, respondents were queried about their 
reasons for choosing CAM treatments (e.g., medications “caused side effects;” “it’s 
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natural;” “it focuses on the whole person, mind, body, and spirit;” “it was part of your 
upbringing”) and whether they had discussed the use of CAM with their health care 
provider. 
Conventional treatment utilization. The NHIS does not include specific items 
related to conventional mental health and substance use treatment. However, 
respondents ere asked if they had seen “a mental health professional such as a 
psychiatrist, psychologist, psychiatric nurse, or clinical social worker” in the past 12 
months.  
 
Analyses 
All analyses were conducted using SPSS version 22.0; the complex samples 
add-on component will be utilized as appropriate. Imputations and recodes for the 
NSDUH and NHIS data were conducted by the Research Triangle Institute (RTI) and 
National Center for Health Statistics (NCHS), respectively, and were provided in the 
publicly available data files. In cases where imputation was conducted, missing data 
were either logically assigned according to responses to other survey questions when 
appropriate, or replaced via statistical imputation with non-missing values (SAMHSA, 
2014; CDC 2002, 2007, 2012). As recommended by RTI and NCHS, final annual survey 
weights were used for both the NSDUH and NHIS data in order to support national-level 
estimates. Subpopulation analyses with sample sizes that fell below 200 (i.e., substance 
use treatment barriers for NSDUH sample, CAM use in both the NSDUH and NHIS 
samples) did not take into account complex sample design features (West, personal 
communication, May 21, 2015).  
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Broadly, analyses fell into three groups: (a) descriptive analyses summarizing 
sample characteristics and prevalence rates; (b) logistic regression analyses to examine 
factors related to cessation in perinatal smoking; and (c) logistic regression analyses to 
investigate factors related to CAM utilization. 
 Sample description and prevalence rates 
Descriptive analyses were used to better understand sample characteristics, to 
investigate prevalence rates across study waves of prenatal smoking, mental health 
issues, and other substance use, and to explore utilization rates of conventional mental 
health and substance use treatment and CAM treatment across the study waves. For 
population-level estimates, 95% confidence intervals are also reported. 
Analyses of factors associated with smoking cessation during pregnancy 
Associations between potential factors related to prenatal smoking (e.g., 
sociodemographic factors, smoking patterns, substance use, mental health, and 
externalizing) were first examined prior to conducting regression analyses. Those 
factors that were significantly related to smoking were included initially in separate 
univariate logistic regression models to predict the dichotomous outcome of cessation in 
smoking during the past year. Only those variables associated with the outcome were 
included in the multivariate logistic regression model to determine the factors most 
strongly associated with cessation in perinatal smoking.  
Analyses of factors associated with CAM usage 
Separate, unweighted univariate logistic regression models examined 
characteristics associated with CAM usage among pregnant smokers (e.g., 
sociodemographic factors, smoking patterns, mental health). Subsequently, those 
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variables associated with lifetime (NHIS) and past year (NSDUH and NHIS) CAM usage 
were included in multivariate regression models to determine the relative importance of 
variables associated with CAM utilization. Due to the smaller sample sizes for CAM use, 
some factors were combined (e.g., alcohol and illicit drug dependence combined into 
substance use dependence) where appropriate. Further, given the ratio of sample size 
relative to the number of predictors, stepwise logistic regression was used to estimate 
adjusted associations between key variables and CAM use in multivariate models.  
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CHAPTER 3 RESULTS 
 In this study, we analyzed data from two national multi-year surveys with the 
broad aim of better understanding the treatment needs and preferences of pregnant 
smokers. First, the prevalence rate of smoking among pregnant women across study 
waves was estimated. Next, we examined characteristics of current smokers compared 
to former smokers. Then, utilization of conventional treatment and CAM treatment was 
also examined, including estimating prevalence of treatment utilization and examining 
the characteristics of pregnant smokers who utilized CAM. It was predicted that a 
number of sociodemographic factors, smoking history and patterns, and mental health 
symptoms would be associated with quitting smoking during pregnancy. It was also 
predicted that pregnant smokers would endorse the use of CAM, and that, although 
rates would be low, there would be a trend toward increasing rates across study years. 
Finally, it was also predicted that sociodemographic and potentially mental health and 
smoking-related factors would be associated with CAM use.  
Description of NSDUH sample 
 See Table 1 for NSDUH sample characteristics. A total of 3,252 pregnant women 
age 12-44 who had smoked in the past year participated in the NSDUH across the 2004 
to 2013 survey years. Of these 3,252 respondents, 1,920 were current smokers who 
had smoked in the past 30 days, while 1,332 had smoked in the past 12 months, but not 
the past 30 days. Approximately 50% of pregnant past-year smokers were between 18 
and 25 (95% CI = 57.7, 53.9). Pregnant women who endorsed smoking were primarily 
White. Overall, current smokers appeared to be more socially disadvantaged than 
former smokers. Current smokers were predominantly unmarried, while former smokers 
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were equally likely to be either married or unmarried. Among pregnant women who 
reported smoking in the past year, fewer current smokers were college graduates 
compared to former smokers. In addition, nearly half of those pregnant women who 
were currently smoking received some form of government assistance, whereas just 
below 30% of pregnant former smokers received any government assistance. Former 
smokers reported a higher rate of current employment compared to current smokers. A 
greater proportion of current smokers reported a total annual family income of less than 
$20,000 compared to former smokers and living below the poverty threshold in greater 
rates. Conversely, a greater proportion of former smokers reported a total annual family 
income of more than $75,000.  
Regarding general health, a greater proportion of pregnant former smokers 
reported their overall health to be “Excellent” or “Very Good”, compared to current 
smokers. Measures of mental health revealed that current smokers experienced greater 
distress and symptoms of poor mental health. Pregnant current smokers endorsed 
higher rates of past month and past year serious psychological distress compared to 
former smokers. The odds of having had serious psychological distress in the past 
month were more than 2.5 times greater for current smokers (OR = 2.58; 95% CI = 
1.55, 4.31), and the odds of having had serious psychological distress in the past year 
were almost twice as great for current smokers (OR = 1.88; 95% CI = 1.48, 2.39). 
Current and former smokers endorsed similar rates of lifetime major depression, with 
approximately 20% meeting criteria for depression within their lifetime. However, former 
smokers had decreased odds of having had depression in the past year (OR = 0.65; 
95% CI = 0.42, 0.99). A similar difference was observed for anxiety disorders. Current 
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smokers had a 1.5 times greater odds of having received a diagnosis of an anxiety 
disorder from a doctor or medical professional in their lifetime. Current smokers also 
had nearly double the odds of an anxiety disorder diagnosis within the past year (OR = 
1.96; 95% CI = 1.31, 2.94).  
Estimates of alcohol and illicit drug use were also examined. The odds of having 
had a drink within the past month were 36% greater for current smokers compared to 
former smokers (OR = 1.36; 95% CI = 1.01, 1.84). The odds of binge drinking (i.e., 
drinking five or more drinks on the same occasion) in the past month were 3 times 
greater for current smokers (OR = 3.08; 95% CI = 2.07, 4.57), with 11.5% of current 
smokers reporting past month binge drinking compared to 4.1% of former smokers. 
There were no significant differences between current and former smokers with regard 
to past year alcohol abuse or dependence. Compared to former smokers, current 
smokers had a 3.1 times greater odds of having used illicit drugs within the past month 
(OR = 3.14; 95% CI = 2.16, 4.58). An equal proportion of current and former smokers 
met criteria for past year illicit substance abuse, but a greater proportion of current 
smokers met criteria for past year illicit substance dependence (OR = 1.68; 95% CI = 
1.24, 2.30). 
Finally, facets of externalizing and risky behavior, including criminal justice 
involvement, driving while intoxicated, and risk seeking, were examined. Currently 
smoking pregnant women were at increased odds of ever having been arrested (OR = 
1.53; 95% CI = 1.18, 1.99) and having been on probation in the past year (OR = 1.94; 
95% CI = 1.31, 2.87). There was no significant difference between current and former 
smokers with regard to driving under the influence of alcohol or drugs within the past 
61 
 
year. On two items related to risky behaviors, current smokers endorsed greater 
engagement in risky behaviors to “test” themselves (OR = 1.5; 95% CI = 1.13, 2.12), but 
there was no difference between current and former smokers in terms of getting a kick 
out of doing something dangerous. Finally, current smokers were less likely to wear a 
seatbelt, whether as a driver (OR = 0.42; 95% CI = 0.31, 0.57) or passenger (OR = .44; 
95% CI = 0.34; 0.58).  
Description of NHIS sample 
 See Table 2 for NHIS sample characteristics. A total of 106 pregnant women age 
18 and up who were currently smoking participated in the NHIS in 2002, 2007, and 
2012. Of these 106 pregnant women, 79 reported smoking every day and 27 reported 
smoking some days. The mean age of pregnant smokers was 26.96 (SD = 6.09). 
Pregnant smokers who participated in the NHIS were primarily White, non-Hispanic and 
married or living with a partner. Approximately 35% had completed high school or 
received a GED. About half of the sample indicated that they were currently employed, 
with over 50% reporting an annual family income of less than $35,000. Just under a 
quarter were on some form of government assistance, and over 75% had health 
insurance coverage.  
Among the pregnant smokers in the NHIS sample, the majority reported that their 
physical health was “Excellent” or “Very Good,” and that their general health was about 
the same compared to last year. In terms of mental health, pregnant smokers who 
participated in the NHIS were highly distressed, with 90% meeting the cutoff for past 
month serious psychological distress. Approximately 30% indicated that they had been 
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frequently anxious or depressed in the past year. In addition, 17.2% of pregnant 
smokers in the NHIS endorsed moderate to heavy alcohol use in the past year.  
Smoking prevalence 
 Across the NSDUH waves, past 30-day smoking prevalence appeared to 
fluctuate slightly, ranging from 13.3% (2012; 95% CI = 10.9, 16.2) to 19.6% (2010; 95% 
CI = 16.1, 23.7), but remained generally stable with a 16% (95% CI = 14.9, 17.2) 
prevalence rate across all waves. See Figure 1. Among all pregnant women, an 
examination of smoking prevalence by trimester across the study waves demonstrated 
a decrease across trimesters: 22.3% (95% CI = 19.8, 24.9) in the first trimester, 13.8% 
(95% CI = 12.2, 15.6) in the second trimester, and 12.2% (95% CI = 10.6, 14.1) in the 
third trimester of pregnancy (see Figure 2). Within the pregnant, current smoker subset, 
43.9% (95% CI = 39.9, 48.0) were in their first trimester, 30.5% (95% CI = 27.3, 34.0) in 
their second trimester, and 25.5% (95% CI = 22.3, 29.0) were in their third trimester. 
Finally, within the pregnant, former smoker subset, 24.6% (95% CI = 21.0, 28.5) were in 
their first trimester, 41.7% (95% CI = 37.1, 46.4) were in their second trimester, and 
33.7% (95% CI = 29.6, 38.1) were in their third trimester.  
The mean age of beginning daily smoking was 16.14 (95% CI = 17.42, 18.31) for 
current smokers and 17.86 (95% CI = 15.91, 16.37) for former smokers. In terms of 
early onset of regular cigarette use, current smokers had a 2.4 times greater odds of 
being an early onset regular smoker (by age 14) compared to former smokers (OR = 
2.41; 95% CI =1.80, 3.23). In terms of smoking risk perception, most women considered 
regular heavy smoking (e.g., one or more packs per day) to be of great risk.  
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On average, most current smokers smoked 6 to 15 cigarettes per day (36.2%; 
95% CI = 33.0, 39.5). Just under a third of current smokers smoked 2 to 5 cigarettes per 
day on average (29.0%; 95% CI = 25.9, 32.3). Nearly two-thirds (65.5%; 95% CI =62.5, 
68.4) of current smokers met criteria for nicotine dependence within the past month. 
When nicotine dependence among current smokers was examined by trimester, 73.6% 
(95% CI = 68.9, 77.9) of women in their third trimester met past month criteria for 
nicotine dependence, while 64.3% (95% CI = 58.0, 70.2) of second trimester and 61.5% 
(95% CI = 56.2, 66.5) of first trimester women met nicotine dependence criteria. 
Regarding a specific feature of nicotine dependence, craving, 25.4% (95% CI = 22.5, 
28.5) of current smokers reported little to no craving for cigarettes. Notably, 32.1% (95% 
CI = 28.8, 35.7) strongly indicated that they felt in control of their smoking, whereas 
21.9% (95% CI = 19.5, 24.5) reported feeling as though they were not in control of their 
smoking.  
 Compared to the NSDUH, the prevalence rate of past-30-day prenatal smoking 
in the NHIS was slightly lower. However, similar to the NSDUH, the prevalence rate in 
the NHIS appeared to fluctuate across study years (see Figure 3), dropping from an 
estimated 11.6% (95% CI = 8.5, 15.6) in 2002 to 8.1% (95% CI = 5.2, 12.4) in 2007, and 
then increasing to 10.7% (95% CI = 7.1, 15.9) in 2012; across the 3 waves, prenatal 
smoking prevalence was estimated to be 10.1% (95% CI = 8.0, 12.6). Notably, the 
percentage of pregnant former smokers and never smokers also appeared to fluctuate 
(see Figure 4). Among pregnant women who had ever been regular smokers (i.e., those 
who had ever smoked 100 cigarettes), the rate of current smoking appeared to 
decrease slightly, ranging from an estimated 43.3% in 2002 to 36.1% in 2012. The 
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majority of former smokers quit smoking within the past year (51.1%). The mean age at 
which current smokers began regularly smoking was 15.92 (SD = 3.33). On average, 
pregnant smokers who participated in the NHIS smoked 12.64 (SD = .029) cigarettes 
per day, with a modal number of 10 cigarettes smoked per day. 
Factors associated with smoking cessation during pregnancy 
 Unadjusted logistic regression analyses revealed that many factors were 
significantly associated with smoking cessation during pregnancy, with the strongest 
factors being greater levels of education, higher annual family income, absence of past 
month serious psychological distress, past month binge drinking, and past year illicit 
drug use. Age, lifetime major depression diagnosis, alcohol use disorders, and past 
year DUI were not associated with perinatal smoking cessation. See Table 3 for 
unadjusted odds ratios. 
Variables related to smoking cessation in pregnancy were included in adjusted 
analyses. The overall adjusted logistic regression model was significant and accounted 
for between 29.5% (Cox and Snell R2) and 39.9% (Nagelkerke R2) of the variance in 
smoking cessation during pregnancy. In the full model, several factors were no longer 
significantly associated with smoking cessation: receipt of government assistance, age 
onset of regular smoking, serious psychological distress (past year and past month), 
past year major depression, lifetime anxiety disorder, past month and past year illicit 
drug use, past year substance dependence, arrest history, probation status, risky 
behavior, conventional treatment utilization, and unmet need for mental health 
treatment. The strongest factors associated with smoking cessation in the overall model 
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included greater education, Hispanic ethnicity, and absence of past month binge 
drinking or past year anxiety disorder diagnosis. See Table 3 for adjusted odds ratios.  
Prevalence rates of conventional treatment utilization 
 Approximately one-fifth of pregnant past-year smokers reported engaging in 
conventional mental health or substance use treatment within the past year (20.2%; 
95% CI = 18.1, 22.4). Currently smoking pregnant women from the NSDUH survey 
reported greater likelihood of having sought conventional treatment within the past year 
as compared to former smokers (OR = 1.77; 95% CI = 1.35, 2.31). Further, current 
smokers were more likely to report an unmet need for mental health treatment (OR = 
2.06; 95% CI = 1.45, 2.92). There was not a significant difference between current and 
former smokers with regard to a substance use treatment gap, or needing treatment but 
not receiving it (see Table 1). 
 Respondents indicated a variety of reasons for seeking treatment, as well as a 
variety of barriers to seeking or receiving treatment. Among the 649 pregnant past-year 
smokers who sought mental health treatment in the past 12 months, 81% (95% CI = 
76.1, 85.1) indicated that they decided on their own to seek treatment; another 13.6% 
(95% CI = 9.9, 18.3) of remaining treatment seekers sought mental health treatment 
because someone else thought they should. Finally, 5.4% (95% CI = 3.9, 7.5) sought 
mental health treatment because they were ordered to get treatment. Regarding 
perceived barriers to receiving mental health treatment, current and former smokers 
endorsed similar reasons for not receiving treatment with a few exceptions. A greater 
proportion of former smokers indicated that an insurance deficit, such as insurance not 
covering any treatment or not covering enough of the cost of treatment, prevented them 
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from receiving treatment. The most common barriers to mental health treatment for both 
current and former smokers included being unable to afford it, not knowing where to go 
for treatment, and believing they could handle the problem without treatment. See Table 
4 for perceived barriers to conventional mental health treatment.  
 Response rates for perceived barriers to substance use treatment were low 
(unweighted count = 58). For current smokers, the most common reason for not seeking 
substance use treatment was that they were not ready to stop using, followed by being 
unable to afford it or not having insurance and not wanting others to find out. For former 
smokers, the most common reasons for not seeking substance use treatment included 
being unable to afford treatment or not having insurance coverage, transportation 
difficulties, and fear that their neighbors would have a negative opinion of them. See 
Table 5 for perceived barriers to conventional substance use treatment. 
 Within the NHIS sample, just over a tenth of pregnant smokers indicated that 
they had seen a mental health professional within the past year (see Table 2). A greater 
proportion of daily smokers (12.8%) reported that they had seen a mental health 
professional in the past year compared to regular (but not daily) smokers (8.8%).  
Prevalence rates of past year CAM utilization 
 Among pregnant NSDUH participants who endorsed smoking within the past 
year, 251 responded to items related to alternative mental health treatment, including 
156 who received treatment from several CAM practitioners (acupuncturist, 
chiropractor, herbalist, massage therapist). Compared to conventional treatment, fewer 
pregnant past-year smokers reported engaging in alternative mental health treatment 
within the past year. Within the larger sample of pregnant women who have smoked 
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within the past year, the prevalence of CAM use was 6.9%: 5.6% among current 
smokers, and 8.5% of former smokers utilized CAM in the past year. Across NSDUH 
survey waves there appeared to be some variability in CAM treatment use. Overall, 
prevalence rates for any CAM use among pregnant, past year smokers varied between 
an estimated 3.7% (95% CI =1.9, 7.4) at the lowest in 2007 to 10.8% (95% CI = 3.7, 
27.5) at the highest in 2011. See Figure 5. 
Of those pregnant women who sought treatment from alternative mental health 
treatment, current smokers were at lower odds of having seen a CAM practitioner for 
alternative mental health treatment within the past year compared to former smokers 
(OR = 0.54; 95% CI = 0.32, 0.91). Chiropractic care was the most commonly utilized 
CAM treatment among current smokers (29.0%), whereas massage was the most 
commonly utilized CAM treatment among former smokers (48.4%). See Table 6 and 
Figure 6 for use rates for each CAM modality. Some reported utilizing more than one 
CAM approach: 18.5% of former smokers and 4.9% of current smokers sought 
treatment from practitioners of 2 different CAM modalities in the last year; 0.7% of 
current smokers used 3 of the 4 CAM approaches.  
NSDUH participants predominantly chose conventional mental health or 
substance use treatment (17.6%; 95% CI = 15.5, 19.9). Nearly 5% sought solely CAM 
treatment (4.7%; 95% CI = 3.0, 7.2). However, a small proportion of pregnant, past year 
smokers utilized both conventional mental health or substance use treatment as well as 
CAM treatment (2.6%; 95% CI = 1.7, 3.9). Although current smokers were greater users 
of conventional treatment, and former smokers were greater users of CAM treatment, 
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there was no difference in smoking status among those using both conventional and 
CAM approaches. 
 Compared to the NSDUH sample, a greater proportion of pregnant smokers who 
participated in the NHIS reported engaging in CAM use: 27.2% of pregnant current 
smokers endorsed using CAM in their lifetime, with 19.1% reporting CAM use within the 
past year. Herbs and supplements were the most commonly used CAM approach within 
the past year, with 9.5% reporting past year use of herbs and supplements, followed by 
meditation (7.9%) and deep breathing exercises (6.3%). Deep breathing exercises 
(including as part of yoga or meditation practice) was the most common CAM practice 
smokers had ever used, with 16.5% reporting that they had ever tried deep breathing 
exercises; deep breathing was followed by meditation (12.0%) and herbs and 
supplements (10.5%).  
Across NHIS study waves, there was a slight decrease in the lifetime prevalence 
of CAM use, dropping from 31.3% in 2002 to 25.5% in 2012. However, increases were 
observed for several CAM approaches: yoga, acupuncture, and herbs and supplements 
(see Figure 7). For past year CAM use, there appeared to be an increase from 19.5% in 
2002 to 26.1% in 2007, but past year CAM use dropped to 19.2% in 2012. In examining 
CAM treatments separately, increases across study waves in past year use were 
observed for yoga, meditation, and massage. See Figure 8. 
Unfortunately, survey items regarding reasons for using CAM had poor response 
rates (1.8%). However, among those who responded to these items, the most 
commonly reported reason for using CAM was to reduce stress levels or help with 
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relaxation, followed by general wellness or disease prevention, improving overall health 
or to feel better, and improving relationships with others.  
Factors associated with CAM use 
 Characteristics associated with CAM use were examined within the NSDUH 
(past year CAM use) and NHIS (lifetime and past year CAM use) samples. Separate 
logistic regressions were first conducted to examine whether factors were related to 
CAM. Within the NSDUH, logistic regression analyses revealed that many factors were 
associated with greater likelihood of past year CAM use, with the strongest factors 
including: higher annual family income (greater than $50,000), being married, White 
racial status, non-reliance on government assistance, and absence of past year serious 
psychological distress or mental health problems. Trimester of pregnancy, age, 
education, perceived health, perceived risk of regular smoking, past month alcohol and 
illicit drug use, past year illicit drug use, alcohol and illicit drug abuse, seatbelt use, risky 
behavior, and past year DUI were not significantly associated with past year CAM use. 
Factors significantly associated with past year CAM use in univariate analyses 
were included in the full model. The overall adjusted logistic regression model was 
significant and accounted for between 27.4% (Cox and Snell R2) and 37.0% 
(Nagelkerke R2) of the variance in past year CAM use. Two factors were retained in the 
adjusted model, with non-reliance on government assistance and absence of past year 
serious psychological distress, depression, or anxiety being associated with greater 
likelihood of past year CAM use. See Table 7 for unadjusted and adjusted odds ratios.  
In the NHIS sample, separate logistic regression analyses indicated that none of 
the factors examined were significantly associated with both lifetime and past year CAM 
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use. Higher income, greater education, Hispanic ethnicity, and abstinence from alcohol 
were among the strongest predictors of lifetime CAM use. All factors were entered into a 
stepwise logistic regression in order to determine whether any significant factors would 
emerge in an adjusted model. The overall adjusted logistic regression model of factors 
associated with lifetime CAM use was significant and accounted for between 13.4% 
(Cox and Snell R2) and 18.9% (Nagelkerke R2) of the variance in lifetime CAM use. 
Several factors were retained in the adjusted model, with greater education and 
abstinence from alcohol emerging as factors most strongly associated with lifetime CAM 
use in the adjusted model. Notably, age onset of regular smoking was also retained in 
the full model; however, the direction of the association changed, such that onset of 
regular smoking after age 15 was associated with a lower likelihood of lifetime CAM 
use. Considering the sample size restrictions, though, these results should be 
interpreted with caution. See Table 9 for unadjusted and adjusted odds ratios for lifetime 
CAM use among NHIS participants. 
Among the univariate factors associated with past year CAM use, White racial 
status, greater education, higher income, past month serious psychological distress, 
and past year depression or anxiety were several of the factors strongly associated with 
past year CAM use. As with lifetime CAM use, all factors were included in the adjusted 
model despite being nonsignificant in univariate comparisons. The overall adjusted 
logistic regression model of factors associated with past year CAM use was 
nonsignificant, and no factors were retained in the overall model. See Table 8 for 
unadjusted odds ratios for past year CAM use among NHIS participants. 
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CHAPTER 4 DISCUSSION 
 The present study sought to investigate the characteristics and treatment 
utilization practices of pregnant smokers who participated in two cross-sectional 
national surveys, in order to better understand their treatment needs and preferences. 
The estimated prevalence rate of prenatal smoking between 2002 and 2013 based on 
both samples was between 8 and 20%, with somewhat lower estimates among the 
NHIS participants. Estimated smoking prevalence rates appeared to be somewhat 
stable across these years and did not appear to reflect a decline in the prevalence of 
prenatal smoking. This highlights the urgency of considering alternate and possibly 
more broadly acceptable intervention approaches.  
Compared to current smokers, former smokers were more likely to be in their 
second or third trimester of pregnancy, of African American or Hispanic descent, college 
educated, employed, and earning a higher annual family income. Former smokers also 
reported better health, greater seatbelt use, and were less likely to have used alcohol in 
the past month or to have been diagnosed with an anxiety disorder in the past year. 
Notably, former smokers also reported that they perceived regular, heavy smoking to be 
of greater risk to one’s health. Although former smokers were less likely to have 
experienced serious psychological distress, engaged in risky behaviors, been arrested 
or on probation in the past year, or used illicit drugs in the past month, these factors did 
not remain significant in the full model. Prior studies emphasized a link between distress 
or mental health problems and persistent smoking, but these relationships did not 
appear to be as strong within the present sample.  
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Within the NSDUH sample, both current and former smokers endorsed distress, 
major depression, and anxiety, with some comparisons reaching statistical significance 
and suggesting that current smokers were more distressed; however, once other factors 
were taken into consideration, many of these associations were no longer significant. A 
similar pattern was observed for substance use: once other factors were accounted for, 
only abstinence from alcohol within the past month was associated with smoking 
cessation. Factors such as nicotine dependence, craving, and smoking self-efficacy 
could not be compared between current and former smokers. Among current smokers, 
however, over 65% were nicotine dependent (particularly those in the third trimester), 
approximately 75% reported experiencing craving, and over 20% felt that they were not 
in control of their smoking. Overall, the results of the present study support the general 
finding from previous investigations that current smokers are more high-risk across a 
number of sociodemographic domains. Importantly, though, these results also highlight 
factors that may be well-suited as intervention targets, such as psychoeducation about 
smoking risk and prenatal alcohol use, general health and safety promotion, managing 
nicotine craving, and boosting smoking self-efficacy. It is possible that CAM treatments 
may be well-suited to address several of these targets, including general health 
promotion, managing craving, and improving self-efficacy.  
 A second aim was to estimate the rates of CAM use among pregnant smokers, 
and to explore how rates have changed across time. Pregnant current and former 
smokers endorsed conventional and CAM treatment use. Use of conventional treatment 
was more common than use of CAM among NSDUH participants, whereas use of CAM 
was more common than use of conventional treatment among NHIS participants; 
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however, it is likely that this difference is driven by methodological differences in how 
the two surveys administer treatment utilization questions. With regard to specific CAM 
modalities, seeking treatment within the past year from a chiropractor or massage 
therapist were most common within the NSDUH sample, whereas NHIS participants 
reported that herbs and supplements, meditation, and deep breathing exercises were 
the most common CAM approaches used within the past year.  
Interestingly, among NSDUH participants, current smokers were greater 
consumers of conventional treatment, whereas formers smokers were greater 
consumers of CAM as a form of alternative mental health treatment. Further, a small 
proportion of participants also endorsed both conventional and CAM treatment use 
within the past year, which may suggest that some pregnant smokers are open to trying 
a variety of approaches to help meet their treatment goals. It is not clear from the 
present data why individuals made these treatment decisions. Thus, these findings 
underscore the need to better understand how treatment preferences drive decisions to 
seek specific treatments. Regardless, these findings also demonstrate that pregnant 
smokers are interested in CAM approaches and that many are already using CAM as a 
form of mental health treatment or for general health promotion.  
NSDUH respondents also identified a number of barriers to seeking conventional 
treatment for mental health and substance use. The cost of treatment emerged as a 
common barrier to both mental health and substance use treatment. Other barriers 
included fears about how others would respond, not knowing where to go for treatment, 
not being ready for treatment, and feeling as though they could handle the problem 
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without treatment. It is unclear whether similar barriers would prevent women from 
seeking CAM treatments.  
 In terms of trends in the prevalence of CAM treatment use among pregnant 
smokers across survey years, our prediction of increased CAM use over time was not 
supported by the data. Instead, it appeared that the prevalence of CAM use was 
variable across study years in both the NSDUH and NHIS with no evidence of a linear 
trend. Considering trends of increasing use observed in the general population, 
including smokers (Hamm et al., 2014), it is possible that this fluctuation in rates of CAM 
use among pregnant smokers may be reflective of uncertainty about the safety and 
efficacy of these modalities during pregnancy. However, within the NHIS sample, there 
appeared to be increases across study years for specific treatments. In particular, rates 
of participation in yoga (both lifetime and past year), acupuncture (lifetime), herbs and 
supplements (lifetime), meditation (past year), and massage (past year) appeared to 
increase between 2002 and 2012 among pregnant smokers.  
Analyses examining factors related to CAM use among pregnant smokers were 
underpowered due to limited sample sizes. These analyses were conducted without 
using sample weights in order to facilitate interpretation, given that applying weights 
appeared to result in artificially inflated significance values for all factors but did not 
generally change the magnitude of odds ratios. Despite these restrictions, a number of 
factors were found to be associated with CAM use among pregnant smokers in both 
samples, including White race, having greater levels of education and higher annual 
family income (a finding that is consistent with previous research in this area; Chuang et 
al., 2009). Interestingly, among the NSDUH sample, lower distress or better mental 
75 
 
health was associated with greater likelihood of CAM use; in contrast, higher distress or 
poor mental health was associated with greater likelihood of CAM use among the NHIS 
sample. This difference may reflect variability in the measurement of distress, mental 
health, and/or CAM use within these surveys.  
Limitations 
 The overall purpose of the NSDUH and NHIS surveys is to provide a general, 
cross-sectional snapshot of the substance use, mental health, and physical health of the 
U.S. non-institutionalized population. Due to the cross-sectional nature of the NSDUH 
and NHIS, conclusions about causality cannot be made. Further, although these study 
designs allows for generalizability of this study’s results to the U.S. population, they also 
present some limitations. For example, certain subgroups, such as individuals who are 
incarcerated, are not included in these surveys. This could result in an underestimation 
of smoking, substance use, and mental health problems among incarcerated pregnant 
women. Further, these surveys were not designed specifically for the subpopulation of 
pregnant smokers, and therefore the choice of variables was restricted to those 
included in the NSDUH and NHIS surveys. Thus, there are several relevant factors that 
were not included or further assessed in these surveys.  
Notably, smoking cessation during pregnancy—a primary focus of this study— 
could only be assessed using the proxy measure of past 30-day cigarette use. As a 
result, it was not possible to directly determine the point at which smokers may have 
quit, and it is possible that some past year smokers may have quit prior to becoming 
pregnant. It was also not possible to explore whether there were differences between 
current and formers smokers with regard to several smoking-related factors (namely, 
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nicotine dependence, craving, smoking self-efficacy, and average number of cigarettes 
smoked per day), since these items were not administered unless respondents 
endorsed past month cigarette use. Further, neither survey assesses smoking cessation 
treatment; it is therefore uncertain whether some women may have sought or benefitted 
from smoking cessation treatment.  
In addition, questions related to CAM use in the NSDUH were embedded within 
the alternative mental health treatment section. Consequently, the sample size for these 
items was limited to those who sought alternative treatment for mental health issues 
and responded to these items. As a result, it is possible that the prevalence of CAM use 
within the NSDUH sample was underestimated. Despite pooling several waves of each 
survey together, the sample size for some analyses within both samples was also small, 
which prevented further exploration of certain aspects of treatment utilization and CAM 
use. Finally, although the NSDUH makes efforts to minimize self-report bias and 
enhance disclosure of stigmatized behaviors by using ACASI, the NHIS relies on only 
face-to-face interviews. However, regardless of methods to minimize bias, data from 
both surveys are based solely on participant self-report; thus, behaviors such as 
prenatal smoking, substance use, mental health issues and criminal justice involvement 
may be underreported.  
Conclusions and future directions 
 Prenatal smoking prevalence estimates appear to be somewhat stable based on 
nationally representative survey data, which suggests that prevention and intervention 
efforts are not reaching enough at-risk women. Overall, the present study found several 
potentially modifiable factors that may help to distinguish between women who are at 
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greater risk for persistent smoking during pregnancy, including smoking risk perception, 
current alcohol use, and factors related to nicotine dependence (e.g., craving, self-
efficacy). Notably, at least two of these (craving and self-efficacy) have been shown to 
be amenable to CAM approaches (e.g., Gwaltney et al., 2002; Vidrine et al., 2009; 
Witkiewitz et al., 2005; Witkiewitz & Bowen, 2010). Further, this study also 
demonstrated that a sizeable proportion of pregnant smokers are interested/already 
accessing alternative treatments. Further, although CAM use appeared to be somewhat 
lower in lower SES and (in some cases) depressed or anxious women, it was 
nevertheless reported by at least 25% of women in these subgroups. They may thus be 
a broadly acceptable approach for pregnant smokers, particularly if barriers such as 
cost and accessibility are addressed. 
Future investigations should further examine pregnancy-related factors that may 
be associated with smoking as well as CAM use, such as receipt of prenatal care, 
whether the pregnancy was planned, or the presence of pregnancy complications. 
Additionally, further exploration of the intended reasons or goals for seeking out CAM—
including whether women use CAM to assist with smoking cessation or manage mental 
health symptoms—is necessary in order to better understand motivations for pursuing 
CAM, and whether women are pursing CAM instead of or in addition to conventional 
treatment.  
Several access-related issues remain to be addressed. As noted, this study 
found that pregnant women, including pregnant smokers, are seeking out CAM 
treatment at moderate and stable rates. However, further research is needed not only to 
validate the use of these treatments for a variety of physical and mental health issues, 
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but also to guide treatment recommendations and to confirm that such treatments can 
be used safely during pregnancy. In particular, pilot studies and larger scale randomized 
clinical trials are required to provide a foundation for the use of CAM in general and for 
specific subpopulations such as pregnant women, whether as a standalone or adjunct 
to conventional evidence-based treatment approaches. In addition, as previous authors 
have noted (e.g., Pallivalapila et al., 2015), the lack of regulatory oversight is a 
significant concern surrounding some CAM treatments. For example, evidence-based 
treatment guidelines for practitioners of other CAM modalities such as acupuncture, 
chiropractic care, and yoga would help to ensure that women who pursue these 
approaches during pregnancy can do so safely.  
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Table 1 
NSDUH Sample Characteristics 
 
Sociodemographic 
Characteristics 
Total 
(n = 3,252) 
Current Smokers 
(n = 1,920) 
Former Smokers 
(n = 1,332) 
 
p 
% 95% CI % 95% CI % 95% CI 
Trimester 
   First 
   Second 
   Third 
 
35.5% 
35.4% 
29.1% 
 
[32.8, 38.3] 
[32.5, 38.4] 
[26.5, 31.8] 
 
43.9% 
30.5% 
25.5% 
 
[39.9, 48.0] 
[27.3, 34.0] 
[22.3, 29.0] 
 
24.6% 
41.7% 
33.7% 
 
[21.0, 28.5] 
[37.1, 46.4] 
[29.6, 38.1] 
 
.000 
Age 
   12 to 17 
   18 to 25 
   26 and older 
 
5.3% 
50.8% 
43.9% 
 
[4.5, 6.2] 
[47.7, 53.9] 
[40.7, 47.2] 
 
5.3% 
53.4% 
41.3% 
 
[4.2, 6.5] 
[49.5, 57.4] 
[37.2, 45.5] 
 
5.4% 
47.3% 
47.3 
 
[4.0, 7.0] 
[43.0, 51.7] 
[42.7, 52.0] 
 
.063 
Race/Ethnicity 
   Non-Hispanic White 
   Non-Hispanic Afr. Amer. 
   Non-Hispanic Other Race 
   Hispanic 
 
70.7% 
13.6% 
4.7% 
11.1% 
 
[67.9, 73.3] 
[11.5, 16.0] 
[3.5, 6.3] 
[9.7, 12.7] 
 
73.9% 
13.7% 
4.8% 
7.5% 
 
[70.2, 77.3] 
[11.4, 16.4] 
[3.3, 7.1] 
[5.7, 9.9] 
 
66.4% 
13.3% 
4.5% 
15.8% 
 
[62.5, 70.1] 
[10.2, 17.3] 
[3.1, 6.4] 
[13.1, 18.8] 
 
.000 
Marital Status 
   Never married 
   Married 
   Widowed, divorced, separated 
 
50.8% 
37.6% 
11.6% 
 
[47.7, 53.9] 
[34.5, 40.8] 
[9.9, 13.6] 
 
54.6% 
30.2% 
15.3% 
 
[50.4, 58.7] 
[26.4, 34.2] 
[12.5, 18.5] 
 
45.9% 
47.3% 
6.8% 
 
[41.4, 50.4] 
[42.8, 51.8] 
[4.7, 9.8] 
 
.000 
Education 
   Less than HS 
   HS graduate or GED 
   Some college 
   College graduate 
 
27.8% 
35.2% 
26.0% 
11.0% 
 
[25.6, 30.0] 
[32.7, 37.9] 
[23.2, 29.1] 
[9.2, 13.0] 
 
33.1% 
37.5% 
25.1% 
4.3% 
 
[30.2, 36.1] 
[33.9, 41.3] 
[21.5, 29.2] 
[2.7, 6.6] 
 
20.8% 
32.2% 
27.2% 
19.8% 
 
[18.0, 24.0] 
[28.3, 36.4] 
[23.4, 31.1] 
[16.5, 23.5] 
 
.000 
Employment Status 
   Currently employed 
   Not currently employed 
 
48.4% 
51.6% 
 
[45.5, 51.4] 
[48.6, 54.5] 
 
52.8% 
47.2% 
 
[49.7, 56.0] 
[44.0, 50.3] 
 
57.3% 
42.7% 
 
[52.7, 61.8] 
[38.2, 47.3] 
 
.000 
Annual Family Income 
   Less than $20,000 
   $20,000 to $49,999 
   $50,000 to $74,999 
   $75,000 or more 
 
35.0% 
35.8% 
14.6% 
14.7% 
 
[32.5, 37.6] 
[33.2, 38.5] 
[12.9, 16.3] 
[12.6, 17.0] 
 
42.5% 
37.8 
12.0% 
7.8% 
 
[39.2, 45.8] 
[34.7, 41.0] 
[10.0, 14.4] 
[6.0, 9.9] 
 
25.2% 
33.1% 
17.9% 
23.8% 
 
[21.4, 29.3] 
[29.1, 37.4] 
[15.5, 20.6] 
[19.7, 28.5] 
 
.000 
Government Assistance 
   Yes 
   No 
 
40.2% 
59.8% 
 
[38.0, 42.3] 
[57.7, 62.0] 
 
48.5% 
51.5% 
 
[45.3, 51.7] 
[48.3, 54.7] 
 
29.2% 
70.8% 
 
[25.5, 33.1] 
[66.9, 74.5] 
 
.000 
Health Status 
   Fair or Poor 
 
8.5% 
 
[7.1, 10.1] 
 
11.2% 
 
[9.1, 13.9] 
 
4.8% 
 
[3.4, 6.8] 
 
.000 
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   Good 
   Very Good 
   Excellent 
30.1% 
36.9% 
24.5% 
[27.7, 32.6] 
[34.3, 39.6] 
[21.9, 27.7] 
35.1% 
35.0% 
18.7% 
[31.7, 38.5] 
[31.5, 38.6] 
[15.9, 21.8] 
23.6% 
39.4% 
32.1% 
[20.4, 27.3] 
[35.5, 43.5] 
[28.0, 36.4] 
Regular Smoking Onset  
   By age 14 
   Age 15 or older 
 
20.1% 
79.9% 
 
[18.0, 22.5] 
[77.5, 82.0] 
 
25.1% 
74.9% 
 
[21.8, 28.7] 
[71.3, 78.2] 
 
12.2% 
87.8% 
 
[10.1, 14.7] 
[85.3, 89.9] 
 
.000 
Smoking Risk Perception 
   No or slight risk 
   Moderate risk 
   Great risk 
 
11.7% 
27.5% 
60.9% 
 
[10.1, 13.4] 
[25.1, 30.0] 
[58.2, 63.5] 
 
14.8% 
32.1% 
53.1% 
 
[12.9, 16.9] 
[28.6, 35.7] 
[49.6, 56.6] 
 
7.6% 
21.4% 
71.0% 
 
[5.2, 11.0] 
[18.8, 24.3] 
[67.4, 74.4] 
 
.000 
SPD, Past Year* 
   No 
   Yes 
 
78.6% 
21.4% 
 
[76.5, 80.5] 
[19.5, 23.5] 
 
74.1% 
25.9% 
 
[71.1, 76.9] 
[23.1, 28.9] 
 
84.3% 
15.7% 
 
[81.7, 86.7] 
[13.3, 18.3] 
 
.000 
SPD, Past Month*  
   No 
   Yes 
 
89.7% 
10.3% 
 
[87.2, 91.8] 
[8.2, 12.8] 
 
86.2% 
13.8% 
 
[82.6, 89.2] 
[10.8, 17.4] 
 
94.2% 
5.8% 
 
[91.0, 96.3] 
[3.7, 9.0] 
 
.000 
MDE, Past Year* 
   No 
   Yes 
 
88.6% 
11.4% 
 
[86.4, 90.4] 
[9.6, 13.6] 
 
86.7% 
13.3% 
 
[83.5, 89.3] 
[10.7, 16.5] 
 
91.0% 
9.0% 
 
[87.7, 93.4] 
[6.6, 12.3] 
 
.043 
MDE, Lifetime* 
   No 
   Yes 
 
80.0% 
20.0% 
 
[76.8, 82.8] 
[17.2, 23.2] 
 
79.9% 
20.1% 
 
[76.3, 83.0] 
[17.0, 23.7] 
 
80.1% 
19.9% 
 
[75.0, 84.4] 
[15.6, 25.0] 
 
.937 
Anxiety Disorder, Past Year 
   No 
   Yes 
 
89.5% 
10.5% 
 
[87.4, 91.4] 
[8.6, 12.6] 
 
86.9% 
13.1% 
 
[83.7, 89.6] 
[10.4, 16.3] 
 
92.9% 
7.1% 
 
[90.5, 94.7] 
[5.3, 9.5] 
 
.001 
Anxiety Disorder, Lifetime 
   No 
   Yes 
 
84.5% 
15.5% 
 
[82.2, 86.5] 
[13.5, 17.8] 
 
82.2% 
17.8% 
 
[79.0, 85.0] 
[15.0, 21.0] 
 
87.4% 
12.6% 
 
[84.1, 90.1] 
[9.9, 15.9] 
 
.020 
Alcohol Use, Past Month 
   No 
   Yes 
 
82.6% 
17.4% 
 
[80.6, 84.4] 
[15.6, 19.4] 
 
80.7% 
19.3% 
 
[78.1, 83.1] 
[16.9, 21.9] 
 
85.1% 
14.9% 
 
[81.6, 88.0] 
[12.0, 18.4] 
 
.042 
Binge Drinking, Past Month 
   No 
   Yes 
 
91.7% 
8.3% 
 
[90.2, 93.0] 
[7.0, 9.8] 
 
88.5% 
11.5% 
 
[86.2, 90.4] 
[9.6, 13.8] 
 
95.9% 
4.1% 
 
[94.3, 97.1] 
[2.9, 5.7] 
 
.000 
Alcohol Abuse 
   No 
   Yes 
 
93.6% 
6.4% 
 
[92.2, 94.8] 
[5.2, 7.8] 
 
93.4% 
6.6% 
 
[91.2, 95.0] 
[5.0, 8.8] 
 
94.0% 
6.0% 
 
[91.7, 95.7] 
[4.3, 8.3] 
 
.648 
Alcohol Dependence 
   No 
   Yes 
 
92.8% 
7.2% 
 
[91.3, 94.0] 
[6.0, 8.7] 
 
92.7% 
7.3% 
 
[90.8, 94.2] 
[5.8, 9.1] 
 
92.8% 
7.2% 
 
[90.4, 94.7] 
[5.3, 9.6] 
 
.910 
Illicit Drug Use, Past Year        
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   No 
   Yes 
63.5% 
36.5% 
[61.3, 65.6] 
[34.4, 38.7] 
59.9% 
40.1% 
[56.8, 63.0] 
[37.0, 43.2] 
68.1% 
31.9% 
[64.7, 71.4] 
[28.6, 35.3] 
.001 
Illicit Drug Use, Past Month 
   No 
   Yes 
 
87.1% 
12.9% 
 
[85.6, 88.5] 
[11.5, 14.4] 
 
82.2% 
17.8% 
 
[79.9, 84.3] 
[15.7, 20.1] 
 
93.6% 
6.4% 
 
[91.2, 95.3] 
[4.7, 8.8] 
 
.000 
Illicit Drug Abuse 
   No 
   Yes 
 
97.7% 
2.3% 
 
[96.9, 98.3] 
[1.7, 3.1] 
 
97.7% 
2.3% 
 
[96.5, 98.5] 
[1.5, 3.5] 
 
97.7% 
2.3% 
 
[96.4, 98.5] 
[1.5, 3.6] 
 
.947 
Illicit Drug Dependence 
   No 
   Yes 
 
92.0% 
8.0% 
 
[90.6, 93.2] 
[6.8, 9.4] 
 
90.4% 
9.6% 
 
[88.4, 92.1] 
[7.9, 11.6] 
 
94.1% 
5.9% 
 
[92.4, 95.4] 
[4.6, 7.6] 
 
.001 
Ever Arrested 
   No 
   Yes 
 
72.1% 
27.9% 
 
[69.7, 74.5] 
[25.5, 30.3] 
 
68.5% 
31.5% 
 
[65.3, 71.5] 
[28.5, 34.7] 
 
76.9% 
23.1% 
 
[72.8, 80.4] 
[19.6, 27.2] 
 
.002 
Probation Status 
   No 
   Yes 
 
92.9% 
7.1% 
 
[91.4, 94.2] 
[5.8, 8.6] 
 
91.2% 
8.8% 
 
[88.8, 93.1] 
[6.9, 11.2] 
 
95.2% 
4.8% 
 
[93.6, 96.5] 
[3.5, 6.4] 
 
.001 
DUI 
   No 
   Yes 
 
79.3% 
20.7% 
 
[76.6, 81.8] 
[18.2, 23.4] 
 
79.8% 
20.2% 
 
[77.0, 82.4] 
[17.6, 23.0] 
 
78.6% 
21.4% 
 
[74.5, 82.2] 
[17.8, 25.5] 
 
.551 
Risky Behavior 
   No 
   Yes 
 
84.8% 
15.2% 
 
[83.0, 86.4] 
[13.6, 17.0] 
 
82.4% 
17.6% 
 
[80.0, 84.6] 
[15.4, 20.0] 
 
87.9% 
12.1% 
 
[84.9, 90.4] 
[9.6, 15.1] 
 
.006 
Seatbelt Use 
   Never, seldom, sometimes 
   Always 
 
24.6% 
75.4% 
 
[22.4, 26.9] 
[73.1, 77.6] 
 
31.0% 
69.0% 
 
[27.7, 34.5] 
[65.5, 72.3] 
 
16.2% 
83.8% 
 
[13.6, 19.2] 
[80.8, 86.4] 
 
.000 
MH or SU Treatment 
   No 
   Yes 
 
79.8% 
20.2% 
 
[77.6, 81.9] 
[18.1, 22.4] 
 
76.0% 
24.0% 
 
[72.9, 78.9] 
[21.1, 27.1] 
 
84.8% 
15.2% 
 
[81.8, 87.4] 
[12.6, 18.2] 
 
.000 
Unmet MH Treatment Need 
   No 
   Yes 
 
89.1% 
10.9% 
 
[87.1, 90.7] 
[9.3, 12.9] 
 
86.2% 
13.8% 
 
[83.4, 88.6] 
[11.4, 16.6] 
 
92.8% 
7.2% 
 
[90.5, 94.5] 
[5.5, 9.5] 
 
.000 
SU Treatment Gap 
   No 
   Yes 
 
82.3% 
17.7% 
 
[80.4, 84.1] 
[15.9, 19.6] 
 
81.9% 
18.1% 
 
[79.2, 84.3] 
[15.7, 20.8] 
 
82.8% 
17.2% 
 
[79.8, 85.5] 
[14.5, 20.2] 
 
.637 
CAM Use, 
   No alternative MH treatment 
   No CAM use 
   Yes 
 
90.3%  
2.8%  
6.9%  
 
[87.5, 92.5] 
[2.0, 4.0] 
[4.8, 9.7] 
 
90.9%  
3.5%  
5.6%  
 
[87.6, 93.3] 
[2.4, 5.2] 
[3.5, 8.7] 
 
89.6%  
1.9%  
8.5%  
 
[85.8, 92.5] 
[1.2, 2.9] 
[5.8, 12.4] 
 
.017 
Note. CI = confidence interval; Afr. Amer. = African American; SPD = serious psychological distress; MDE = major 
depressive episode; DUI = driving under the influence of alcohol or drugs; MH = mental health; SU = substance use; 
CAM = complementary and alternative medicine. 
*Sample size for NSDUH waves 2005-2013 = 2,894 total (1,705 current smokers, 1,189 former smokers). 
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Table 2 
NHIS Sample Characteristics 
 
Sociodemographic 
Characteristics 
 
Total 
(n = 106)* 
Everyday 
Smokers 
(n = 79)* 
Some Days 
Smokers 
(n = 27)* 
 
 
p 
Age 
   18 to 25 
   26 and older 
 
31.3% 
67.9% 
 
29.7% 
70.3% 
 
37.0% 
63.0% 
 
.000 
Race 
   White 
   African American 
   Other Race 
 
84.2% 
9.0% 
6.8% 
 
85.4% 
5.7% 
8.9% 
 
80.5% 
18.9% 
0.6% 
 
.000 
Hispanic Ethnicity 
   No 
   Yes 
 
91.6% 
8.4% 
 
97.1% 
2.9% 
 
74.7% 
25.3% 
 
.000 
Marital Status 
   Never married 
   Living with partner 
   Married 
   Widowed, divorced or separated 
 
12.7% 
31.4% 
44.8% 
11.1% 
 
14.6% 
31.2% 
42.5% 
11.8% 
 
7.0% 
32.0% 
52.0% 
9.1% 
 
.000 
Education 
   Less than HS 
   HS, no diploma 
   HS graduate or GED 
   Some college 
   College graduate 
 
4.8% 
26.8% 
34.9% 
20.7% 
12.9% 
 
5.8% 
27.3% 
33.4% 
19.0% 
14.6% 
 
1.6% 
25.2% 
39.4% 
26.0% 
7.8% 
 
.000 
Employment Status 
   Currently employed 
   Not currently employed 
 
46.6% 
52.9% 
 
44.8% 
55.2% 
 
52.9% 
47.1% 
 
.000 
Annual Family Income 
   $0 to $34,999 
   $35,000 to $74,999 
   $75,000 or more 
 
50.1% 
36.6% 
7.7% 
 
54.5% 
39.1% 
6.4% 
 
48.0% 
37.6% 
14.4% 
 
.000 
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Government Assistance 
   No 
   Yes 
 
77.8% 
22.2% 
 
73.2% 
26.8% 
 
91.8% 
8.2% 
 
.000 
Health Insurance Coverage 
   Covered 
   Not covered 
 
77.0% 
23.0% 
 
80.0% 
20.0% 
 
67.6% 
32.4% 
 
.000 
Health Status 
   Fair or Poor 
   Good 
   Very Good 
   Excellent 
 
9.6% 
29.8% 
40.5% 
20.0% 
 
11.6% 
31.3% 
37.4% 
19.7% 
 
3.8% 
25.4% 
50.1% 
20.7% 
 
.000 
Regular Smoking Onset  
   By age 14 
   Age 15 or older 
 
29.6% 
70.4% 
 
37.1% 
62.9% 
 
6.9% 
93.1% 
 
.000 
SPD, Past Month 
   No 
   Yes 
 
9.9% 
90.1% 
 
10.2% 
89.8% 
 
8.9% 
91.1% 
 
.000 
Frequently Depressed or Anxious 
   No 
   Yes 
 
71.0% 
29.0% 
 
71.1% 
28.9% 
 
70.6% 
29.4% 
 
.018 
Alcohol Use Status 
   Lifetime abstainer 
   Former drinker 
   Current infrequent drinker 
   Current light drinker 
   Current moderate to heavy drinker 
 
7.4% 
28.6% 
22.7% 
23.7% 
17.2% 
 
8.6% 
26.0% 
23.8% 
23.6% 
18.0% 
 
3.9% 
37.0% 
19.7% 
24.5% 
14.8% 
 
.000 
Seen a Mental Health Professional 
   No 
   Yes 
 
88.0% 
11.8% 
 
87.2% 
12.8% 
 
91.2% 
8.8% 
 
.000 
Note. SPD = serious psychological distress. 
* Unweighted count. 
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Table 3 
Odds Ratios and Confidence Intervals for Smoking Cessation During Pregnancy 
 
Variable 
Unadjusted Adjusteda 
OR 95% CI OR 95% CI 
Trimester 
   First 
   Second 
   Third 
 
Ref 
2.44 
2.36  
 
 
[1.81, 3.29] 
[1.74, 3.22] 
 
Ref 
3.23  
2.88  
 
 
[1.88, 5.54] 
[1.92, 4.55] 
Race/Ethnicity 
   Non-Hispanic White 
   Non-Hispanic African American 
   Non-Hispanic Other Race 
   Hispanic 
 
Ref 
1.08 
1.03  
2.33  
 
 
[0.77, 1.52] 
[0.65, 1.64] 
[1.52, 3.57] 
 
Ref 
2.30 
1.73  
4.71  
 
 
[1.21, 4.37] 
[0.83, 3.63] 
[2.31, 9.61] 
Marital Status 
   Never married 
   Married 
   Widowed, divorced, separated 
 
Ref 
1.87  
0.53  
 
 
[1.46, 2.39] 
[0.33, 0.88] 
 
Ref 
1.25  
0.47  
 
 
[0.79, 1.99] 
[0.25, 0.91] 
Education 
   Less than HS 
   HS graduate 
   Some college 
   College graduate 
 
Ref 
1.36  
1.72  
7.32  
 
 
[1.04, 1.79] 
[1.29, 2.30] 
[4.19, 12.76] 
 
Ref 
1.59  
1.58  
5.51  
 
 
[0.88, 2.90] 
[0.87, 2.90] 
[2.01, 15.11] 
Annual Family Income 
   Less than $20,000 
   $20,000-$49,999 
   $50,000-$75,000 
   $75,000 and up 
 
Ref 
1.48  
2.51  
5.21  
 
 
[1.11, 1.97] 
[1.88, 3.36] 
[3.41, 7.96] 
 
Ref 
1.13  
1.47  
2.89  
 
 
[0.66, 1.92] 
[0.90, 2.40] 
[1.21, 6.91] 
Employment Status 
   Not currently employed 
   Currently employed 
 
Ref 
1.50  
 
 
[1.22, 1.85] 
 
Ref 
1.54  
 
 
[1.04, 2.27] 
Government Assistance 
   No 
   Yes 
 
Ref 
2.29  
 
 
[1.79, 2.93] 
 
Ref 
1.30  
 
 
[0.77, 2.19] 
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Health Status 
   Fair or Poor 
   Good 
   Very Good 
   Excellent 
 
Ref 
1.57  
2.62  
4.00  
 
 
[0.96, 2.58] 
[1.65, 4.17] 
[2.53, 6.34] 
 
Ref 
2.40  
2.63  
3.83  
 
 
[1.00, 5.02] 
[1.25, 5.54] 
[1.71, 8.58] 
Regular Smoking Onset 
   By age 14 
   Age 15 or later 
 
Ref 
2.41  
 
 
[1.80, 3.23] 
 
Ref 
1.21  
 
 
[0.73, 1.99] 
Smoking Risk Perception  
   No or slight risk 
   Moderate risk 
   Great risk 
 
Ref 
1.30  
2.61  
 
 
[0.82, 2.08] 
[1.69, 4.04] 
 
Ref 
1.37  
2.72  
 
 
[0.75, 2.48] 
[1.65, 4.49] 
SPD, Past Year (2005-2013) 
   No 
   Yes 
 
Ref 
0.53  
 
 
[0.42, 0.68] 
 
Ref 
1.02  
 
 
[0.51, 2.06] 
SPD, Past Month (2005-2013) 
   No 
   Yes 
 
Ref 
0.39  
 
 
[0.23, 0.65] 
 
Ref 
0.78  
 
 
[0.29, 2.09] 
MDE, Past Year (2005-2013) 
   No 
   Yes 
 
Ref 
0.65  
 
 
[0.42, 1.00] 
 
Ref 
0.88  
 
 
[0.40, 1.92] 
Anxiety Disorder, Past Year 
   No 
   Yes 
 
Ref 
0.51  
 
 
[0.34, 0.77] 
 
Ref 
0.23  
 
 
[0.08, 0.64] 
Anxiety Disorder, Lifetime 
   No 
   Yes 
 
Ref 
0.66  
 
 
[0.47, 0.94] 
 
Ref 
1.93  
 
 
[0.93, 4.01] 
Alcohol Use, Past Month 
   No 
   Yes 
 
Ref 
0.73  
 
 
[0.54, 0.99] 
 
Ref 
0.47  
 
 
[0.22, 0.99] 
Binge Drinking, Past Month 
   No 
   Yes 
 
Ref 
0.33  
 
 
[0.22, 0.48] 
 
Ref 
0.31  
 
 
[0.12, 0.80] 
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Illicit Drug Use, Past Year 
   No 
   Yes 
Ref 
0.32  
 
[0.22, 0.46] 
Ref 
0.94  
 
[0.56, 1.59] 
Illicit Drug Use, Past Month 
   No 
   Yes 
 
Ref 
0.70  
 
 
[0.57, 0.86] 
 
Ref 
0.51  
 
 
[0.24, 1.07] 
Illicit Drug Dependence, Past Year 
   No 
   Yes 
 
Ref 
0.59  
 
 
[0.44, 0.81] 
 
Ref 
1.92  
 
 
[0.77, 4.28] 
Ever Arrested 
   No 
   Yes 
 
Ref 
0.66  
 
 
[0.51, 0.85] 
 
Ref 
1.06  
 
 
[0.67, 1.67] 
Probation Status, Past Year 
   No 
   Yes 
 
Ref 
0.52  
 
 
[0.35, 0.77] 
 
Ref 
0.89  
 
 
[0.43, 1.85] 
Risky Behavior 
   No 
   Yes 
 
Ref 
0.65  
 
 
[0.47, 0.89] 
 
Ref 
0.94  
 
 
[0.54, 1.61] 
Seatbelt Use 
   Never, seldom or sometimes 
   Always 
 
Ref 
2.33  
 
 
[1.78, 3.05] 
 
Ref 
2.24  
 
 
[1.36, 3.68] 
Treatment, Past Year 
   No 
   Yes 
 
Ref 
0.57  
 
 
[0.43, 0.74] 
 
Ref 
0.68  
 
 
[0.38, 1.23] 
Unmet Treatment Need 
   No 
   Yes 
 
Ref 
0.49  
 
 
[0.34, 0.69] 
 
Ref 
1.21  
 
 
[0.57, 2.58] 
Note. OR = odds ratio; CI = confidence interval; SPD = serious psychological distress; MDE = 
major depressive episode.  
aAdjusted model goodness-of-fit (Wald X2 (37, 60) = 343.67, p < .001). 
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Table 4 
Perceived Barriers to Mental Health Treatment 
 
 
Barrier 
Total Current Smokers 
(n = 229)* 
Former Smokers 
(n = 104)* 
 
% 95% CI % 95% CI % 95% CI p 
Fear of neighbors’ negative 
opinion 
10.6 [6.3, 17.2] 11.5 [6.1, 20.8] 8.3 [3.4, 18.7] .542 
Fear of negative effect on 
job 
4.8 [2.0, 11.0] 3.7 [0.9, 14.1] 7.4 [3.1, 16.6] .413 
Didn’t want others to find 
out 
7.6 [4.1, 13.5] 5.7 [3.1, 10.3] 12.2 [3.8, 32.4] .259 
Insurance didn’t cover it at 
all 
2.2 [1.0, 4.7] 0.6 [0.2, 1.7] 6.1 [2.3, 15.1] .000 
Insurance didn’t pay 
enough 
8.8 [4.9, 15.4] 4.4 [1.5, 12.5] 19.7 [10.4, 34.3] .013 
Didn’t know where to go 20.1 [13.5, 28.9] 18.1 [11.3, 27.7] 25.1 [13.6, 41.5] .341 
Confidentiality concerns 10.2 [6.4, 15.8] 9.2 [4.7, 17.2] 12.8 [7.0, 22.1] .479 
Fear of being committed or 
medicated 
17.5 [12.2, 24.9] 15.7 [9.9, 24.2] 22.4 [12.1, 37.7] .356 
Didn’t think treatment was 
needed 
3.6 [2.0, 6.1] 3.4 [1.7, 6.4] 4.0 [1.7, 8.8] .741 
Couldn’t afford cost 48.7 [41.7, 55.8] 47.1 [38.5, 55.9] 52.6 [39.7, 65.2] .509 
Thought problem could be 
handled without treatment 
19.7 [13.8, 27.2] 16.1 [10.4, 24.0] 28.7 [15.9, 46.3] .118 
Didn’t think treatment would 
help 
6.1 [3.3, 11.1] 4.5 [2.2, 8.9] 10.2 [3.8, 24.7] .170 
Didn’t have time 11.0 [7.2, 16.5] 9.3 [5.2, 16.0] 15.3 [7.9, 27.3] .252 
No transportation, too far 
away, not convenient 
3.6 [2.0, 6.3] 3.2 [1.5, 6.8] 4.6 [1.6, 12.5] .259 
* Unweighted counts. 
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Table 5 
Perceived Barriers to Substance Use Treatment 
 
 
Barrier 
 
 
Total 
Current 
Smokers 
(n = 41)* 
Former 
Smokers 
(n = 17)* 
 
 
p 
Fear of neighbors’ negative opinion 14.7% 13.0% 21.4% .000 
Fear of negative effect on job 10.5% 13.1% 0% .000 
Didn’t want others to find out 18.5% 21.5% 6.4% .000 
Insurance didn’t cover treatment 8.4% 8.1% 9.8% .006 
No program had preferred treatment type 0.0% 0.1% 0% .326 
Not ready to stop using 27.5% 30.7% 20.1% .000 
No openings in programs 2.9% 3.6% 0% .000 
Didn’t know where to go 18.9% 18.9% 18.9% .496 
Didn’t think treatment was needed 1.4% 0.1% 6.4% .000 
Couldn’t afford cost or no insurance 26.1% 24.4% 32.6% .000 
Thought problem could be handled without 
treatment 
0.9% 1.0% 0.4% .005 
Didn’t have time 0.3% 0.4% 0% .001 
No transportation, too far away, not convenient 10.1% 6.8% 23.0% .000 
* Unweighted counts. 
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Table 6 
Past Year CAM Use Among Alternative Mental Health Treatment Seekers (NSDUH) 
 
CAM Treatment Provider 
Total 
(n =251) 
Current 
Smokers 
(n = 143)* 
Former Smokers 
(n = 108)* 
 
p 
Acupuncturist 8.3% 9.2% 7.2% .000 
Chiropractor 35.3% 29.0% 42.5% .000 
Herbalist 4.1% 6.0% 2.0% .000 
Massage therapist 36.3% 25.9% 48.4% .000 
All CAM approaches 70.9% 61.3% 82.1% .000 
Note. CAM = complementary and alternative medicine. 
*Unweighted counts. 
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Table 7 
Odds Ratios and Confidence Intervals for Past Year CAM Use (NSDUH) 
 
 
Variable 
Unadjusted 
 
Adjusteda 
OR 95% CI OR 95% CI 
Race/Ethnicity 
   Non-Hispanic White 
   Non-Hispanic African American 
   Non-Hispanic Other Race 
   Hispanic 
 
Ref 
0.15 
0.47 
0.42 
 
 
[0.06, 0.40] 
[0.18, 1.22] 
[0.20, 0.89] 
 
 
-- 
 
 
-- 
Marital Status 
   Not married 
   Married 
 
Ref 
2.52 
 
 
[1.41, 4.50] 
 
-- 
 
-- 
Annual Family Income 
   Less than $20,000 
   $20,000-$49,999 
   $50,000-$75,000 
   $75,000 and up 
 
Ref 
2.24 
3.56 
3.62 
 
 
[1.21, 4.15] 
[1.46, 8.72] 
[1.64, 8.00] 
 
 
-- 
 
 
-- 
Employment Status 
   Not currently employed 
   Currently employed 
 
Ref 
0.30 
 
 
[0.18, 0.51] 
 
-- 
 
-- 
Government Assistance 
   No 
   Yes 
 
Ref 
0.18 
 
 
[0.10, 0.31] 
 
Ref 
0.13 
 
 
[0.06, 0.29] 
Smoking, Past Month 
   No 
   Yes 
 
Ref 
0.54 
 
 
[0.32, 0.91] 
 
-- 
 
-- 
MH and/or SPD, Past Year (2005-2013) 
   No 
   Yes 
 
Ref 
0.20 
 
 
[0.11, 0.38] 
 
Ref 
0.26 
 
 
[0.11, 0.60] 
SPD, Past Month (2005-2013) 
   No 
   Yes 
 
Ref 
0.26 
 
 
[0.11, 0.62] 
 
-- 
 
-- 
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MDE and/or Anxiety Disorder, Lifetime 
   No 
   Yes 
 
Ref 
0.36 
 
 
[0.20, 0.63] 
 
-- 
 
-- 
Substance Dependence, Past Year 
   No 
   Yes 
 
Ref 
0.38 
 
 
[0.21, 0.68] 
 
-- 
 
-- 
Ever Arrested 
   No 
   Yes 
 
Ref 
0.52 
 
 
[0.30, 0.88] 
 
-- 
 
-- 
Probation Status, Past Year 
   No 
   Yes 
 
Ref 
0.29 
 
 
[0.12, 0.71] 
 
-- 
 
-- 
Treatment, Past Year 
   No 
   Yes 
 
Ref 
0.22  
 
 
[0.12, 0.37] 
 
-- 
 
-- 
MH or SU Treatment Gap 
   No 
   Yes 
 
Ref 
0.42 
 
 
[0.25, 0.70] 
 
-- 
 
-- 
Note. OR = odds ratio; CI = confidence interval; CAM = complementary and alternative 
medicine; Ref = reference category; SPD = serious psychological distress; MDE = major 
depressive episode; MH = mental health; SU = substance use.  
aAdjusted model goodness-of-fit: X2 (1, 2) = 44.78, p < .001. 
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Table 8 
Odds Ratios and Confidence Intervals for Past Year CAM Use (NHIS) 
 
Variable 
Unadjusted  
OR 95% CI 
Age 
   18 to 25 
   26 and older 
 
Ref 
0.95 
 
 
[0.36, 2.49] 
Race 
   White 
   African American 
   Other Race 
 
Ref 
0.21 
0.27 
 
 
[0.03, 1.67] 
[0.03, 2.22] 
Hispanic Ethnicity 
   No 
   Yes 
 
Ref 
0.83 
 
 
[0.22, 3.23] 
Marital Status 
   Never married 
   Living with partner 
   Married 
   Widowed, divorced, separated 
 
Ref 
0.37 
1.08 
0.55 
 
 
[0.08, 1.82] 
[0.31, 3.69] 
 [0.12, 2.43] 
Education 
   College graduate 
   Some college 
   HS graduate or GED 
   HS, no diploma 
   Less than HS 
 
Ref 
0.90 
0.29 
0.35 
0.28 
 
 
[0.23, 3.52] 
[0.07, 1.15] 
[0.09, 1.40] 
[0.03, 2.90] 
Employment Status 
   Currently employed 
   Not currently employed 
 
Ref 
0.47 
 
 
[0.18, 1.20] 
Annual Family Income 
   Less than $34,999 
   $35,000 to $74,999 
   $75,000 or more 
 
Ref 
0.71 
3.27 
 
 
[0.23, 2.19] 
[0.60, 17.91] 
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Government Assistance 
   No 
   Yes 
 
Ref 
0.84 
 
 
[0.31, 2.27] 
Health Insurance Coverage 
   Covered 
   Not covered 
 
Ref 
0.47 
 
 
[0.13, 1.76] 
Health Status 
   Very Good to Excellent 
   Fair to Good 
 
Ref 
1.49 
 
 
[0.60, 3.70] 
Smoking Frequency 
   Some days 
   Everyday 
 
Ref 
1.03 
 
 
[0.36, 2.95] 
Regular Smoking Onset  
   By age 14 
   Age 15 or older 
 
Ref 
0.51 
 
 
[0.20, 1.32] 
Cigarettes Per Day 
   16 or more 
   6 to 15 
   1 to 5 
 
Ref 
1.06 
0.53 
 
 
[0.34, 3.33] 
[0.15, 1.90] 
SPD, Past Month 
   No 
   Yes 
 
Ref 
2.84 
 
 
[0.34, 23.59] 
Frequently Depressed or Anxious, Past Year 
   No 
   Yes 
 
Ref 
1.73 
 
 
[0.67, 4.42] 
Alcohol Use Status 
   Current drinker 
   Former drinker or lifetime abstainer 
 
Ref 
1.04 
 
 
[0.41, 2.66] 
Note. OR = odds ratio; CI = confidence interval; CAM = complementary and alternative 
medicine; SPD = serious psychological distress. No factors were retained in the multivariate 
model using stepwise logistic regression; therefore, adjusted ORs are not reported. 
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Table 9 
Odds Ratios and Confidence Intervals for Lifetime CAM Use (NHIS) 
 
 
Variable 
Unadjusted 
 
Adjusteda 
 
OR 95% CI OR 95% CI 
Age 
   18 to 25 
   26 and older 
 
Ref 
1.05  
 
 
[0.43, 2.58] 
 
-- 
 
-- 
Race 
   White 
   African American 
   Other Race 
 
Ref 
0.32 
0.43 
 
 
[0.07, 1.54] 
[0.09, 2.12] 
 
-- 
 
-- 
Hispanic Ethnicity 
   No 
   Yes 
 
Ref 
1.95  
 
 
[0.62, 6.19] 
 
-- 
 
-- 
Marital Status 
   Never married 
   Living with partner 
   Married 
   Widowed, divorced, separated 
 
Ref 
0.99 
1.16 
0.85  
 
 
[0.25, 3.87] 
[0.34, 3.98] 
[0.21, 3.43] 
 
 
-- 
 
 
-- 
Education 
   College graduate 
   Some college 
   HS graduate or GED 
   HS, no diploma 
   Less than HS 
 
Ref 
0.94 
0.30 
0.31 
0.46 
 
 
[0.24, 3.58] 
[0.08, 1.10] 
[0.08, 1.21] 
[0.07, 3.14] 
 
 
0.79 
0.17 
0.16 
0.39 
 
 
[0.18, 3.44] 
[0.04, 0.81] 
[0.03, 0.80] 
[0.05, 3.20] 
Employment Status 
   Currently employed 
   Not currently employed 
 
Ref 
0.76 
 
 
[0.32, 1.78] 
 
-- 
 
-- 
Annual Family Income 
   Less than $34,999 
   $35,000 to $74,999 
 
Ref 
0.95 
 
 
[0.36, 2.52] 
 
-- 
 
-- 
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   $75,000 or more 2.37  [0.44, 12.81] 
Government Assistance 
   No 
   Yes 
 
Ref 
1.20 
 
 
[0.49, 2.90] 
 
-- 
 
-- 
Health Insurance Coverage 
   Covered 
   Not covered 
 
Ref 
1.13 
 
 
[0.41, 3.11] 
 
-- 
 
-- 
Health Status 
   Very Good to Excellent 
   Fair to Good 
 
Ref 
1.12  
 
 
[0.48, 2.60] 
 
-- 
 
-- 
Smoking Frequency 
   Some days 
   Everyday 
 
Ref 
1.21 
 
 
[0.45, 3.25] 
 
-- 
 
-- 
Regular Smoking Onset  
   By age 14 
   Age 15 or older 
 
Ref 
1.67 
 
 
[0.69, 4.06] 
 
Ref 
0.40 
 
 
[0.14, 1.15] 
Cigarettes Per Day 
   16 or more 
   6 to 15 
   1 to 5 
 
Ref 
0.55 
0.36  
 
 
[0.19, 1.56] 
[0.12, 1.12] 
 
-- 
 
-- 
SPD, Past Month 
   No 
   Yes 
 
Ref 
1.79  
 
 
[0.36, 8.93] 
 
-- 
 
-- 
Frequently Depressed or Anxious, 
Past Year 
   No 
   Yes 
 
 
Ref 
1.79  
 
 
 
[0.75, 4.29] 
 
-- 
 
-- 
Alcohol Use Status 
   Current drinker 
   Former drinker or lifetime 
abstainer 
 
Ref 
2.04  
 
 
[0.86, 4.82] 
 
 
3.24 
 
 
[1.17, 9.00] 
Note. OR = odds ratio; CI = confidence interval; CAM = complementary and alternative 
medicine; SPD = serious psychological distress.  
aAdjusted model goodness-of-fit: X2 (1, 6) = 13.61, p < .05. 
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Figure 1 
NSDUH Smoking Prevalence Rates Among Pregnant Women by Year 
 
Note: Never-smokers not included. 
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Figure 2 
Current Smokers by Trimester Across NSDUH Survey Years 
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Figure 3 
Smoking Prevalence Across NHIS Years 
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Figure 4 
Smoking Frequency Among Pregnant Women Who Were Ever Regular Smokers, 
Across NHIS Years 
 
  
33.70%
21.20%
31.60% 27.50%
9.60%
15.20%
4.50% 9.10%
56.70%
63.60% 63% 63.50%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
2002 2007 2012 Total
Every day Some days Not at all
100 
 
Figure 5 
Prevalence Rate of Any CAM Use Across NSDUH Study Years  
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Figure 6 
Prevalence Rate of CAM Modalities Among Alternative Mental Health Treatment 
Seekers Across NSDUH Study Years 
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Figure 7 
Past Year Prevalence Rate of CAM Use Across NHIS Study Years 
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Figure 8 
Lifetime Prevalence Rate of CAM Use Across NHIS Study Years 
 
 
  
0.00%
5.00%
10.00%
15.00%
20.00%
25.00%
30.00%
35.00%
2002
2007
2012
All years
104 
 
APPENDIX A 
NSDUH Demographic Items 
What is your date of birth? __/__/____ 
That would make you [CALCAGE] years old. Is this correct? 
1 YES 
2 NO 
Are you of Hispanic, Latino, or Spanish origin or descent? 
1 YES 
2 NO 
Which of these groups describes you? 
1 WHITE 
2 BLACK OR AFRICAN AMERICAN 
3 AMERICAN INDIAN OR ALASKA NATIVE (AMERICAN INDIAN INCLUDES 
NORTH AMERICAN, 
CENTRAL AMERICAN, AND SOUTH AMERICAN INDIANS) 
4 NATIVE HAWAIIAN 
5 GUAMANIAN OR CHAMORRO 
6 SAMOAN 
7 OTHER PACIFIC ISLANDER 
8 ASIAN (INCLUDING: ASIAN INDIAN, CHINESE, FILIPINO, JAPANESE, 
KOREAN, AND VIETNAMESE) 
9 OTHER (SPECIFY) 
Are you now married, widowed, divorced or separated, or have you never married? 
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1 MARRIED 
2 WIDOWED 
3 DIVORCED OR SEPARATED 
4 HAVE NEVER MARRIED 
What is the highest grade or year of school you have completed? 
0 NEVER ATTENDED SCHOOL 
1 1ST GRADE COMPLETED 
2 2ND GRADE COMPLETED 
3 3RD GRADE COMPLETED 
4 4TH GRADE COMPLETED 
5 5TH GRADE COMPLETED 
6 6TH GRADE COMPLETED 
7 7TH GRADE COMPLETED 
8 8TH GRADE COMPLETED 
9 9TH GRADE COMPLETED 
10 10TH GRADE COMPLETED 
11 11TH GRADE COMPLETED 
12 12TH GRADE COMPLETED 
13 COLLEGE OR UNIVERSITY / 1ST YEAR COMPLETED 
14 COLLEGE OR UNIVERSITY / 2ND YEAR COMPLETED 
15 COLLEGE OR UNIVERSITY / 3RD YEAR COMPLETED 
16 COLLEGE OR UNIVERSITY / 4TH YEAR COMPLETED 
17 COLLEGE OR UNIVERSITY / 5TH OR HIGHER YEAR COMPLETED 
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This question is about your overall health. Would you say your health in general is 
excellent, very good, good, fair, or poor? 
1 EXCELLENT 
2 VERY GOOD 
3 GOOD 
4 FAIR 
5 POOR 
Are you currently pregnant? 
 1 Yes 
 2 No 
How many months pregnant are you? ________ 
Medicaid is a public assistance program that pays for medical care for low income and 
disabled persons. The Medicaid program in [STATE FILL] is also called [MEDIFILL]. Are 
you covered by Medicaid? 
1 YES 
2 NO 
These next questions are about the kinds and amounts of income that you receive. 
These questions refer to the calendar year [CURRENT YEAR - 1] rather than to the 
past 12 months that were referred to in some earlier questions. The calendar year 
[CURRENT YEAR - 1] would be from January 1st, [CURRENT YEAR - 1], through 
December 31st, [CURRENT YEAR - 1]. 
In [CURRENT YEAR - 1], did you receive Social Security or Railroad Retirement 
payments? 
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1 YES 
2 NO 
In [CURRENT YEAR - 1], did you receive income from wages or pay earned while 
working at a job or business? 
1 YES 
2 NO 
In [CURRENT YEAR - 1], did you receive Supplemental Security Income or SSI? 
1 YES 
2 NO 
In [CURRENT YEAR - 1], did you receive food stamps? 
1 YES 
2 NO 
At any time during [CURRENT YEAR - 1], even for one month, did you receive any cash 
assistance from a state or county welfare program such as [TANFFILL]? 
1 YES 
2 NO 
In [CURRENT YEAR - 1], because of low income, did you receive any other kind of 
welfare or public assistance, such as help with getting a job, placement in education or 
job training programs, or help with transportation, child care, or housing? 
1 YES 
2 NO 
Next, we would like to know about the total family income from all sources during 
[CURRENT YEAR - 1]. Before taxes and other deductions, was the total combined 
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family income during [CURRENT YEAR - 1] more or less than 20,000 dollars? 
1 $20,000 OR MORE 
2 LESS THAN $20,000 
Of these income groups, which category best represents your total combined family 
income during [CURRENT YEAR – 1] before taxes and other deductions. 
1 LESS THAN $1,000 (INCLUDING LOSS) 
2 $1,000 - $1,999 
3 $2,000 - $2,999 
4 $3,000 - $3,999 
5 $4,000 - $4,999 
6 $5,000 - $5,999 
7 $6,000 - $6,999 
8 $7,000 - $7,999 
9 $8,000 - $8,999 
10 $9,000 - $9,999 
11 $10,000 - $10,999 
12 $11,000 - $11,999 
13 $12,000 - $12,999 
14 $13,000 - $13,999 
15 $14,000 - $14,999 
16 $15,000 - $15,999 
17 $16,000 - $16,999 
18 $17,000 - $17,999 
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19 $18,000 - $18,999 
20 $19,000 - $19,999 
The next questions are about working. Did you work at a job or business at any time last 
week? By last week, I mean the week beginning on Sunday, [STARTDATE] and ending 
on Saturday, [ENDDATE]. 
1 YES 
2 NO 
Even though you did not work at any time last week, did you have a job or business? 
1 YES 
2 NO 
Do you usually work 35 hours or more per week at all jobs or businesses? 
1 YES 
2 NO 
Please look at this card and tell me which one of these reasons best describes why you 
did not have a job or business last week. Just give me the number. 
1 LOOKING FOR WORK 
2 ON LAYOFF AND NOT LOOKING FOR WORK 
3 KEEPING HOUSE OR CARING FOR CHILDREN FULL TIME 
4 GOING TO SCHOOL/TRAINING 
5 RETIRED 
6 DISABLED FOR WORK 
7 DIDN’T WANT A JOB 
8 SOME OTHER REASON 
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Now, think about the past 12 months, from [DATEFILL] through today. Did you work at a 
job or business at any time during the past 12 months? 
1 YES 
2 NO  
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APPENDIX B 
NSDUH Cigarette Use 
Have you ever smoked part or all of a cigarette? 
1 Yes 
2 No 
If one of your best friends offered you a cigarette, would you smoke it? 
 1 Definitely Yes 
 2 Probably Yes 
 3 Probably Not 
 4 Definitely Not 
At any time during the next 12 months do you think you will smoke a cigarette? 
 1 Definitely Yes 
 2 Probably Yes 
 3 Probably Not 
 4 Definitely Not 
How old were you the first time you smoked part or all of a cigarette? ______ 
Now think about the past 30 days – that is, from [DATEFILL] up to and including today. 
During the past 30 days, have you smoked part or all of a cigarette? 
1 Yes 
2 No 
How long has it been since you last smoked part or all of a cigarette? 
1 More than 30 days ago but within the past 12 months 
2 More than 12 months ago but within the past 3 years 
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3 More than 3 years ago 
During the past 30 days, that is, since [DATEFILL], on how many days did you smoke 
part or all of a cigarette? # OF DAYS: __________ 
On the [______] days you smoked cigarettes during the past 30 days, how many 
cigarettes did you smoke per day, on average? 
1 Less than one cigarette per day 
2 1 cigarette per day 
3 2 to 5 cigarettes per day 
4 6 to 15 cigarettes per day (about ½ pack) 
5 16 to 25 cigarettes per day (about 1 pack) 
6 26 to 35 cigarettes per day (about 1 ½ packs) 
7 More than 35 cigarettes per day (about 2 packs or more) 
Has there ever been a period in your life when you smoked cigarettes every day for at 
least 30 days? 
1 Yes 
2 No 
How old were you when you first started smoking cigarettes every day? AGE: _______ 
Have you smoked at least 100 cigarettes in your entire life? 
1 Yes 
2 No 
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APPENDIX C 
Nicotine Dependence Syndrome Scale 
(NDSS; Shiffman, Hickcox, Gnys, Paty, & Kessel, 1995) 
Think about your use of cigarettes during the past 30 days as you answer these next 
questions.  
1. After not smoking for a while, you need to smoke in order to feel less restless and 
irritable.  
1. Not at all true 
2. Somewhat true 
3. Moderately true 
4. Very true 
5. Extremely true 
2. When you don’t smoke for a few hours, you start to crave cigarettes.  
1. Not at all true 
2. Somewhat true 
3. Moderately true 
4. Very true 
5. Extremely true 
3. You sometimes have strong cravings for a cigarette where it feels like you’re in the 
grip of a force you can’t control.  
1. Not at all true 
2. Somewhat true 
3. Moderately true 
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4. Very true 
5. Extremely true 
4. You feel a sense of control over your smoking — that is, you can “take it or leave it” 
at any time.  
1. Not at all true 
2. Somewhat true 
3. Moderately true 
4. Very true 
5. Extremely true 
5. You tend to avoid places that don’t allow smoking, even if you would otherwise enjoy 
them.  
1. Not at all true 
2. Somewhat true 
3. Moderately true 
4. Very true 
5. Extremely true 
6. Do you have any friends who do not smoke cigarettes? 
1. Yes 
2. No 
7. There are times when you choose not to be around your friends who don’t smoke 
because they won’t like it if you smoke. 
1. Not at all true 
2. Somewhat true 
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3. Moderately true 
4. Very true 
5. Extremely true 
8. Even if you are traveling a long distance, you would rather not travel by airplane 
because you would not be allowed to smoke. 
1. Not at all true 
2. Somewhat true 
3. Moderately true 
4. Very true 
5. Extremely true 
9. You sometimes worry that you will run out of cigarettes. 
1. Not at all true 
2. Somewhat true 
3. Moderately true 
4. Very true 
5. Extremely true 
10. You smoke cigarettes fairly regularly throughout the day. 
1. Not at all true 
2. Somewhat true 
3. Moderately true 
4. Very true 
5. Extremely true 
11. You smoke about the same amount on weekends as on weekdays. 
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1. Not at all true 
2. Somewhat true 
3. Moderately true 
4. Very true 
5. Extremely true 
12. You smoke just about the same number of cigarettes from day to day It’s hard for 
you to say how many cigarettes you smoke per day because the number often changes. 
1. Not at all true 
2. Somewhat true 
3. Moderately true 
4. Very true 
5. Extremely true 
13. It’s normal for you to smoke several cigarettes in an hour, then not have another 
one until hours later. 
1. Not at all true 
2. Somewhat true 
3. Moderately true 
4. Very true 
5. Extremely true 
14. The number of cigarettes you smoke per day is often influenced by other things–
how you are feeling, or what you are doing for example. 
1. Not at all true 
2. Somewhat true 
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3. Moderately true 
4. Very true 
5. Extremely true 
15. Your smoking is not affected much by other things. For example, you smoke about 
the same amount whether you’re relaxing or working, happy or sad, alone or with 
others. 
1. Not at all true 
2. Somewhat true 
3. Moderately true 
4. Very true 
5. Extremely true 
16. Since you started smoking, the amount you smoke has increased. 
1. Not at all true 
2. Somewhat true 
3. Moderately true 
4. Very true 
5. Extremely true 
17. Compared to when you first started smoking, you need to smoke a lot more now in 
order to be satisfied. 
1. Not at all true 
2. Somewhat true 
3. Moderately true 
4. Very true 
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5. Extremely true 
18. Compared to when you first started smoking, you can smoke much, much more now 
before you start to feel anything. 
1. Not at all true 
2. Somewhat true 
3. Moderately true 
4. Very true 
5. Extremely true 
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APPENDIX D 
NSDUH Alcohol and Other Substance Use 
ALCOHOL 
These questions are about drinks of alcoholic beverages. Throughout these questions, 
by a “drink,” we mean a can or bottle of beer, a glass of wine or a wine cooler, a shot of 
liquor, or a mixed drink with liquor in it. We are not asking about times when you only 
had a sip or two from a drink. 
 
Have you ever, even once, had a drink of any type of alcoholic beverage? Please do not 
include times when you only had a sip or two from a drink. 
1 Yes 
2 No 
How long has it been since you last drank an alcoholic beverage? 
1 Within the past 30 days — that is, since [DATEFILL] 
2 More than 30 days ago but within the past 12 months 
3 More than 12 months ago 
 
Now think about the past 12 months, from [DATEFILL] through today. We want to know 
how many days you’ve had a drink of an alcoholic beverage during the past 12 months. 
What would be the easiest way for you to tell us how many days you drank alcoholic 
beverages? 
1 Average number of days per week during the past 12 months 
2 Average number of days per month during the past 12 months 
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3 Total number of days during the past 12 months 
[IF PREVIOUS ITEM = 3 OR DK/REF] On how many days in the past 12 months did 
you drink an alcoholic beverage?  TOTAL # OF DAYS: ______ 
[IF PREVIOUS ITEM = 2 OR ALYRAVE = DK/REF] On average, how many days did 
you drink an alcoholic beverage each month during the past 12 months? AVG # OF 
DAYS PER MONTH: _____ 
[IF PREVIOUS ITEM = 1 OR ALMONAVE = DK/REF] On average, how many days did 
you drink an alcoholic beverage each week during the past 12 months? AVG # OF 
DAYS PER WEEK: _____ 
 
Think specifically about the past 30 days, from [DATEFILL], up to and including today. 
During the past 30 days, on how many days did you drink one or more drinks of an 
alcoholic beverage? # OF DAYS: _____ 
On the [#DAYS] days that you drank during the past 30 days, how many drinks did you 
usually have each day? Count as a drink a can or bottle of beer; a wine cooler or a 
glass of wine, champagne, or sherry; a shot of liquor or a mixed drink or cocktail. # OF 
DRINKS: _____ 
During the past 30 days, that is, since [DATEFILL], on how many days did you have 5 
or more drinks on the same occasion? By ‘occasion,’ we mean at the same time or 
within a couple of hours of each other. # OF DAYS: _____ 
Have you ever had 4 or more drinks on the same occasion? 
1 Yes 
2 No 
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During the past 30 days, that is, since [DATEFILL], on how many days did you have 4 
or more drinks on the same occasion? # OF DAYS: _____ 
 
MARIJUANA 
The next questions are about marijuana and hashish. Marijuana is also called pot or 
grass. Marijuana is usually smoked, either in cigarettes, called joints, or in a pipe. It is 
sometimes cooked in food. Hashish is a form of marijuana that is also called “hash.” It is 
usually smoked in a pipe. Another form of hashish is hash oil. 
Have you ever, even once, used marijuana or hashish? 
1 Yes 
2 No 
How long has it been since you last used marijuana or hashish? 
1 Within the past 30 days — that is, since [DATEFILL] 
2 More than 30 days ago but within the past 12 months 
3 More than 12 months ago 
 
[IF PREVIOUS ITEM = 1 - 2] Now think about the past 12 months, from [DATEFILL] 
through today. We want to know how many days you’ve used marijuana or hashish 
during the past 12 months. 
What would be the easiest way for you to tell us how many days you’ve used it? 
1 Average number of days per week during the past 12 months 
2 Average number of days per month during the past 12 months 
3 Total number of days during the past 12 months 
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[IF PREVIOUS ITEM = 3 OR DK/REF] On how many days in the past 12 months did 
you use marijuana or hashish? TOTAL # OF DAYS: _____ 
[IF PREVIOUS ITEM = 2] On average, how many days did you use marijuana or 
hashish each month during the past 12 months? AVERAGE # OF DAYS PER MONTH: 
_____ 
[IF PREVIOUS ITEM = 1] On average, how many days did you use marijuana or 
hashish each week during the past 12 months? AVERAGE # OF DAYS PER WEEK: 
_____ 
Think specifically about the past 30 days, from [DATEFILL] up to and including today. 
During the past 30 days, on how many days did you use marijuana or hashish? 
NUMBER OF DAYS: _____ 
 
COCAINE 
These questions are about cocaine, including all the different forms of cocaine such as 
powder, ‘crack,’ free base, and coca paste. 
Have you ever, even once, used any form of cocaine? 
1 Yes 
2 No 
How long has it been since you last used any form of cocaine? 
1 Within the past 30 days -- that is, since [DATEFILL] 
2 More than 30 days ago but within the past 12 months 
3 More than 12 months ago 
Now think about the past 12 months, from [DATEFILL] through today. We want to know 
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how many days you’ve used cocaine during the past 12 months. 
What would be the easiest way for you to tell us how many days you’ve used it? 
1 Average number of days per week during the past 12 months 
2 Average number of days per month during the past 12 months 
3 Total number of days during the past 12 months 
 
[IF PREVIOUS ITEM = 3] On how many days in the past 12 months did you use 
cocaine? TOTAL # OF DAYS: _____ 
[IF PREVIOUS ITEM = 2] On average, how many days did you use cocaine each month 
during the past 12 months? AVERAGE # OF DAYS PER MONTH: _____ 
[IF PREVIOUS ITEM = 1] On average, how many days did you use cocaine each week 
during the past 12 months? AVERAGE # OF DAYS PER WEEK: _____ 
Think specifically about the past 30 days, from [DATEFILL] up to and including today. 
During the past 30 days, on how many days did you use cocaine? # OF DAYS: _____ 
 
The next questions are about ‘crack’, that is cocaine in rock or chunk form, and not the 
other forms of cocaine. 
Have you ever, even once, used ‘crack’? 
1 Yes 
2 No 
How long has it been since you last used ‘crack’? 
1 Within the past 30 days -- that is, since [DATEFILL] 
2 More than 30 days ago but within the past 12 months 
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3 More than 12 months ago 
Now think about the past 12 months, from [DATEFILL] through today. We want to know 
how many days you’ve used ‘crack’ during the past 12 months. 
What would be the easiest way for you to tell us how many days you’ve used it? 
1 Average number of days per week during the past 12 months 
2 Average number of days per month during the past 12 months 
3 Total number of days during the past 12 months 
[IF PREVIOUS ITEM = 3] On how many days in the past 12 months did you use ‘crack’? 
TOTAL # OF DAYS: _____ 
[IF PREVIOUS ITEM = 2] On average, how many days did you use ‘crack’ each month 
during the past 12 months? AVERAGE # OF DAYS PER MONTH: _____ 
[IF PREVIOUS ITEM = 1] On average, how many days did you use ‘crack’ each week 
during the past 12 months? AVERAGE # OF DAYS PER WEEK: _____ 
Think specifically about the past 30 days, from [DATEFILL] up to and including today. 
During the past 30 days, on how many days did you use ‘crack’? # OF DAYS: _____ 
 
HEROIN 
These next questions are about heroin. 
Have you ever, even once, used heroin? 
1 Yes 
2 No 
How long has it been since you last used heroin? 
1 Within the past 30 days -- that is, since [DATEFILL] 
125 
 
2 More than 30 days ago but within the past 12 months 
3 More than 12 months ago 
Now think about the past 12 months, from [DATEFILL] through today. We want to know 
how many days you’ve used heroin during the past 12 months. 
What would be the easiest way for you to tell us how many days you’ve used it? 
1 Average number of days per week during the past 12 months 
2 Average number of days per month during the past 12 months 
3 Total number of days during the past 12 months 
[IF PREVIOUS ITEM = 3] On how many days in the past 12 months did you use heroin? 
TOTAL # OF DAYS: _____ 
[IF PREVIOUS ITEM = 2] On average, how many days did you use heroin each month 
during the past 12 months? AVERAGE # OF DAYS PER MONTH: _____ 
[IF PREVIOUS ITEM = 1] On average, how many days did you use heroin each week 
during the past 12 months? AVERAGE # OF DAYS PER WEEK: _____ 
Think specifically about the past 30 days, from [DATEFILL] up to and including today. 
During the past 30 days, on how many days did you use heroin? # OF DAYS: _____ 
 
HALLUCINOGENS 
The next questions are about substances called hallucinogens. These drugs often 
cause people to see or experience things that are not real. A list of some common 
hallucinogens is shown below. These and many other substances that people use as 
hallucinogens are often known by street names, and we can’t list them all. Please take a 
moment to look at the substances listed below so you know what kind of drugs the next 
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questions are about. 
LSD, also called ‘acid’ 
PCP, also called ‘angel dust’ or phencyclidine 
Peyote 
Mescaline 
Psilocybin 
‘Ecstasy’, also called MDMA 
Have you ever, even once, used LSD, also called “acid”? 
1 Yes 
2 No 
Have you ever, even once, used PCP, also called ‘angel dust’ or phencyclidine? 
1 Yes 
2 No 
Have you ever, even once, used peyote? 
1 Yes 
2 No 
Have you ever, even once, used mescaline? 
1 Yes 
2 No 
Have you ever, even once, used psilocybin, found in mushrooms? 
1 Yes 
2 No 
Have you ever, even once, used ‘Ecstasy’, also known as MDMA? 
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1 Yes 
2 No 
How long has it been since you last used [LSFILL]? 
1 Within the past 30 days -- that is, since [DATEFILL] 
2 More than 30 days ago but within the past 12 months 
3 More than 12 months ago 
Now think about the past 12 months, from [DATEFILL] through today. We want to know 
how many days you’ve used [LSFILL] during the past 12 months. 
What would be the easiest way for you to tell us how many days you’ve used it? 
1 Average number of days per week during the past 12 months 
2 Average number of days per month during the past 12 months 
3 Total number of days during the past 12 months 
[IF PREVIOUS ITEM = 3] On how many days in the past 12 months did you use 
[LSFILL]? TOTAL # OF DAYS: _____ 
[IF PREVIOUS ITEM = 2] On average, how many days did you use [LSFILL] each 
month during the past 12 months? AVERAGE # OF DAYS PER MONTH: _____ 
[IF PREVIOUS ITEM = 1] On average, how many days did you use [LSFILL] each week 
during the past 12 months? AVERAGE # OF DAYS PER WEEK: _____ 
Think specifically about the past 30 days, from [DATEFILL] up to and including today. 
During the past 30 days, on how many days did you use [LSFILL]? NUMBER OF 
DAYS: _____ 
 
INHALANTS 
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These next questions are about liquids, sprays, and gases that people sniff or inhale to 
get high or to make them feel good. We are not interested in times when you inhaled a 
substance accidentally — such as when painting, cleaning an oven, or filling a car with 
gasoline. The questions use the word ‘inhalant’ to include all the things listed below, as 
well as any other substances that people sniff or inhale for kicks or to get high. Take a 
moment to look at the substances listed below so you know what kinds of liquids, 
sprays, and gases these questions are about. 
Amyl nitrite, ‘poppers,’ locker room odorizers, or ‘rush’ 
Correction fluid, degreaser, or cleaning fluid 
Gasoline or lighter fluid 
Glue, shoe polish, or toluene 
Halothane, ether, or other anesthetics 
Lacquer thinner, or other paint solvents 
Lighter gases, such as butane or propane 
Nitrous oxide or ‘whippits’ 
Spray paints 
Other aerosol sprays 
Have you ever, even once, inhaled amyl nitrite, ‘poppers,’ locker room odorizers, or 
‘rush’ for kicks or to get high? 
1 Yes 
2 No 
Have you ever, even once, inhaled correction fluid, degreaser, or cleaning fluid for kicks 
or to get high? 
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1 Yes 
2 No 
Have you ever, even once, inhaled gasoline or lighter fluid for kicks or to get high? 
1 Yes 
2 No 
Have you ever, even once, inhaled glue, shoe polish, or toluene for kicks or to get high? 
1 Yes 
2 No 
Have you ever, even once, inhaled halothane, ether, or other anesthetics for kicks or to 
get high? 
1 Yes 
2 No 
Have you ever, even once, inhaled lacquer thinner or other paint solvents for kicks or to 
get high? 
1 Yes 
2 No 
Have you ever, even once, inhaled lighter gases, such as butane or propane for kicks or 
to get high? 
1 Yes 
2 No 
Have you ever, even once, inhaled nitrous oxide or ‘whippits’ for kicks or to get high? 
1 Yes 
2 No 
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Have you ever, even once, inhaled spray paints for kicks or to get high? 
1 Yes 
2 No 
Have you ever, even once, inhaled some other aerosol spray for kicks or to get high? 
1 Yes 
2 No 
How long has it been since you last used any inhalant for kicks or to get high? 
1 Within the past 30 days – that is, since [DATEFILL] 
2 More than 30 days ago but with the past 12 months 
3 More than 12 months ago 
Now think about the past 12 months, from [DATEFILL] through today. We want to know 
how many days you’ve used an inhalant of any kind for kicks or to get high during the 
past 12 months. 
What would be the easiest way for you to tell us how many days you’ve done this? 
1 Average number of days per week during the past 12 months 
2 Average number of days per month during the past 12 months 
3 Total number of days during the past 12 months 
[IF PREVIOUS ITEM = 3] On how many days in the past 12 months did you use an 
inhalant of any kind for kicks or to get high? TOTAL # OF DAYS: _____ 
[IF PREVIOUS ITEM = 2] On average, how many days did you use an inhalant of any 
kind for kicks or to get high each month during the past 12 months? 
AVERAGE # OF DAYS PER MONTH: _____ 
[IF PREVIOUS ITEM = 1] On average, how many days did you use an inhalant of any 
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kind for kicks or to get high each week during the past 12 months? AVERAGE # OF 
DAYS PER WEEK: _____ 
Think specifically about the past 30 days, from [DATEFILL] up to and including today. 
During the past 30 days, on how many days did you use any inhalant for kicks or to get 
high? NUMBER OF DAYS: _____ 
 
PAIN RELIEVERS 
These questions are about the use of pain relievers. We are not interested in your use 
of “over-the-counter” pain relievers such as aspirin, Tylenol, or Advil that can be bought 
in drug stores or grocery stores without a doctor’s prescription. Card A shows pictures 
of some different kinds of prescription pain relievers and lists the names of some others. 
These pictures show only pills, but we are interested in your use of any form of 
prescription pain relievers that were not prescribed for you or that you took only for the 
experience or feeling they caused. 
Have you ever, even once, used any of these pain relievers when they were not 
prescribed for you or that you took only for the experience or feeling they caused? 
1 Yes 
2 No 
How long has it been since you last used any prescription pain reliever that was not 
prescribed for you or that you took only for the experience or feeling it caused? 
1 Within the past 30 days — that is, since [DATEFILL] 
2 More than 30 days ago but within the past 12 months 
3 More than 12 months ago 
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Now think about the past 12 months, from [DATEFILL] through today. We want to know 
how many days you’ve used any prescription pain reliever that was not prescribed for 
you or that you took only for the experience or feeling it caused during the past 12 
months. 
What would be the easiest way for you to tell us how many days you used a prescription 
pain reliever in either of these ways? 
1 Average number of days per week during the past 12 months 
2 Average number of days per month during the past 12 months 
3 Total number of days during the past 12 months 
[IF PREVIOUS ITEM = 3] On how many days in the past 12 months did you use any 
prescription pain reliever that was not prescribed for you or that you took only for the 
experience or feeling it caused? TOTAL # OF DAYS: _____ 
[IF PREVIOUS ITEM = 2] On average, how many days each month during the past 12 
months did you use any prescription pain reliever that was not prescribed for you or that 
you took only for the experience or feeling it caused? AVG # OF DAYS PER MONTH: 
_____ 
[IF PREVIOUS ITEM = 1] On average, how many days each week during the past 12 
months did you use any prescription pain reliever that was not prescribed for you or that 
you took only for the experience or feeling it caused? AVG # OF DAYS PER WEEK: 
_____ 
 
TRANQUILIZERS 
These next questions ask about the use of tranquilizers. Tranquilizers are usually 
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prescribed to relax people, to calm people down, to relieve anxiety, or to relax muscle 
spasms. Some people call tranquilizers ‘nerve pills.’ Card B shows pictures of some 
different kinds of prescription tranquilizers. These pictures show only pills, but we are 
interested in your use of any form of prescription tranquilizers that were not prescribed 
for you or that you took only for the experience or feeling they caused. 
Have you ever, even once, used any of these tranquilizers when they were not 
prescribed for you or that you took only for the experience or feeling they caused? 
1 Yes 
2 No 
How long has it been since you last used any prescription tranquilizer that was not 
prescribed for you or that you took only for the experience or feeling it caused? 
1 Within the past 30 days — that is, since [DATEFILL] 
2 More than 30 days ago but within the past 12 months 
3 More than 12 months ago 
Now think about the past 12 months, from [DATEFILL] through today. We want to know 
how many days you’ve used any prescription tranquilizer that was not prescribed for 
you or that you took only for the experience or feeling it caused during the past 12 
months. 
What would be the easiest way for you to tell us how many days you used a prescription 
tranquilizer in either of these ways? 
1 Average number of days per week during the past 12 months 
2 Average number of days per month during the past 12 months 
3 Total number of days during the past 12 months 
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[IF PREVIOUS ITEM = 3] On how many days in the past 12 months did you use any 
prescription tranquilizer that was not prescribed for you or that you took only for the 
experience or feeling it caused? TOTAL # OF DAYS: _____ 
 [IF PREVIOUS ITEM = 2] On average, how many days each month during the past 12 
months did you use any prescription tranquilizer that was not prescribed for you or that 
you took only for the experience or feeling it caused? AVG # OF DAYS PER MONTH: 
_____ 
[IF PREVIOUS ITEM = 1] On average, how many days each week during the past 12 
months did you use any prescription tranquilizer that was not prescribed for you or that 
you took only for the experience or feeling it caused? AVG # OF DAYS PER WEEK: 
_____ 
 
STIMULANTS 
These next questions ask about the use of drugs such as amphetamines that are known 
as stimulants, ‘uppers,’ or ‘speed.’ People sometimes take these drugs to lose weight, 
to stay awake, or for attention deficit disorders. We are not interested in the use of 
“over-the-counter” stimulants such as Dexatrim or No-Doz that can be bought in drug 
stores or grocery stores without a doctor’s prescription. Card C shows pictures of some 
different kinds of prescription stimulants and lists the names of some others. These 
pictures show only pills, but we are interested in your use of any form of prescription 
stimulants that were not prescribed for you or that you took only for the experience or 
feeling they caused. 
Have you ever, even once, used any of these stimulants when they were not prescribed 
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for you or that you took only for the experience or feeling they caused? 
1 Yes 
2 No 
How long has it been since you last used any prescription stimulant that was not 
prescribed for you or that you took only for the experience or feeling it caused? 
1 Within the past 30 days — that is, since [DATEFILL] 
2 More than 30 days ago but within the past 12 months 
3 More than 12 months ago 
Now think about the past 12 months, from [DATEFILL] through today. We want to know 
how many days you’ve used any prescription stimulant that was not prescribed for you 
or that you took only for the experience or feeling it caused during the past 12 months. 
What would be the easiest way for you to tell us how many days you used a prescription 
stimulant in either of these ways? 
1 Average number of days per week during the past 12 months 
2 Average number of days per month during the past 12 months 
3 Total number of days during the past 12 months 
[IF PREVIOUS ITEM = 3] On how many days in the past 12 months did you use any 
prescription stimulant that was not prescribed for you or that you took only for the 
experience or feeling it caused? TOTAL # OF DAYS: _____ 
 [IF PREVIOUS ITEM = 2] On average, how many days each month during the past 12 
months did you use any prescription stimulant that was not prescribed for you or that 
you took only for the experience or feeling it caused? AVG # OF DAYS PER MONTH: 
_____ 
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[IF PREVIOUS ITEM = 1] On average, how many days each week during the past 12 
months did you use any prescription stimulant that was not prescribed for you or that 
you took only for the experience or feeling it caused? AVG # OF DAYS PER WEEK: 
_____ 
 
SEDATIVES 
These next questions ask about the use of sedatives or barbiturates. These drugs are 
also called “downers” or “sleeping pills.” People take these drugs to help them relax or 
to help them sleep. We are not interested in the use of “over-the-counter” sedatives 
such as Sominex, Unisom, Nytol, or Benadryl that can be bought in drug stores or 
grocery stores without a doctor’s prescription. Card D shows pictures of some different 
kinds of prescription sedatives and lists the names of some others. These pictures show 
only pills, but we are interested in your use of any prescription sedatives that were not 
prescribed for you, or that you took only for the experience or feeling they caused. 
 
Have you ever, even once, used any of these sedatives when they were not prescribed 
for you or that you took only for the experience or feeling they caused? 
1 Yes 
2 No 
How long has it been since you last used any prescription sedative that was not 
prescribed for you or that you took only for the experience or feeling it caused? 
1 Within the past 30 days — that is, since [DATEFILL] 
2 More than 30 days ago but within the past 12 months 
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3 More than 12 months ago 
Now think about the past 12 months, from [DATEFILL] through today. We want to know 
how many days you’ve used any prescription sedative that was not prescribed for you 
or that you took only for the experience or feeling it caused during the past 12 months. 
What would be the easiest way for you to tell us how many days you used a prescription 
sedative in either of these ways? 
1 Average number of days per week during the past 12 months 
2 Average number of days per month during the past 12 months 
3 Total number of days during the past 12 months 
[IF PREVIOUS ITEM = 3] On how many days in the past 12 months did you use any 
prescription sedative that was not prescribed for you or that you took only for the 
experience or feeling it caused? TOTAL # OF DAYS: _____ 
 [IF PREVIOUS ITEM = 2] On average, how many days each month during the past 12 
months did you use any prescription sedative that was not prescribed for you or that you 
took only for the experience or feeling it caused? AVG # OF DAYS PER MONTH: 
_____ 
[IF PREVIOUS ITEM = 1] On average, how many days each week during the past 12 
months did you use any prescription sedative that was not prescribed for you or that you 
took only for the experience or feeling it caused? AVG # OF DAYS PER WEEK: _____ 
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APPENDIX E 
NSDUH Risk Section 
How often do you get a real kick out of doing things that are a little dangerous? 
1 Never 
2 Seldom 
3 Sometimes 
4 Always 
How often do you like to test yourself by doing something a little risky? 
1 Never 
2 Seldom 
3 Sometimes 
4 Always 
How often do you wear a seatbelt when you ride in the front passenger seat of a car? 
1 Never 
2 Seldom 
3 Sometimes 
4 Always 
How often do you wear a seatbelt when you drive a car? 
1 Never 
2 Seldom 
3 Sometimes 
4 Always 
5 I don’t drive 
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APPENDIX F 
NSDUH Substance Dependence and Abuse 
Think about your use of alcohol during the past 12 months as you answer these next 
questions. During the past 12 months, was there a month or more when you spent a lot 
of your time getting or drinking alcohol? 
1 Yes 
2 No 
During the past 12 months, was there a month or more when you spent a lot of time 
getting over the effects of the alcohol you drank? 
1 Yes 
2 No 
During the past 12 months, did you try to set limits on how often or how much alcohol 
you would drink? 
1 Yes 
2 No 
Were you able to keep to the limits you set, or did you often drink more than you 
intended to? 
1 Usually kept to the limits set 
2 Often drank more than intended 
During the past 12 months, did you need to drink more alcohol than you used to in order 
to get the effect you wanted? 
1 Yes 
2 No 
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During the past 12 months, did you notice that drinking the same amount of alcohol had 
less effect on you than it used to? 
1 Yes 
2 No 
During the past 12 months, did you want to or try to cut down or stop drinking alcohol? 
1 Yes 
2 No 
[IF PREVIOUS ITEM = 1] During the past 12 months, were you able to cut down or stop 
drinking alcohol every time you wanted to or tried to? 
1 Yes 
2 No 
[IF EITHER OF THE PREVIOUS TWO ITEMS = 2] During the past 12 months, did you 
cut down or stop drinking at least one time? 
1 Yes 
2 No 
Please look at the symptoms listed below. During the past 12 months, did you have 2 or 
more of these symptoms after you cut back or stopped drinking alcohol? 
• Sweating or feeling that your heart was beating fast 
• Having your hands tremble 
• Having trouble sleeping 
• Vomiting or feeling nauseous 
• Seeing, hearing, or feeling things that weren’t really there 
• Feeling like you couldn’t sit still 
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• Feeling anxious 
• Having seizures or fits 
1 Yes 
2 No 
Please look at the symptoms listed below. During the past 12 months, did you have 2 or 
more of these symptoms at the same time that lasted for longer than a day after you cut 
back or stopped drinking alcohol? 
• Sweating or feeling that your heart was beating fast 
• Having your hands tremble 
• Having trouble sleeping 
• Vomiting or feeling nauseous 
• Seeing, hearing, or feeling things that weren’t really there 
• Feeling like you couldn’t sit still 
• Feeling anxious 
• Having seizures or fits 
1 Yes 
2 No 
During the past 12 months, did you have any problems with your emotions, nerves, or 
mental health that were probably caused or made worse by drinking alcohol? 
1 Yes 
2 No 
[IF PREVIOUS ITEM = 1] Did you continue to drink alcohol even though you thought 
drinking was causing you to have problems with your emotions, nerves, or mental 
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health? 
1 Yes 
2 No 
[IF EITHER OF THE PREVIOUS TWO ITEMS= 2] During the past 12 months, did you 
have any physical health problems that were probably caused or made worse by 
drinking alcohol? 
1 Yes 
2 No 
[IF PREVIOUS ITEM = 1] Did you continue to drink alcohol even though you thought 
drinking was causing you to have physical problems? 
1 Yes 
2 No 
This question is about important activities such as working, going to school, taking care 
of children, doing fun things such as hobbies and sports, and spending time with friends 
and family. During the past 12 months, did drinking alcohol cause you to give up or 
spend less time doing these types of important activities? 
1 Yes 
2 No 
Sometimes people who drink alcohol have serious problems at home, work or school — 
such as: 
• neglecting their children 
• missing work or school 
• doing a poor job at work or school 
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• losing a job or dropping out of school 
During the past 12 months, did drinking alcohol cause you to have serious problems like 
this either at home, work, or school? 
1 Yes 
2 No 
During the past 12 months, did you regularly drink alcohol and then do something where 
being drunk might have put you in physical danger? 
1 Yes 
2 No 
During the past 12 months, did drinking alcohol cause you to do things that repeatedly 
got you in trouble with the law? 
1 Yes 
2 No 
During the past 12 months, did you have any problems with family or friends that were 
probably caused by your drinking? 
1 Yes 
2 No 
[IF PREVIOUS ITEM = 1] Did you continue to drink alcohol even though you thought 
your drinking caused problems with family or friends? 
1 Yes 
2 No 
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For each of the drugs of abuse below that respondents endorsed using in the past 12 
months, respondents are asked the following:  
• Marijuana or hashish 
• Cocaine or crack 
• Heroin 
• Hallucinogens 
• Inhalants 
• Prescription pain relievers 
• Prescription tranquilizers 
• Prescription stimulants 
• Prescription sedatives 
Think about your use of _______ during the past 12 months as you answer these next 
questions. During the past 12 months, was there a month or more when you spent a lot 
of your time getting or using _______? 
1 Yes 
2 No 
[IF PREVIOUS ITEM = 2] During the past 12 months, was there a month or more when 
you spent a lot of your time getting over the effects of the _______ you used? 
1 Yes 
2 No 
During the past 12 months, did you try to set limits on how often or how much _______ 
you would use? 
1 Yes 
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2 No 
[IF PREVIOUS ITEM = 1] Were you able to keep to the limits you set, or did you often 
use _______ more than you intended to? 
1 Usually kept to the limits set 
2 Often used more than intended 
During the past 12 months, did you need to use more _______ than you used to in 
order to get the effect you wanted? 
1 Yes 
2 No 
[IF PREVIOUS ITEM =2] During the past 12 months, did you notice that using the same 
amount of _______ had less effect on you than it used to? 
1 Yes 
2 No 
During the past 12 months, did you want to or try to cut down or stop using _______? 
1 Yes 
2 No 
[IF PREVIOUS ITEM = 1] During the past 12 months, were you able to cut down or stop 
using _______ every time you wanted to or tried to? 
1 Yes 
2 No 
During the past 12 months, did you have any problems with your emotions, nerves, or 
mental health that were probably caused or made worse by your use of _______? 
1 Yes 
146 
 
2 No 
[IF PREVIOUS ITEM = 1] Did you continue to use _______ even though you thought it 
was causing you to have problems with your emotions, nerves, or mental health? 
1 Yes 
2 No 
[IF EITHER OF THE PREVIOUS 2 ITEMS = 2] During the past 12 months, did you have 
any physical health problems that were probably caused or made worse by your use of 
_______? 
1 Yes 
2 No 
[IF PREVIOUS ITEM = 1] Did you continue to use _______ even though you thought it 
was causing you to have physical problems? 
1 Yes 
2 No 
This question is about important activities such as working, going to school, taking care 
of children, doing fun things such as hobbies and sports, and spending time with friends 
and family. During the past 12 months, did using _______ cause you to give up or 
spend less time doing these types of important activities? 
1 Yes 
2 No 
Sometimes people who use _______ have serious problems at home, work or school — 
such as: 
• neglecting their children 
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• missing work or school 
• doing a poor job at work or school 
• losing a job or dropping out of school 
During the past 12 months, did using _______ cause you to have serious problems like 
this either at home, work, or school? 
1 Yes 
2 No 
During the past 12 months, did you regularly use _______ and then do something 
where using marijuana or hashish might have put you in physical danger? 
1 Yes 
2 No 
During the past 12 months, did using _______ cause you to do things that repeatedly 
got you in trouble with the law? 
1 Yes 
2 No 
During the past 12 months, did you have any problems with family or friends that were 
probably caused by your use of _______? 
1 Yes 
2 No 
Did you continue to use _______ even though you thought it caused problems with 
family or friends? 
1 Yes 
2 No 
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APPENDIX G 
NSDUH Special Topics 
The next questions are about encounters with the police or the court system. 
 
Not counting minor traffic violations, have you ever been arrested and booked for 
breaking the law? Being ‘booked’ means that you were taken into custody and 
processed by the police or by someone connected with the courts, even if you were 
then released. 
1 Yes 
2 No 
Not counting minor traffic violations, how many times during the past 12 months have 
you been arrested and booked for breaking a law? _____ 
 
In the past 12 months, were you arrested and booked for driving under the influence of 
alcohol or drugs? 
1 Yes 
2 No 
Were you on probation at any time during the past 12 months? 
1 Yes 
2 No 
Were you on parole, supervised release, or other conditional release from prison at any 
time during the past 12 months? 
1 Yes 
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2 No 
During the past 12 months, have you driven a vehicle while you were under the 
influence of a combination of alcohol and illegal drugs used together? 
1 Yes 
2 No 
During the past 12 months, have you driven a vehicle while you were under the 
influence of alcohol? 
1 Yes 
2 No 
During the past 12 months, have you driven a vehicle while you were under the 
influence of illegal drugs? 
1 Yes 
2 No 
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APPENDIX H 
K6 (Furukawa, Kessler, Slade, & Andrews, 2003; Kessler et al., 2003) 
During the past 30 days, about how often did you feel nervous? 
1 All of the time 
2 Most of the time 
3 Some of the time 
4 A little of the time 
5 None of the time 
During the past 30 days, about how often did you feel hopeless? 
1 All of the time 
2 Most of the time 
3 Some of the time 
4 A little of the time 
5 None of the time 
During the past 30 days, about how often did you feel restless or fidgety? 
1 All of the time 
2 Most of the time 
3 Some of the time 
4 A little of the time 
5 None of the time 
During the past 30 days, about how often did you feel so sad or depressed that nothing 
could cheer you up? 
1 All of the time 
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2 Most of the time 
3 Some of the time 
4 A little of the time 
5 None of the time 
During the past 30 days, about how often did you feel that everything was an effort? 
1 All of the time 
2 Most of the time 
3 Some of the time 
4 A little of the time 
5 None of the time 
During the past 30 days, about how often did you feel down on yourself, no good or 
worthless? 
1 All of the time 
2 Most of the time 
3 Some of the time 
4 A little of the time 
5 None of the time 
The last questions asked about how you have been feeling during the past 30 days. 
Now think about the past 12 months. Was there a month in the past 12 months when 
you felt more depressed, anxious, or emotionally stressed than you felt in the past 30 
days? 
1 Yes 
2 No 
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[IF YES TO PREVIOUS ITEM] Think of one month in the past 12 months when you 
were the most depressed, anxious, or emotionally stressed. During that month, how 
often did you feel nervous? 
1 All of the time 
2 Most of the time 
3 Some of the time 
4 A little of the time 
5 None of the time 
During that same month when you were at your worst emotionally, how often did you 
feel hopeless? 
1 All of the time 
2 Most of the time 
3 Some of the time 
4 A little of the time 
5 None of the time 
During that same month when you were at your worst emotionally, how often did you 
feel restless or fidgety? 
1 All of the time 
2 Most of the time 
3 Some of the time 
4 A little of the time 
5 None of the time 
During that same month when you were at your worst emotionally, how often did you 
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feel so sad or depressed that nothing could cheer you up? 
1 All of the time 
2 Most of the time 
3 Some of the time 
4 A little of the time 
5 None of the time 
During that same month when you were at your worst emotionally, how often did you 
feel that everything was an effort? 
1 All of the time 
2 Most of the time 
3 Some of the time 
4 A little of the time 
5 None of the time 
During that same month when you were at your worst emotionally, how often did you 
feel down on yourself, no good, or worthless? 
1 All of the time 
2 Most of the time 
3 Some of the time 
4 A little of the time 
5 None of the time 
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APPENDIX I 
NSDUH Anxiety and Depression 
Which, if any, of these conditions did a doctor or other medical professional tell you that 
you had in the past 12 months? 
1 Anxiety disorder 
2 Asthma 
3 Bronchitis 
4 Cirrhosis of the liver 
5 Depression 
6 Diabetes 
7 Heart disease 
8 Hepatitis 
9 High blood pressure 
10 HIV/AIDS 
11 Lung cancer 
12 Pancreatitis 
13 Pneumonia 
14 Sexually transmitted disease, such as chlamydia, gonorrhea, herpes or 
syphilis 
15 Sinusitis 
16 Sleep apnea 
17 Stroke 
18 Tinnitus 
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19 Tuberculosis 
20 Ulcer or ulcers 
95 None of the above - I have not had any of these conditions in the past 12 
months 
 
ADULT DEPRESSION 
[Questions administered only to respondents 18 years of age and older] 
ASC21 Have you ever in your life had a period of time lasting several days or longer 
when most of the day you felt sad, empty or depressed? 
1 Yes 
2 No 
ASC22 [IF ASC21 = 2] Have you ever had a period of time lasting several days or 
longer when most of the day you were very discouraged about how things were going in 
your life? 
1 Yes 
2 No 
ASC23 [IF ASC22 = 2] Have you ever had a period of time lasting several days or 
longer when you lost interest in most things you usually enjoy like work, hobbies, and 
personal relationships? 
1 Yes 
2 No 
AD01 [IF ASC21 =1] During times when you felt sad, empty, or depressed most of the 
day, did you ever feel discouraged about how things were going in your life? 
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1 Yes 
2 No 
AD01a [IF AD01 = 1] During the times when you felt sad, empty, or depressed, did you 
ever lose interest in most things like work, hobbies, and other things you usually enjoy? 
1 Yes 
2 No 
AD01b [IF AD01 = 2] During the times when you felt sad, empty, or depressed, did you 
ever lose interest in most things like work, hobbies, and other things you usually enjoy? 
1 Yes 
2 No 
AD02 [IF ASC22 = 1] During times when you felt discouraged about how things were 
going in your life, did you ever lose interest in most things like work, hobbies, and other 
things you usually enjoy? 
1 Yes 
2 No 
AD09 [IF ASC23= 1] Did you ever have a period of time like this that lasted most of the 
day nearly every day for two weeks or longer? 
1 Yes 
2 No 
DEFINE FEELFILL: 
IF (AD01a = 1), THEN FEELFILL = “were sad, discouraged, or lost interest in most 
things” 
IF (AD01a = 2), THEN FEELFILL = “were sad or discouraged” 
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IF (AD01b = 1), THEN FEELFILL = “were sad or lost interest in most things” 
IF (AD02 = 1), THEN FEELFILL = “were discouraged or lost interest in most things” 
IF (AD02 = 2 OR DK/REF), THEN FEELFILL = “were discouraged about the way things 
were going in your life” 
IF (AD09 = 1), THEN FEELFILL = “lost interest in most things” 
ELSE, FEELFILL = BLANK 
DEFINE FEELNOUN: 
IF (AD01a = 1), THEN FEELNOUN = “sadness, discouragement, or lack of interest” 
IF (AD01a = 2 OR DK/REF), THEN FEELNOUN = “sadness or discouragement” 
IF (AD01b = 1), THEN FEELNOUN = “sadness or lack of interest” 
IF (AD01b = 2 OR DK/REF), THEN FEELNOUN = “sadness” 
IF (AD02 = 1), THEN FEELNOUN = “discouragement or lack of interest” 
IF (AD02 = 2 OR DK/REF), THEN FEELNOUN = “discouragement” 
IF (AD09 = 1), THEN FEELNOUN = “lack of interest in most things” 
ELSE FEELNOUN = BLANK 
DEFINE NUMPROBS 
IF AD01a NE BLANK OR AD01b = 1 OR AD02 = 1, THEN NUMPROBS = “these 
problems” 
IF AD01b = (2 OR DK/REF) OR AD02 = (2 OR DK/REF) OR AD09 = 1, THEN 
NUMPROBS = “this problem” 
ELSE NUMPROBS = BLANK 
DEFINE WASWERE: 
IF AD01a NE BLANK OR AD01b = 1 OR AD02 = 1, THEN WASWERE = “were” 
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IF AD01b = (2 OR DK/REF) OR AD02 = (2 OR DK/REF) OR AD09 = 1, THEN 
WASWERE = “was” 
ELSE WASWERE = BLANK 
 
AD12 [IF AD01a NE BLANK OR AD01b NE BLANK OR AD02 NE BLANK] Think about 
the times when you [FEELFILL]. Did you ever have a period of time like this that lasted 
most of the day, nearly every day, for two weeks or longer? 
1 Yes 
2 No 
AD16 [IF AD09 = 1 OR AD12 = 1] Think of times lasting two weeks or longer when 
[NUMPROBS] with your mood [WASWERE] most severe and frequent. During those 
times, how long did your [FEELNOUN] usually last? 
1 Less than 1 hour 
2 At least 1 hour but no more than 3 hours 
3 At least 3 hours but no more than 5 hours 
4 5 hours or more 
AD17 [IF AD16 = 2, 3, OR 4] Still thinking of times lasting two weeks or longer when 
[NUMPROBS] with your mood [WASWERE] most severe and frequent, how severe was 
your emotional distress during those times? 
1 Mild 
2 Moderate 
3 Severe 
4 Very severe 
159 
 
AD18 [IF AD16 = 2, 3, OR 4] Again, think of times lasting two weeks or longer when 
[NUMPROBS] with your mood [WASWERE] most severe and frequent. 
How often, during those times, was your emotional distress so severe that nothing could 
cheer you up? 
1 Often 
2 Sometimes 
3 Rarely 
4 Never 
AD19 [IF AD16 = 2, 3, OR 4] Once again, please think of times lasting two weeks or 
longer when [NUMPROBS] with your mood [WASWERE] most severe and frequent. 
How often, during those times, was your emotional distress so severe that you could not 
carry out your daily activities? 
1 Often 
2 Sometimes 
3 Rarely 
4 Never 
AD21 [IF AD16 = (2, 3, OR 4) AND NOT (AD17 = 1 AND AD18 = 4 AND AD19 = 4) 
AND (ASC21=1 OR ASC22=1 OR ASC23=1) AND AD09 NE (2) People who have 
problems with their mood often have other problems at the same time. These problems 
may include things like changes in: 
• sleep 
• appetite 
• energy 
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• the ability to concentrate and remember 
• feelings of low self-worth 
Did you ever have any of these problems during a period of time when you [FEELFILL] 
for two weeks or longer? 
1 Yes 
2 No 
AD22 [IF AD21 = 1] Think again about these other problems we just mentioned. They 
include things like changes in 
• sleep 
• appetite 
• energy 
• the ability to concentrate and remember 
• feelings of low self-worth 
Please think of a time when you [FEELFILL] for two weeks or longer and you also had 
the largest number of these other problems at the same time. Is there one particular 
time like this that stands out in your mind as the worst one you ever had? 
1 Yes 
2 No 
AD22c [IF AD22 = 2 OR DK/REF] Then think of the most recent time when you 
[FEELFILL] for two weeks or longer and you also had the largest number of these other 
problems at the same time.  
 
DEFINE TIMEFILL: 
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IF AD22a NE BLANK, THEN TIMEFILL = ‘worst’ 
IF AD22c NE BLANK, THEN TIMEFILL = ‘most recent’ 
AD24a [IF AD22a NE BLANK] In answering the next questions, think about the period of 
time when your [FEELNOUN] and other problems were the worst. 
[IF AD22c NE BLANK] In answering the next questions, think about the most recent 
period of time when you [FEELFILL] and had other problems at the same time. 
During that time, did you feel sad, empty, or depressed most of the day nearly every 
day? 
1 Yes 
2 No 
AD24c [IF AD22a NE BLANK OR AD22c NE BLANK] During that [TIMEFILL] period of 
time, did you feel discouraged about how things were going in your life most of the day 
nearly every day? 
1 Yes 
2 No 
AD24e [IF AD22a NE BLANK OR AD22c NE BLANK] During that [TIMEFILL] period of 
time, did you lose interest in almost all things like work and hobbies and things you like 
to do for fun? 
1 Yes 
2 No 
AD24f [IF AD22a NE BLANK OR AD22c NE BLANK] During that [TIMEFILL] period of 
time, did you lose the ability to take pleasure in having good things happen to you, like 
winning something or being praised or complimented? 
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1 Yes 
2 No 
AD26a [IF ANY AD24a – AD24f = 1] The next questions are about changes in appetite 
and weight. 
[IF AD22a NE BLANK] In answering the next questions, think about the period of time 
when your [FEELNOUN] and other problems were the worst. 
[IF AD22c NE BLANK] In answering the next questions, think about the most recent 
period of time when you [FEELFILL] and had other problems at the same time. 
Did you have a much smaller appetite than usual nearly every day during that time? 
1 Yes 
2 No 
AD26b [IF AD26a = 2] Did you have a much larger appetite than usual nearly every 
day? 
1 Yes 
2 No 
AD26c [IF AD26a = 2] Did you gain weight without trying to during that [TIMEFILL] 
period of time? 
1 Yes 
2 No 
AD26c1 [IF AD26c = 1 AND (AD22a ≤ 21 OR AD22c ≤ 21)] Did you gain weight without 
trying to because you were growing? 
1 Yes 
2 No 
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AD26c2 [IF AD26c = 1 AND AD26c1 NE YES AND QD01 = 9] Did you gain weight 
without trying to because you were pregnant? 
1 Yes 
2 No 
AD26d [IF AD26c = 1 AND AD26c1 NE YES AND AD26c2 NE YES] How many pounds 
did you gain? Please enter your answer as a whole number. # OF 
POUNDS:__________  
AD26e [IF (AD26a = 1 OR AD26c=(2 OR DK/REF)] Did you lose weight without trying 
to? 
1 Yes 
2 No 
AD26e1 [IF AD26e = 1] Did you lose weight without trying to because you were sick or 
on a diet? 
1 Yes 
2 No 
AD26f [IF AD26e1 = 2 OR DK/REF] How many pounds did you lose? Please enter your 
answer as a whole number. # OF POUNDS:__________  
AD26g [IF AD26a NE BLANK] 
[IF AD22a NE BLANK] Again, please think about the period of time when your 
[FEELNOUN] and other problems were the worst. 
[IF AD22c NE BLANK] Again, please think about the most recent period of time when 
you [FEELFILL] and had other problems at the same time. 
Did you have a lot more trouble than usual falling asleep, staying asleep, or waking too 
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early nearly every night during that [TIMEFILL] period of time? 
1 Yes 
2 No 
AD26h [IF AD26g = 2 OR DK/REF] During that [TIMEFILL] period of time, did you sleep 
a lot more than usual nearly every night? 
1 Yes 
2 No 
AD26j [IF AD26a NE BLANK] During that [TIMEFILL] period of time, did you feel tired or 
low in energy nearly every day, even when you had not been working very hard? 
1 Yes 
2 No 
AD26l [IF AD26a NE BLANK] Did you talk or move more slowly than is normal for you 
nearly every day? 
1 Yes 
2 No 
AD26m [IF AD26l = 1] Did anyone else notice that you were talking or moving slowly? 
1 Yes 
2 No 
AD26n [IF AD26l = 2 OR DK/REF] Were you so restless or jittery nearly every day that 
you paced up and down or couldn't sit still? 
1 Yes 
2 No 
AD26o [AD26n = 1] Did anyone else notice that you were restless? 
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1 Yes 
2 No 
AD26p [IF AD26a NE BLANK] The next questions are about changes in your ability to 
concentrate, and your feelings about yourself. 
[IF AD22a NE BLANK] Again, in answering these questions, think about the period of 
time when your [FEELNOUN] and other problems were the worst. 
[IF AD22c NE BLANK] Again, in answering these questions, think about the most recent 
period of time when you [FEELFILL] and had other problems at the same time. 
During that [TIMEFILL] time, did your thoughts come much more slowly than usual or 
seem confused nearly every day? 
1 Yes 
2 No 
AD26r [IF AD26a NE BLANK] Did you have a lot more trouble concentrating than usual 
nearly every day? 
1 Yes 
2 No 
AD26s [IF AD26a NE BLANK] Were you unable to make decisions about things you 
ordinarily have no trouble deciding about? 
1 Yes 
2 No 
AD26u [IF AD26a NE BLANK] Did you feel that you were not as good as other people 
nearly every day? 
1 Yes 
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2 No 
AD26v [IF AD26u = 1] Did you feel totally worthless nearly every day? 
1 Yes 
2 No 
AD26aa [IF AD26a NE BLANK] The next questions are about thoughts of death or 
suicide. 
[IF AD22a NE BLANK] Again, in answering these questions, think about the period of 
time when your [FEELNOUN] and other problems were the worst. 
[IF AD22c NE BLANK] Again, in answering these questions, think about the most recent 
period of time when you 
[FEELFILL] and had other problems at the same time. 
Did you often think a lot about death, either your own, someone else’s, or death in 
general? 
1 Yes 
2 No 
AD26bb [IF AD26a NE BLANK] During that period, did you ever think that it would be 
better if you were dead? 
1 Yes 
2 No 
AD26cc [IF AD26a NE BLANK] Did you think about committing suicide? 
1 Yes 
2 No 
AD26dd [IF AD26cc = 1] Did you make a suicide plan? 
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1 Yes 
2 No 
AD26ee [IF AD26cc = 1] Did you make a suicide attempt? 
1 Yes 
2 No 
 
You mentioned having some of the problems I just asked you about. During that 
[TIMEFILL] period of time, how much did your [FEELNOUN] and these other problems 
interfere with your work, your social life, or your personal relationships? 
1 Not at all 
2 A little 
3 Some 
4 A lot 
5 Extremely 
AD28a [IF AD28 NE (BLANK OR 1)] During that [TIMEFILL] period of time, how often 
were you unable to carry out your daily activities because of these problems with your 
mood? 
1 Often 
2 Sometimes 
3 Rarely 
4 Never 
AD38 [IF AD28 NE BLANK ] In the past 12 months, did you have a period of time when 
you felt [FEELNOUN] for two weeks or longer while also having some of the other 
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problems we asked about? 
1 Yes 
2 No 
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APPENDIX J 
NSDUH Mental Health Treatment Utilization 
These next questions are about treatment and counseling for problems with emotions, 
nerves or mental health. Please do not include treatment for alcohol or drug use. 
 
During the past 12 months, have you stayed overnight or longer in a hospital or other 
facility to receive treatment or counseling for any problem you were having with your 
emotions, nerves, or mental health? 
1) Yes 
2) No 
Where did you stay overnight or longer to receive mental health treatment or counseling 
during the past 12 months? 
1) A private or public psychiatric hospital 
2) A psychiatric unit of a general hospital 
3) A medical unit of a general hospital 
4) Another type of hospital 
5) A residential treatment center 
6) Some other type of facility 
The list below includes some of the services where people can get outpatient treatment 
or counseling for problems with their emotions, nerves, or mental health. During the 
past 12 months, did you receive outpatient treatment or counseling for any problem you 
were having with your emotions, nerves, or mental health at any of the places listed 
below? Please do not include treatment for alcohol or drug use. 
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• An outpatient mental health clinic or center 
• The office of a private therapist, psychologist, psychiatrist, social worker, or 
counselor that was not part of a clinic. 
• A doctor’s office that was not part of a clinic 
• An outpatient medical clinic  
• A partial day hospital or day treatment program 
• Some other place 
1) Yes 
2) No 
 
Where did you receive outpatient mental health treatment or counseling during the past 
12 months? 
1) An outpatient mental health clinic or center 
2) The office of a private therapist, psychologist, psychiatrist, social worker, or 
counselor that was not part of a clinic. 
3) A doctor’s office that was not part of a clinic 
4) An outpatient medical clinic  
5) A partial day hospital or day treatment program 
6) Some other place 
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APPENDIX K 
NSDUH Substance Use Treatment Utilization 
During the past 12 months, did any doctor or other health care professional ask, either 
in person or on a form, if you: 
a. Smoke cigarettes or use any other tobacco products? 1. Yes 2. No 
b. Drink alcohol? 1. Yes 2. No 
c. Use illegal drugs? 1. Yes 2. No 
During the past 12 months, did any doctor or other health care professional advise you 
to quit smoking cigarettes or quit using any other tobacco products? 
1 Yes 
2 No 
Please think about all of the talks you have had with a doctor or other health care 
professional during the past 12 months when you answer this question. Choose the 
statement or statements below that describe any discussions you may have had in 
person with a doctor or other health professional about your alcohol use. 
1. The doctor asked how much I drink. 
2. The doctor asked how often I drink. 
3. The doctor asked if I have any problems because of my drinking. 
4. The doctor advised me to cut down on my drinking. 
5. The doctor offered to give me more information about alcohol use and 
treatment for problems with alcohol use. 
95 The doctor didn’t discuss my alcohol use with me in the past 12 months. 
During the past 12 months, did any doctor or other health care professional talk to you 
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about your use of [FILLMARIJUANA/COCAINE/CRACK/HEROIN/INHALANTS/ 
HALLUCINOGENS/METHAMPHETAMINE]? 
1 Yes 
2 No 
 
These next questions deal with treatment for alcohol and drug problems, not including 
cigarettes. Please report treatment or counseling designed to help you reduce or stop 
your alcohol or drug use. Please include detoxification and any other treatment for 
medical problems associated with your alcohol or drug use.  
Have you ever received treatment or counseling for your use of alcohol or any drug, not 
counting cigarettes? 
1 Yes 
2 No  
[IF PREVIOUS ITEM = 1] During the past 12 months, that is, since [DATEFILL], have 
you received treatment or counseling for your use of alcohol or any drug, not counting 
cigarettes? 
1 Yes 
2 No  
[IF PREVIOUS ITEM = 1] During the past 12 months when you received treatment, was 
the treatment for alcohol use only, drug use only, or both alcohol and drug use? 
1 Alcohol use only 
2 Drug use only 
3 Both alcohol and drug use  
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DEFINE TXFILL1: 
IF PREVIOUS ITEM= 1, TXFILL1 = alcohol use 
IF PREVIOUS ITEM = 2, TXFILL1 = drug use 
IF PREVIOUS ITEM = 3 OR DK/REF, TXFILL1 = alcohol or drug use 
During the past 12 months, have you received treatment for your [TXFILL1] in a hospital 
overnight as an inpatient? 
1 Yes 
2 No 
During the past 12 months, have you received treatment for your [TXFILL1] in a 
residential drug or alcohol rehabilitation facility where you stayed overnight? 
1 Yes 
2 No 
During the past 12 months, have you received treatment for your [TXFILL1] in a drug or 
alcohol rehabilitation facility as an outpatient? 
1 Yes 
2 No 
During the past 12 months, have you received treatment for your [TXFILL1] in a mental 
health center or facility as an outpatient? 
1 Yes 
2 No 
During the past 12 months, have you received treatment for your [TXFILL1] in an 
emergency room? 
1 Yes 
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2 No 
During the past 12 months, have you received treatment for your [TXFILL1] in a private 
doctor’s office? 
1 Yes 
2 No 
During the past 12 months, have you received treatment for your [TXFILL1] in a prison 
or jail? 
1 Yes 
2 No 
During the past 12 months, have you received treatment for your [TXFILL1] in a self-
help group such as Alcoholics Anonymous or Narcotics Anonymous? 
1 Yes 
2 No 
During the past 12 months, have you received treatment for your [TXFILL1] in some 
other place besides these that have been listed? 
1 Yes 
2 No 
Please type in a description of the place where you received treatment or counseling for 
your [TXFILL1] other than the places just mentioned. ___________ 
Are you currently receiving treatment or counseling for your [TXFILL1]? 
1 Yes 
2 No 
During the past 12 months, did you need treatment or counseling for your alcohol or 
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drug use? 
1 Yes 
2 No 
During the past 12 months, did you need additional treatment or counseling for your 
alcohol or drug use? 
1 Yes 
2 No 
During the past 12 months, for which of the following drugs did you need additional 
treatment or counseling? [TXFILL2] 
1 Alcohol 
2 Marijuana or hashish 
3 Cocaine or ‘crack’ 
4 Heroin 
5 Hallucinogens 
6 Inhalants 
7 Prescription pain relievers 
8 Prescription tranquilizers 
9 Prescription stimulants 
10 Prescription sedatives 
11 Some other drug  
During the past 12 months, did you make an effort to get treatment or counseling for 
your use of [TXFILL2]? 
1 Yes 
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2 No  
Which of these statements explain why you did not get the treatment or counseling you 
needed for your use of [TXFILL2]?  
1 You had no health care coverage, and you couldn’t afford the cost. 
2 You did have health care coverage, but it didn’t cover treatment for [TXFILL2], 
or didn’t cover the full cost. 
3 You had no transportation to a program, or the programs were too far away, or 
the hours were not convenient. 
4 You didn’t find a program that offered the type of treatment or counseling you 
wanted. 
5 You were not ready to stop using [TXFILL2]. 
6 There were no openings in the programs. 
7 You did not know where to go to get treatment. 
8 You were concerned that getting treatment or counseling might cause your 
neighbors or community to have a 
negative opinion of you. 
9 You were concerned that getting treatment or counseling might have a 
negative effect on your job. 
10 Some other reason or reasons.  
[IF PREVIOUS ITEM = 10] Which of these statements explain why you did not get the 
treatment or counseling you needed for your use of [TXFILL2]? 
1 You didn't think you needed treatment at the time. 
2 You thought you could handle the problem without treatment. 
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3 You didn't think treatment would help. 
4 You didn't have time (because of job, childcare, or other commitments). 
5 You didn't want others to find out that you needed treatment. 
6 Some other reason or reasons.   
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APPENDIX L 
NHIS Demographic Items 
How old are you? ______ 
Are you now married, widowed, divorced, separated, never married, or living with a 
partner?  
1 Married  
2 Widowed  
3 Divorced  
4 Separated  
5 Never Married  
6 Living with partner 
The next few questions are about employment status. 
Which of the following were you doing last week?  
1 Working for pay at a job or business  
2 With a job or business but not at work  
3 Looking for work  
4 Working, but not for pay, at a family-owned job or business  
5 Not working at a job or business and not looking for work 
Did you receive income in [last calendar year] from wages and salaries? 
1 Yes  
2 No 
Did you receive income in [last calendar year] from self-employment including business 
and farm income? 
1 Yes  
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2 No 
 
Did [you receive Supplemental Security Income (SSI)?  
1 Yes  
2 No 
At any time during [last calendar year], even for one month, did you receive any CASH 
assistance from a state or county welfare program, such as (* fill specific program 
name)? 
1 Yes  
2 No 
At any time during [last calendar year], did you receive any OTHER kind of welfare 
assistance such as help with getting a job, placement in education or job training 
programs, or help with transportation or child care? 
1 Yes  
2 No 
Did you receive income from child support? 
1 Yes  
2 No 
Did you receive income from other sources such as alimony, contributions from 
family/others, VA payments, Worker’s Compensation, or unemployment compensation? 
1 Yes  
2 No 
What is your best estimate of your total income from all sources, before taxes, in [last 
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calendar]? _____ 
Was your total family income from all sources less than [fill based on poverty threshold] 
or [ fill based on poverty threshold] or more?  
1 Less than [$10,500/$11,500/$13,500/$15,000/$18,000/$23,000/$27,000]  
2 [$10,500/$11,500/$13,500/$15,000/$18,000/$23,000/$27,000] or more 
Is this house/apartment owned or being bought, rented, or occupied by some other 
arrangement by you or someone in your family?  
1 Owned or being bought  
2 Rented  
3 Other arrangement 
Are you paying lower rent because the Federal, State, or local government is paying 
part of the cost? 
1 Yes  
2 No 
At any time during [last calendar year], did you receive food stamp benefits? 
1 Yes  
2 No 
At any time during [last calendar year] did you receive benefits from the WIC program, 
that is, the Women, Infants and Children program? 
1 Yes  
2 No 
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APPENDIX M 
NHIS Cigarette Use 
These next questions are about cigarette smoking.  
Have you smoked at least 100 cigarettes in your ENTIRE LIFE? 
1 Yes  
2 No  
How old were you when you FIRST started to smoke fairly regularly? ____________ 
Do you NOW smoke cigarettes every day, some days or not at all? 
1 Every day  
2 Some days  
3 Not at all 
[If not currently smoking] How long has it been since you quit smoking cigarettes? 
____________ 
[If currently smoking] On the average, how many cigarettes do you now smoke a day? 
____________ 
On how many of the PAST 30 DAYS did you smoke a cigarette? ____________ 
On the average, when you smoked during the PAST 30 DAYS, about how many 
cigarettes did you smoke a day? ____________ 
During the PAST 12 MONTHS, have you stopped smoking for more than one day 
BECAUSE YOU WERE TRYING TO QUIT SMOKING? 
1 Yes  
2 No  
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APPENDIX N 
NHIS Alcohol Use 
These next questions are about drinking alcoholic beverages. Included are liquor such 
as whiskey or gin, beer, wine, wine coolers, and any other type of alcoholic beverage  
In ANY ONE YEAR, have you had at least 12 drinks of any type of alcoholic beverage?  
1 Yes  
2 No 
In the past year, how often did you drink any type of alcoholic beverage? How many 
days per week, per month or per year did you drink? ______ 
In the PAST YEAR, on those days that you drank alcoholic beverages, on the average, 
how many drinks did you have? _____ 
In the PAST YEAR, on how many DAYS did you have 5 or more drinks of any alcoholic 
beverage? _____ 
How many days per week, per month or per year did you have 5 or more drinks in a 
single day? _____ 
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APPENDIX O 
NHIS Mental Health (includes K6; Furukawa et al., 2003; Kessler et al., 2003) 
Have you EVER been told by a doctor or other health professional that you had  
...Phobia or fears?  
1 Yes  
2 No  
DURING THE PAST 12 MONTHS have you had  
...Phobia or fears?  
1 Yes  
2 No  
Have you EVER been told by a doctor or other health professional that you had  
...Attention Deficit Hyperactivity Disorder (ADHD) or Attention Deficit Disorder 
(ADD)?  
1 Yes  
2 No  
Have you EVER been told by a doctor or other health professional that you had  
…Bipolar Disorder?  
1 Yes  
2 No  
Have you EVER been told by a doctor or other health professional that you had  
…Depression?  
1 Yes  
2 No 
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DURING THE PAST 12 MONTHS have you had  
…Depression?  
1 Yes  
2 No  
Have you EVER been told by a doctor or other health professional that you had  
…Other mental health disorders?  
1 Yes  
2 No  
DURING THE PAST 12 MONTHS have you had  
…Other mental health disorders?  
1 Yes  
2 No  
DURING THE PAST 12 MONTHS, have you had  
…Excessive use of alcohol or tobacco?  
1 Yes  
2 No  
DURING THE PAST 12 MONTHS, have you had  
…Substance abuse, other than alcohol or tobacco?  
1 Yes  
2 No  
DURING THE PAST 12 MONTHS, have you  
…Frequently felt anxious, nervous, or worried?  
1 Yes  
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2 No  
DURING THE PAST 12 MONTHS, have you  
…Frequently felt stressed?  
1 Yes  
2 No  
DURING THE PAST 30 DAYS, how often did you feel  
... So sad that nothing could cheer you up?  
1 ALL of the time  
2 MOST of the time  
3 SOME of the time  
4 A LITTLE of the time  
5 NONE of the time 
During the PAST 30 DAYS, how often did you feel  
... Nervous?  
1 ALL of the time  
2 MOST of the time  
3 SOME of the time  
4 A LITTLE of the time  
5 NONE of the time 
During the PAST 30 DAYS, how often did you feel  
... Restless or fidgety?  
1 ALL of the time  
2 MOST of the time  
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3 SOME of the time  
4 A LITTLE of the time  
5 NONE of the time 
During the PAST 30 DAYS, how often did you feel  
... Hopeless?  
1 ALL of the time  
2 MOST of the time  
3 SOME of the time  
4 A LITTLE of the time  
5 NONE of the time 
During the PAST 30 DAYS, how often did you feel  
...That everything was an effort?  
1 ALL of the time  
2 MOST of the time  
3 SOME of the time  
4 A LITTLE of the time  
5 NONE of the time 
During the PAST 30 DAYS, how often did you feel  
...Worthless?  
1 ALL of the time  
2 MOST of the time  
3 SOME of the time  
4 A LITTLE of the time  
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5 NONE of the time 
We just talked about a number of feelings you had during the PAST 30 DAYS. 
Altogether, how MUCH did these feelings interfere with your life or activities: a lot, 
some, a little, or not at all?  
1 A lot  
2 Some  
3 A little  
4 Not at all 
DURING THE PAST 12 MONTHS, have you seen or talked to any of the following 
health care providers about your own health?  
...A mental health professional such as a psychiatrist, psychologist, psychiatric nurse, or 
clinical social worker. 
1 Yes  
2 No  
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APPENDIX P 
NHIS Complementary and Alternative Medicine Utilization 
Have you EVER used any of these therapies for your health? 
Chiropractic or Osteopathic Manipulation? 
1 Yes 
2 No 
Have you EVER seen a provider or practitioner for chiropractic or osteopathic 
manipulation for yourself? 
DURING THE PAST 12 MONTHS, did you see a practitioner for chiropractic or 
osteopathic manipulation? 
DURING THE PAST 12 MONTHS, use chiropractic or osteopathic manipulation? 
Do you know the exact number of times you saw a practitioner for 
chiropractic/osteopathic manipulation in the past 12 months? 
1 Yes 
2 No 
DURING THE PAST 12 MONTHS, how many times did you see a practitioner for 
chiropractic/osteopathic manipulation? _____ 
Massage? 
1 Yes 
2 No 
Have you EVER seen a provider or practitioner for massage for yourself? 
1 Yes 
2 No 
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DURING THE PAST 12 MONTHS, did you see a practitioner for massage? 
1 Yes 
2 No 
DURING THE PAST 12 MONTHS, did you use massage?  
1 Yes 
2 No 
Do you know the exact number of times you saw a practitioner for massage in 
the past 12 months? 
1 Yes 
2 No 
DURING THE PAST 12 MONTHS, how many times did you see a practitioner for 
massage? _____ 
Acupuncture? 
1 Yes 
2 No 
Have you EVER seen a provider or practitioner for acupuncture for yourself? 
1 Yes 
2 No 
DURING THE PAST 12 MONTHS, did you see a practitioner for acupuncture? 
1 Yes 
2 No 
DURING THE PAST 12 MONTHS, did you use acupuncture?  
1 Yes 
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2 No 
Do you know the exact number of times you saw a practitioner for acupuncture in 
the past 12 months? 
1 Yes 
2 No 
DURING THE PAST 12 MONTHS, how many times did you see a practitioner for 
acupuncture? _____ 
 
Herbs or supplements 
Herbs or other non-vitamin supplements are pills, capsules, tablets, or liquids that have 
been labeled as a DIETARY SUPPLEMENT. This does NOT include vitamin or mineral 
supplements, homeopathic treatments, or drinking herbal or green teas.  
Have you EVER taken any herbal or other non-vitamin supplements listed on this card 
for yourself? 
1 Yes 
2 No 
DURING THE PAST 12 MONTHS, have you taken any herbal or other non-vitamin 
supplements listed on this card for yourself? 
1 Yes 
2 No 
01 Combination herb pill  
02 Acai (pills, gelcaps)  
03 Bee Pollen and other Bee products  
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04 Chondroitin  
05 Co-enzyme Q10 (CoQ10)  
06 Cranberry (pills or capsules)  
07 Digestive Enzymes (lactaid)  
08 Echinacea  
09 Fish Oil or omega 3 or DHA fatty acid or EPA fatty acid supplements  
10 Garlic supplements (pills, gelcaps)  
11 Ginkgo Biloba  
12 Ginseng  
13 Glucosamine  
14 Green tea pills (not brewed tea) or EGCG (pills)  
15 Melatonin  
16 Milk Thistle (silymarin)  
17 MSM (Methylsulfonylmethane)  
18 Probiotics or Prebiotics  
19 SAM-e  
20 Saw Palmetto  
21 Valerian  
22 Other herbs or non-vitamin supplements 
Did you take any of these DURING THE PAST 30 DAYS?  
1 Yes 
2 No 
Have you ever seen a practitioner for herbs or other non-vitamin supplements? 
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1 Yes 
2 No 
DURING THE PAST 12 MONTHS, did you see a practitioner for herbs or other non-
vitamin supplements? 
1 Yes 
2 No 
Do you know the exact number of times you saw a practitioner for herbs or other non-
vitamin supplements in the past 12 months? 
1 Yes 
2 No 
DURING THE PAST 12 MONTHS, how many times did you see a practitioner for herbs 
or other non-vitamin supplements? _____ 
 
Meditation 
Have you EVER used meditation, guided imagery, or progressive relaxation? 
1 Yes 
2 No 
Have you EVER used any of the following for your own health or treatment?  
Mantra Meditation, including Transcendental Meditation ®, Relaxation Response, 
and Clinically Standardized Meditation? 
1 Yes 
2 No 
Mindfulness meditation, including Vipassana (vih-PAS-sah-nah), Zen Buddhist 
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meditation, Mindfulness-based Stress Reduction, and Mindfulness-based 
Cognitive Therapy 
1 Yes 
2 No 
Spiritual meditation including Centering Prayer and Contemplative Meditation 
 1 Yes 
2 No 
Guided imagery 
1 Yes 
2 No 
Progressive relaxation 
1 Yes 
2 No 
DURING THE PAST 12 MONTHS, did you use...  
Mantra Meditation, including Transcendental Meditation ®, Relaxation Response, 
and Clinically Standardized Meditation? 
1 Yes 
2 No 
Mindfulness meditation, including Vipassana (vih-PAS-sah-nah), Zen Buddhist 
meditation, Mindfulness-based Stress Reduction, and Mindfulness-based 
Cognitive Therapy 
1 Yes 
2 No 
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Spiritual meditation including Centering Prayer and Contemplative Meditation? 
1 Yes 
2 No 
Guided imagery? 
1 Yes 
2 No 
Progressive relaxation? 
1 Yes 
2 No 
DURING THE PAST 12 MONTHS, which of these did you use the most? 
1 Mantra meditation  
2 Mindfulness meditation  
3 Spiritual meditation  
4 Guided imagery  
5 Progressive relaxation  
Did you do breathing exercises as part of meditation? Breathing exercises may involve 
actively controlling the way air is drawn in, or the rate or depth of breathing. 
1 Yes 
2 No 
DURING THE PAST 12 MONTHS, did you see a practitioner or take a class for 
meditation? 
1 Yes 
2 No 
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Do you know the exact number of times you saw a practitioner or took a class for 
meditation in the past 12 months? 
1 Yes 
2 No 
DURING THE PAST 12 MONTHS, how many times did you see a practitioner or take a 
class for meditation? _____ 
 
Have you EVER practiced any of the following? 
...Yoga? 
DURING THE PAST 12 MONTHS, did you practice Yoga for yourself? 
1 Yes 
2 No 
Did you do breathing exercises as part of Yoga? Breathing exercises may involve 
actively controlling the way air is drawn in, or the rate or depth of breathing. 
1 Yes 
2 No 
Did you do meditation as part of Yoga?  
1 Yes 
2 No 
DURING THE PAST 12 MONTHS, did you take a Yoga class or in some way receive 
formal training? Attending only one session does not count. 
1 Yes 
2 No 
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Do you know the exact number of times you saw an instructor for Yoga in the past 12 
months? 
1 Yes 
2 No 
DURING THE PAST 12 MONTHS, how many times did you see an instructor for Yoga? 
_____ 
 
Did you see a practitioner for/use [modality] for any of these reasons? 
For general wellness or general disease prevention? 
1 Yes 
2 No 
To improve your energy? 
1 Yes 
2 No 
To improve your immune function? 
1 Yes 
2 No 
To improve your athletic or sports performance? 
1 Yes 
2 No 
To improve your memory or concentration? 
1 Yes 
2 No 
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Did seeing a practitioner for/using [modality] motivate you to: 
Eat healthier? 
1 Yes 
2 No 
Eat more organic foods? 
1 Yes 
2 No 
Cut back or stop drinking alcohol?  
1 Yes 
2 No 
Cut back or stop smoking cigarettes?  
1 Yes 
2 No 
Exercise more regularly? 
1 Yes 
2 No 
Did {seeing a practitioner for/using [modality] lead to any of these outcomes? 
Give you a sense of control over your health? 
1 Yes 
2 No 
Help to reduce your stress level or to relax? 
1 Yes 
2 No 
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Help you to sleep better? 
1 Yes 
2 No 
Make you feel better emotionally? 
1 Yes 
2 No 
Make it easier to cope with health problems? 
1 Yes 
2 No 
Improve your overall health and make you feel better? 
1 Yes 
2 No 
Improve your relationships with others? 
1 Yes 
2 No 
Improve your attendance at a job or school]?  
1 Yes 
2 No 
DURING THE PAST 12 MONTHS, did you see a practitioner for/use [modality] for one 
or more specific health problems, symptoms, or conditions? 
1 Yes 
2 No 
Did you receive any of the following medical treatments for [condition]?  
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Prescription medications?  
1 Yes 
2 No 
Over-the-counter medications?  
1 Yes 
2 No 
Surgery?  
1 Yes 
2 No 
Physical therapy?  
1 Yes 
2 No 
Mental health counseling?  
1 Yes 
2 No 
DURING THE PAST 12 MONTHS, did you see a practitioner for/use [modality] for any 
of these reasons?  
These medical treatments were too expensive? 
1 Yes 
2 No 
[modality] combined with these medical treatments would help you? 
1 Yes 
2 No 
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These medical treatments do not work for the health problem you want to treat or 
prevent? 
1 Yes 
2 No 
[Prescription medications/Over the counter medications/Prescription or over-the-
counter medications] cause side effects? 
1 Yes 
2 No 
You can do it on your own?  
1 Yes 
2 No 
It is natural? 
1 Yes 
2 No 
It focuses on the whole person, mind, body, and spirit? 
1 Yes 
2 No 
It treats the cause and not just the symptoms? 
1 Yes 
2 No 
It was part of your upbringing? 
1 Yes 
2 No 
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Did you {see a practitioner for/use [modality] because it was recommended by any of 
the following people?  
A medical doctor? 
1 Yes 
2 No 
A family member? 
1 Yes 
2 No 
A friend? 
1 Yes 
2 No 
A co-worker? 
1 Yes 
2 No 
Not including the practitioner you saw for] [fill2: modality] DURING THE PAST 12 
MONTHS, did you let your personal health care provider know about your use of [fill3: 
modality]? 
1 Yes 
2 No 
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Tobacco is the most widely used drug of abuse during pregnancy. Despite efforts 
to reduce perinatal tobacco use, its prevalence has remained steady over at least the 
past decade, suggesting that efforts to reduce smoking prevalence before and during 
pregnancy have not been effective. Although a range of effective treatments exist, most 
pregnant smokers neither seek nor receive any kind of treatment. Complementary and 
alternative medicine (CAM) treatments may be ideal as alternative, low-cost approaches 
capable of reaching and assisting a greater proportion of pregnant women with smoking 
cessation. This study examined characteristics and treatment utilization practices of 
pregnant smokers in two national samples —the National Survey on Drug Use and 
Health and the National Health Interview Survey—in order to better understand the 
unique treatment needs and preferences of pregnant smokers, and to explore the 
prevalence and predictors of CAM use within this population. Results suggest that 
smoking in pregnancy is stable, but that several potentially modifiable factors that may 
help identify women who are at greater risk for persistent smoking during pregnancy, 
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including smoking risk perception, current alcohol use, and factors related to nicotine 
dependence. Findings of this study also demonstrated that a sizeable proportion of 
pregnant smokers are already accessing CAM treatments, particularly among those of 
greater socioeconomic status. Further research is needed not only to validate the use of 
CAM treatments, but also to guide safety and treatment recommendations during 
pregnancy. 
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